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Abstract 
This Thesis is based on the surface modification of a platform-technology polymer, 
POSS-PCU. This POSS-PCU polymer has been primarily developed for use as a 
small diameter vascular bypass graft. The mechanical properties and compliance of 
this material is thought to be superior to current vascular graft materials in clinical 
use. However, the lack of endothelialisation of this polymer in preclinical evaluation 
is a cause for concern. The hydrophobic nature of the POSS-PCU polymer is thought 
to be the culprit and therefore the need to render the surface of the polymer suitable 
for endothelialisation forms the basis of this Thesis. 
It is possible to engineer the surface of the polymer without affecting the beneficial 
bulk properties of the polymer. Recent technological advances have made this 
possible. A combination of plasma treatment and surface topology modification on 
the micro- and nanoscale has been shown to encourage the growth of endothelial 
cells. However, nanofeatures show a subtle improvement in endothelial cell 
adherence. 
Two different nanopit topographies, SQ and NSQ, have formed the main focus of 
this Thesis to further investigate the effect of nanotopography on endothelial cells. 
These two topographies are different from each other only by an offset of 50nm and 
therefore are very similar. Despite this, they have shown to illicit different responses 
by the endothelial cells, especially in the up-regulation of different adhesion proteins. 
These topographies also have a strong effect on mesenchymal stem cells, by either 
directing them to maintenance or osteogenic differentiation, and unfortunately this 
effect can also be enhanced by the presence of endothelial cells, causing 
calcification. This can be detrimental in a vascular graft. 
The results of this Thesis highlight the potential of using a combination of plasma 
treatment and surface nanoengineering to create a new generation of vascular graft, 
that requires further investigation.       
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Chapter 1 Introduction 
1.1 Vascular Disease 
Atherosclerotic peripheral arterial disease (PAD) has been quoted to be ‘one of the 
most prevalent, morbid and mortal diseases’(1, 2). A recent published systematic 
review looked at the prevalence of PAD from 2000-2010 and revealed a global 
estimate of 202 million people in 2010, which is a 23.5% increase over the 10 years. 
It was also noted that more than two-thirds (69.7%) of PAD was concentrated in the 
lower-middle income class(3).  If left untreated, this can lead to loss of limbs or even 
mortality. However, despite these high numbers, there appears to be not much in the 
place of preventative measures being undertaken and recent studies have advocated a 
more preventative stance needs to be taken.  
The advent of endovascular interventions has led to first line recommendations for 
the treatment of peripheral vascular disease, usually, being angioplasty and 
endovascular stenting. This is done on the basis that the least invasive procedures 
should be tackled first line and this should be continued until they are no longer 
suitable, prior to more invasive techniques being utilized. However, in a proportion 
of patients this will not be suitable. This can be due to repeated unsuccessful 
endovascular interventions, lesions which are unsuitable for endovascular 
intervention or multi-level lesions. These patients will have to undergo surgical 
intervention in the form of a peripheral bypass. This is a very invasive procedure, 
leaving the patient with unsightly scars on their limbs and with success rates which 
are dependent on the vascular graft material. The most common peripheral bypasses 
are usually femoro-popliteal bypass and femoro-crural bypasses. 
The use of autologous vessels for these surgeries have always been thought to be the 
‘gold standard’ as their patency rates have been found to be far superior to any other 
synthetic material. The autologous vessel is harvested from the patient’s own vein 
and is usually sourced from the superficial venous system of their leg. These veins 
are also the same venous source for patients who require operation for their coronary 
artery bypass. A large portion of patients who go on requiring vascular surgery 
would also have a previous surgical history of having undergone coronary artery 
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bypass surgery. This means that these veins would have previously been harvested 
and therefore will not be available for their peripheral bypass surgery. In addition, 
varicose veins, small and unsuitable veins (usually in diabetic patients) and other 
previous surgical procedures on them would render these veins unsuitable or 
unavailable for autologous vein bypass. Although there are other potential sources of 
autologous vein, such as from the upper limb or internal mammary artery, these are 
less used due to the poor quality of vein for a peripheral vascular bypass and the 
greater morbidity and invasiveness in accessing some of these vein sources. 
Autologous vein bypass grafting has the benefit of being less likely to be prone to 
infection, good integration within the host’s environment and obviously 
biocompatible, especially when compared with synthetic grafts. In some cases, due 
to the unavailability of the autologous vessel, patients are then limited to synthetic or 
alternative graft materials.  
 
1.2 ‘Ideal’ Properties of Vascular Grafts 
Vascular grafts are used when there is a discontinuation of blood supply leading to 
critical limb ischaemia and a threatened limb. In this Thesis, vascular grafts for the 
peripheral arterial side will be mainly considered. These vascular grafts are usually 
known as small-diameter vascular grafts (<6 mm diameter) to distinguish them from 
the aortic grafts which are of larger diameter. This is important as the haemodynamic 
flow and pressure properties will be different and accounting for these factors play 
an important part in the success of the graft.   
The ideal vascular graft would be a native human vessel replacement. However, a 
direct arterial replacement is mostly impossible, but instead, autologous vein 
replacements have tended to be an excellent substitute. Unfortunately, a variety of 
conditions can mean that patients do not have adequate supply of autologous veins 
and will require synthetic vascular graft replacements as mentioned. Traditionally, 
these synthetic vascular grafts do not have patency rates which match autologous 
vein replacements. The patency rates of autologous vein grafts have been found to 
have patency rates of 77% and 50% at 5 and 10 years respectively(4, 5).  
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Therefore, the ‘ideal’ properties of a vascular graft would need to be anti-
thrombogenic, have mechanical and compliant properties like a native vessel as well 
as be able to allow tissue integration as well as the formation of an endothelial layer 
within the luminal surface of the vascular graft. The grafts also need to be durable 
and non-toxic and, in paediatric cases, be able to grow with the child. There should 
also be properties incorporated within the graft to make it less prone to infection. 
1.3 Current Vascular Graft Materials  
Vascular bypass grafts for peripheral arterial disease are usually known as small 
diameter bypass grafts with a luminal diameter of <6mm. Traditional materials have 
mainly been made of polytetrafluorethylene (PTFE) and polyethylene terephthalate 
(PET or Dacron®). These materials have been utilized by many vascular surgeons 
for the last 30 years. However, patency rates have mainly been variable and are not 
as high as those of autologous vessel. 
PTFE is made of the monomer tetrafluoroethylene which is then reacted together by 
free radical vinyl polymerization. It was discovered by Roy Plunkett in 1938 and 
patented in 1941(6). Since 1946, it has been sold commercially as Teflon®. There 
are many beneficial properties of PTFE making it a very popular polymer for a large 
range of applications. Unlike other carbon-based polymer chains, PTFE differs in 
having its hydrogens in reactive C-H bonds replaced by flourines. These then 
become strong C-F bonds that are extremely resistant to attack by any other agents. 
This gives PTFE a strong chemical stability and makes it resistant to attack by other 
reagents and as well as allowing it to be inert. In 1969, Gore patented expanded 
PTFE (ePTFE) calling it Gore-tex®. ePTFE is manufactured by means of heating, 
stretching and extruding processes that produces a microporous material which is 
more supportive of tissue adhesion. This has been found to be a very durable 
material and does not degrade within the body as well as having biocompatible 
properties making it suitable for medical implantation(6). 
Patency rates of ePTFE vascular grafts for femoro-popliteal bypasses have been 
found to have patency rates at 3 and 5 years, respectively, of 61% and 45%(4, 7). 
Compared with those of autologous vein, these can be seen to have a much poorer 
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outcome. Despite these poorer outcomes, ePTFE has been a stable synthetic material 
in vascular bypass surgery for the last 30 years, for patients who do not have the 
option of an autologous vein bypass.  
Commercially known as Dacron®, the polymer is also known as polyethylene 
terephthalate or PET, and is another material which is clinically available for 
vascular bypass grafting. Dacron® vascular grafts were first implanted by Julian in 
1957 and DeBakey in 1958(6). Commercially Dacron® grafts can be woven or 
knitted as they can be made into thin fibrils. Multifilament Dacron® threads in 
woven grafts are fabricated in ‘over-and-under’ patterns which results in a very 
limited porosity and minimal creep of the final material and finished graft. In 
contrast, knitted grafts are made with a textile technique in which the Dacron® 
threads are looped to create greater porosity and radial distensibility. Nowadays, due 
to this, Dacron® grafts tend to be knitted over woven. Other techniques such as the 
velour technique extends the loops of yarn on the surfaces of the fabrics and this has 
been done in an attempt to increase tissue incorporation. A crimping technique has 
also been employed to increase the flexibility, distensibility and kink-resistance of 
textile grafts. 
In above knee applications, there is no differences in the patency rates between 
Dacron® and ePTFE vascular(8). However in below knee applications, there is a 
trend towards increased patency rates in ePTFE vascular grafts which reaches 
statistical significance at 24 months(7). Due to this, there is a trend towards 
preference by clinicians to use ePTFE vascular grafts for peripheral vascular bypass 
procedures. 
Recently, there is introduction of another polymer which has shown some initial 
promise, polyurethane. This is a biocompatible, non-toxic, elastic and compliant 
polymer. The polyurethane elastomers comprise of a family of block co-polymers 
with alternating soft and hard segments. Their advantageous physical properties are a 
result of their 2-phase morphology caused by the incompatibility of the hard and soft 
segments(9). Unfortunately, the first few polyurethane-based polymers available 
commercially were found to have poor long-term biostability but this was soon found 
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to be due to the chemical ‘make-up’ of the polyurethane. Poly(ester) polyurethanes 
have been found to hydrolyse and poly(ether) polyurethanes have been found to 
oxidize in a biological environment (10). It is thought that the soft-segment of the 
polyurethane chemistry is of significance and would need altering to improve the 
final biostability of the final polymer.  
A few groups have worked to modifying the polyurethane polymer to improve the 
mechanical properties by modifying the soft segments. Pursil® is a commercially 
available material which has an altered soft segment to try and combat the oxidation 
propensity of the polyurethane. Silicon-based elastomers (poly(dimethyl siloxanes 
[PDMS]) were used due to their good blood compatibility, low toxicity and good 
oxidation and thermal stability. PDMS was incorporated as the soft segment of the 
polyurethane so as to improve polymer stability(11). Unfortunately, the resulting 
polymer was not compliant and elastic enough to be a vascular graft. Therefore, 
Soldani(9) et al altered this formulation to produce a more versatile elastomeric 
polymer in the form of a semi-interpenetrating polymeric network. Initial large 
animal studies have shown that this formulation is comparable with ePTFE grafts.  
Salacinski(12) et al also tried to formulate a polymer that was more resistant to 
breakdown whilst retaining its compliance and replaced the soft segment to make a 
final polymer, a polycarbonate urea urethane, which was commercially known as 
Myolink®. To further enhance the mechanical properties, a nanoparticle has been 
added to the formulation, polyhedral oligomeric silsesquioxane (POSS), and to date 
this has been found to have improved mechanical properties(13). This vascular graft 
material is currently undergoing a clinical ‘first in man’ evaluation and forms part of 
this Thesis.           
1.4 Modification of Existing Materials   
 Prosthetic rings and coils have been applied to the external surfaces of the vascular 
grafts. This external support was deemed necessary to resist kinking and possible 
mechanical compression. It is thought to be invaluable in bypasses which go past a 
limb joint, especially one that is a hinge joint such as the knee, where kinking and 
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compression of the graft can alter haemodynamic flow leading to graft failure. 
Externally reinforced vascular grafts are currently available commercially.  
More recently, there has been the addition of heparin sulfate bonded to the luminal 
surface of ePTFE vascular grafts and this is meant to prevent thrombogenic 
occlusion of the graft especially immediately post-implantation.   
The heparin-bonded graft is manufactured and produced as the Gore PropatenTM 
vascular graft (W.L. Gore and Associates, Inc. Flagstaff, Arizona) and uses the 
Carmeda® Bioactive Surface (CBAS) which uses covalent end-point linkage to 
retain heparin on the device surface, in this case, ePTFE graft. There have been many 
attempts to bind heparin to the surface of either PET or ePTFE grafts. The aim is to 
control the formation of initial fibrin and platelet layers. The mechanism of action is 
that the immobilized heparin binds to anti-thrombin and therefore retains its 
anticoagulant properties on the graft surface. The heparin-binding process occurs at 
the nanometer level and therefore does not affect the overall structure of ePTFE 
grafts. They retain their 30µm intermodal distance and porosity structure and 
therefore elasticity, mechanical and handling properties are retained. This graft is 
also noted in in vivo studies to have a decrease in thrombin and platelet deposition. 
The heparin activity of the PropatenTM grafts is noted to be maintained for up to 12 
weeks in vivo (14).  
One of the first large clinical evaluations of the graft by Bosiers(15) et al, looked at 
the patency rates of these grafts when implanted as femoro-popliteal and femoro-
crural bypass grafts. They found that the primary patency rate at 1 year was 82% and 
97% for secondary patency rates. The limb salvage rate for patients with critical limb 
ischaemia (CLI) was 87%. These were very encouraging initial results and were 
thought to be better than those obtained for non-heparin bonded ePTFE bypass 
grafts. For comparison, a 2003 meta-analysis showed non-heparin ePTFE bypass 
grafts had a 1-year patency rate of 59% for primary patency and 66% for secondary 
patency(16). 
In a larger multi-center study (The Scandinavian PropatenTM Trial), Lindholt(17) et 
al analyzed the patencies of 454 grafts. The primary patency rate after 1-year was 
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86.4% for PropatenTM grafts and 79.9% for PTFE grafts with significance (p=0.043). 
And again, at 1-year, the secondary patency was 88% for PropatenTM grafts and 81% 
in PTFE grafts. On comparison with autologous vein, primary patency rates at 48 
months were significantly higher in the autologous vein group (63.5%) compared 
with the PropatenTM group (46.3%)(p<0.03). However interestingly when it comes to 
secondary patency rates there were no statistical significance between the two groups 
where autologous vein was 69.6% and PropatenTM was 57.5%(14). This observation 
with the secondary patencies was considered interesting in that it was possible to 
salvage the PropatenTM graft once occlusion has occurred. However, on a practical 
note, surgeons have noted that once occlusion has occurred in vein grafts, it is much 
more difficult technically to salvage these grafts. 
These clinical results show that surface modification using heparin can have a 
positive result clinically on patients and illustrates a good example of the current 
research in modifications of existing materials.    
1.5 Decellularized Vascular Grafts 
The concept of decellularised vascular grafts has been around for a while and has 
evolved over the years. The use of decellularized natural matrices allows the 
advantage of retaining the natural structure, especially the 3D microarchitecture of 
natural tissue and mechanical performance of natural tissue and extracellular matrix 
(ECM) whilst avoiding any immunological adverse reactions. This is the aim of the 
decellularization process which removes all the antigenic cellular material from the 
tissue and allows repopulation with the host’s cellular material. Another added 
advantage of the decellularization technique is that there is the potential for repair, 
growth and remodeling in vivo. This makes the decelluarization technique a 
technique which, if it works, has lots of advantages and uses, including suitability for 
paediatric use as the graft can be incorporated within the host tissues and ‘grow’ with 
the child.   
The decellularization technique has evolved over the years and involves the use of 
chemical agents, hypo- and hypertonic solutions, detergents, solvents, biological 
agents (enzymes and chelating agents) and also physical methods such as abrasion 
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and agitation. All these techniques have been used to remove all the cellular material 
without destroying the integrity of the scaffold itself(18).  
The technique was first developed in the 1960s using animal tissue and since then a 
range of vascular grafts have been developed with some even making it to 
commercial availability. The source of these vascular grafts can be from allogenic or 
xenogenic sources with the more popular ones mainly being bovine blood vessels 
and bovine ureter. There have since been prospective randomized trials using these 
grafts which have concluded that there is no clear advantage of the grafts compared 
with synthetic grafts(19-21). In addition to these grafts there is concern that cellular 
components of the allogenic or xenogenic tissues will trigger immune responses in 
the host. Therefore, techniques have to be employed in which the immunogenic 
components need to be masked or eliminated, again, without destroying the 
mechanical integrity of the scaffold itself.  
Small intestinal submucosa (SIS) was a scaffold which was explored as a possibility 
for decellularized vascular grafts. It is essentially a cell-free collagen matrix derived 
from small intestine. It was implanted as small diameter vascular grafts into carotid 
and femoral interposition of 18 dogs for 8 weeks. Although there was graft patency 
rate of 75% and the grafts showed no evidence of infection, thrombus or intimal 
hyperplasia; the SIS grafts tended towards developing aneurysmal dilation in 11% of 
the arterial grafts(22). Histologically the grafts tended to develop a dense organized 
collagenous connective tissue with very little trace of endothelial layer on the 
luminal surface. The lack of efficient cellular infiltration and poor remodeling of SIS 
vascular grafts suggested that in the long term this methodology may not be 
appropriate for vascular graft production.    
The main technical problem which was noticed by vascular surgeons was that these 
vascular grafts tend to lose mechanical strength and post-implantation will result in 
false aneurysm formation. Another problem with decellularized scaffolds were that 
they require ‘re-seeding’ with the recipient’s cells prior to implantation. This tends to 
be difficult in normal hospitals without associated specialist tissue culture facilities 
and means that these grafts do not have ‘off-the-shelf’ potential. Due to these 
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complications and issues, clinical favour towards decellularized grafts were quickly 
withdrawn. 
 
 
Figure 1-1 A simplified diagram to show the decellularization process using porcine arteries to 
create a functional vascular graft. This diagram has been taken from (23). 
  
Although in recent years, the decellularizing techniques have become more refined 
and there have been highly optimized techniques coming through which also focus 
on preserving the mechanical integrity of the scaffolds(24). A combination of either 
allogenic or xenogenic scaffolds have been used such as ovine arteries(24) and 
human umbilical arteries(25) and there has been some initial success. However, due 
to previous failed attempts, there is still concern within the clinical community about 
the mechanical integrity of these grafts. In the clinical scenario of infection, these 
grafts would be invaluable and therefore there is still hope that there will be a 
successful decellularized vascular graft which would be commercially available for 
these scenarios.  
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1.6 Biodegradable Polymeric Vascular Grafts 
There are essentially two types of synthetic polymeric vascular grafts, biodegradable 
and non-biodegradable. Currently PTFE and Dacron® vascular graft materials are 
considered non-biodegradable synthetic materials. Popular known biodegradable 
polymers are usually polyglycolic acid (PGA) and polylactic acid-based constitutents 
and these polymers have been mainly used in biodegradable vascular graft research. 
As the polymer is biodegradable, it is thought that the polymer would act initially as 
an important scaffold for the pre-seeded cells to integrate and gain mechanical 
strength post-implantation whilst the scaffold slowly degrades over time and in the 
end, leaving a vessel which is made of only the recipients’ cells and tissues. It is 
important that the original polymer is biocompatible, as well as the breakdown end-
products being the non-toxic and excreted by the recipient’s body without any 
systemic or local effect. One of the main struggles for these biodegradable vascular 
grafts is achieving the balance of scaffold degradation rate with tissue deposition and 
maintaining mechanical strength. This is highly affected by the type of polymer used, 
their degradation rate in vivo and various other additional factors such as interpatient 
variability to take into account.  
Initially these biodegradable scaffolds were implanted without prior seeding. 
However, it was difficult to control the degradation of the scaffolds and usually there 
was not enough time for the host’s cells to repopulate the graft in its entirety. Despite 
these problems, there has been quite few high-profile attempts in human implantation 
of these grafts. As one of the main concerns of these graft materials is mechanical 
strength, arterial substitutes using these materials were not initially advocated. In 
2001, Shin’oka(26) et al reported the first use of a biodegradable scaffold for use in a 
4 year old girl with occlusion of a right intermediate pulmonary artery (a low flow 
vessel). They isolated a 2 cm peripheral vein for sourcing autologous cells and 
cultured them for 8 weeks prior to implantation. A tube made of polycaprolactone-
polylactic (PLA) acid co-polymer reinforced with woven polyglycolic acid (PGA) 
was fabricated as the biodegradable scaffold and this was seeded with the autologous 
cells prior to implantation. This scaffold was designed to degrade in 8 weeks. This 
operation was a success and led to further attempts at human implantation, whilst 
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over the years refining their technique.  In 2010, Hibino(27) et al reported late term 
results for these further implantations using this technique. Instead of vein harvest 
and prolonged cell cultures, bone marrow aspirates were now taken and the 
mononuclear cell component were separated and used to seed the scaffolds. 25 
patients underwent implantation of these grafts and although there was no graft 
related mortality of an average follow-up period of 5.8 years, they did find a 24% 
incidence of graft stenosis, which was higher than those found in synthetic non-
biodegradable vascular grafts. Of note, there were no cases of graft-related mortality, 
aneurysmal dilatation, graft infection, graft rupture or calcification. 96% of patients 
were also able to discontinue anticoagulation therapy after 6 months which is a huge 
advantage when compared with patients with synthetic grafts who have to have long-
term anticoagulation. 
Shin’oka and Chris Breuer have led their multidisciplinary team at Yale, and now at 
Ohio, over the years, in their quest for a biodegradable vascular graft. Their research 
and clinical team went back and forth from ‘bench to clinic’ multiple times to 
elucidate the exact mechanisms they observed in vivo. Because of their seminal 
work, they were able to demonstrate the natural history post-implantation of their 
vascular graft. They found that there was rapid initial infiltration by macrophages, 
late endothelialization, initial dilation of the grafts with PLA followed by fiber 
degradation and late contraction of the grafts. There was also increased collagen 
deposition over time and increasingly organized tissue resembling native vessel over 
the course of the following year post implantation(28). They also found the cause of 
the stenosis which they had observed in their human trials. This was thought to be 
due to due to initial macrophage infiltration and was inversely related to bone 
marrow (BM) – mononuclear cell seeding (MNC) on the scaffolds. There was early 
stenosis seen in 80% on unseeded scaffolds and only 20% in seeded. The seeding of 
the BM-MNC recruited the appropriate cells which induced the correct inflammatory 
response. A lot of work was conducted over the last few years to understand the 
mechanisms underlying their therapeutic approach(29). In 2011, the team received 
the United States Food and Drug Administration (FDA) approval to conduct a 
clinical trial in the US. Results from their clinical trial is still awaited.  
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Although Shin’oka and Breuer are not the only research group to initiate research 
into biodegradable vascular grafts, they are one of the leading research groups in the 
world and the timeline of their research gives a very good illustration of the 
evaluation of their vascular grafts both in vitro and in vivo.  
From another angle, Wu(30) et al used a fast-degrading polymer composed of a 
composite polymers containing poly(glycerol sebacate) and polycaprolactone. There 
was no prior cell-seeding prior to implantation as interposition grafts within the rats’ 
abdominal aorta for 3 months. At the end of the time point, the grafts were found to 
have fully integrated and remodeled within the host’s environment and showed high 
patency rates of 80.9%. The explanted arteries were found to be compliant and had 
high burst pressures of up to 2360±673mmHg, which is approaching that of native 
aorta 3415±529mmHg. In comparison with human saphenous vein which has a burst 
pressure of 1680±307mmHg, and this is a well-known conduit in peripheral bypass 
surgery.  They found that despite the lack of pre-seeding, the grafts were very well-
integrated within the host environment despite the results found by Shin’oka. These 
grafts would have a large ‘off the shelf’ potential. Unfortunately, one of the 
downfalls of this type of approach is the question of ‘what would happen’ in the 
event that the graft material degrades before host integration has taken place. 
The Niklason Group(31) has taken a combination of techniques to try and produce 
vascular grafts with a reduced fabrication time. They sourced smooth muscle cells 
from cadaveric donors and seeded them onto polyglycolic acid (PGA) polymer 
scaffolds and incubated them in a pulsatile bioreactor. During this period the cells 
would secrete extracellular matrix proteins, mainly collagen, building its own 
biological scaffold over the polymer scaffold. At the end of the incubation period, 
which is when the polyglycolic acid scaffold has degraded away, the resultant tissue 
is then decellularized to remove all the antigenic components within the tissue. These 
grafts can then be stored in phosphate buffer solution (PBS) until use or if required 
they can be seeded, prior to implantation, with endothelial cells.     
These are examples of the different approaches which have been taken by different 
research teams looking into the use of biodegradable polymers as vascular grafts. 
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The interest in biodegradable vascular grafts comes from paediatric surgeons who 
require a vascular graft which will eventually be remodeled into a native vessel, with 
eventual biodegradation of the synthetic components. The biodegradable vascular 
graft means that in paediatric cases, these grafts can grow with the child. In the case 
of the traditional synthetic grafts, PTFE and Dacron®, the grafts are not ‘living 
grafts’ and will not grow with the child. Therefore, operations, sometimes, have to be 
delayed till the child reaches a certain size so that much of normal growth has 
already taken place, before the implantation of the graft.       
  
1.7 Tissue-Engineering Vascular Grafts by Self-Assembly 
Tissue-engineered vascular grafts were first produced by Weinberg and Bell in the 
1980’s(32). They used bovine endothelial cells, fibroblasts and smooth muscle cells 
and these were co-cultured in a collagen matrix and then shaped into tubes. Although 
tissue architectures analogous to natural blood vessels were achieved, the constructs 
required the support of a Dacron® mesh for extra strength and despite this, the 
mechanical properties were still poor.  
Despite this, Weinberg and Bell had set a trend in attempting to construct a 
completely biological, ‘living’ laboratory-grown vascular graft in a ‘self-assembly’ 
approach. Although there have been a few attempts in manufacturing these vascular 
grafts, L’Heureux(33) et al were able to develop one of the first implantable 
biological-based tissue engineered vascular graft that was free from any synthetic 
material for extra support. The fabrication process is complex and long for one of 
these grafts but recently has shown some initial success in being used as a vascular 
access graft. 
The methodology for making these grafts required time and patience. The resulting 
blood vessel was to be composed of three layers which was a functional endothelium 
seeded onto an ‘internal membrane’ layer made of smooth muscle cells and 
fibroblasts. The internal membrane layer is constructed by rolling a sheet of 
fibroblasts around a cylindrical support and culturing it until the individual layers are 
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fused together forming a homogenous tissue. This tissue is then devitalized by 
dehydration and thus is itself a scaffold for the vascular graft itself. After this tissue 
has been devitalized a further sheet of smooth muscle cells is then rolled around it 
forming the medial layer.  A further sheet of fibroblasts is then rolled around this 
layer and the layers are then allowed to fused for a further 8 weeks. At the end of this 
maturation period, the mandrel is removed and the resulting lumen is then further 
seeded with endothelial cells(34). 
Over time the methodology for production of these vascular grafts have improved in 
particular to fit a commercial setting. Recently the graft has been commercialized as 
Lifeline® (Cytograft Tissue Engineering Inc., Novato, California) and is undergoing 
clinical evaluation. They have undergone clinical evaluation as haemodialysis access 
grafts. Initially, these grafts were constructed from autologous cells from patients 
with end-stage renal failure and were delivered as ‘living’ grafts with a production 
time of 6-9 months(35). Post implantation of the graft there was a safety phase of 3 
months prior to grafts being used for dialysis access. They initially enrolled 10 
patients for the study but one had to be withdrawn prior to implantation due to poor 
health. Of the 9 implanted, 3 grafts failed prior to the end of the safety period with 1 
patient dying shortly after implantation of unrelated causes and 1 patient withdrawn 
due to successful kidney transplantation. Of the remaining patients only 4 of the 
grafts were still function at the end of 21 months. Failures were due to dilatation, 
thrombosis and aneurysm formation. 
Further evolution of the Lifeline® graft meant that although produced in the same 
way, these grafts were then dehydrated and then stored in -80ºC and stored for 9 
months. Pre-implantation testing showed that this treatment did not destroy the 
mechanical properties of these grafts and these grafts were not endothelialized prior 
to implantation. This was a trial at making the Lifeline® graft ‘off the shelf.’ 
Wystrychowski(36) et al reported 3 cases which used the ‘non-living’ version of the 
Lifeline® graft. These grafts were inserted in the brachio-axillary position and were 
first used for dialysis at 8-12 weeks. Immunological and inflammatory blood markers 
were within normal limits. However, there were 2 thrombogenic failures at 3 and 5 
months respectively. The third failure was due to pre-existing sepsis which the 
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patient succumbed to. There were some questions as to the graft performance due to 
the lack of ‘pre-seeding’ as it was noted that at the puncture site there was delayed 
extravasation and slight bleeding which was not seen with the ‘living’ Lifeline® 
grafts which are ‘pre-seeded’. They thought that this might be due to slower repair 
processes due to the absent cells. Furthermore, the thrombogenic failures were 
thought to be due to stenosis occurring within the graft rather than the lack of 
endothelium. 
Although there is some initial success in these clinical evaluations of these grafts, 
there are still concerns about the mechanical properties especially seen with failures 
due to dilatation and aneurysm formation. The ‘living’ version of the Lifeline® 
grafts have a long fabrication time and therefore this makes these graft unsuitable for 
‘off the shelf’ uses. There is potential that the ‘non-living’ version may make this use 
a possibility but at present, further optimization and development is still required. 
However, these grafts do possess many advantages such as lack of immunological 
activation, low infection risk as native tissue, lack of synthetic graft material and the 
ability of the host system to integrate and remodeled with the graft, thereby being 
integrated like a native vessel. Unfortunately the long fabrication time of 6 to 9 
months and the high associated cost >US$15,000 means that these grafts are unlikely 
to be regularly adopted by clinicians in the future(31).   
 
1.8 Why Synthetic Non-Biodegradable Vascular Grafts May Still have the 
Advantage? 
Although at present there are still many avenues of research being undertaken to 
produce the ‘ideal’ vascular grafts, none of the methods have managed to produce 
the ‘perfect’ vascular graft. Some of the common techniques which have been 
employed to produce vascular grafts have been discussed in this introduction.  
However, at present, although there have been some very interesting grafts which are 
currently undergoing clinical evaluation, they all suffer from a variety of faults. The 
most common cause of graft failure of the newer grafts tends to be mechanical 
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integrity and the unavailability of these grafts for ‘off the shelf’ use. Synthetic non-
biodegradable vascular grafts may have the present advantage. These materials do 
not degrade in vivo and are also available as ‘off the shelf’ entities and thereby 
allowing usage in emergency situations.  
With the current and emergent vascular graft materials, there is still a lot of scope for 
improvement as these grafts still do not promote endothelialization. A layer within 
the luminal surface of the graft ensures the patency of the vascular graft. The 
endothelial layer is able to release protective factors that lead to anti-thrombogenicity 
thereby protecting the graft from premature failure(37).  They also have anti-
inflammatory and angiogenesis properties and lead to reduce intimal hyperplasia, 
thereby increasing graft patency. Professor Zilla and his team conducted a clinical 
trial in which endothelial cells were seeded onto ePTFE grafts prior to 
implantation(38) and their results showed significantly improved long term patency 
of PTFE groups pre-seeded with endothelial cells compared with standard. Primary 
patency was 69% at 5 years for endothelialised ePTFE grafts compared with 45% at 
5 years with unendothelialised grafts(7). 
Thereby the rational lies that currently, due to limited technology, we are still limited 
in our efforts to come up with the ‘ideal’ vascular graft. Thereby, modification of 
current biomaterials remains the best course of action to ensure that these vascular 
grafts do not fail mechanically post implantation and also are available as ‘off the 
shelf’ options. 
The current idea is to modify the luminal surface of these grafts so that they are able 
to incorporate a layer of endothelial cells. To ensure that this is possible, as well as 
eliminate the ‘pre-seeding’ step, which would not allow these grafts to be ‘off the 
shelf’, there are efforts to produce ‘self-endothelialising’ vascular grafts. These grafts 
would ideally be able to recruit endothelial cells through a variety of methods; 
inward migration of endothelial cells, or transmural migration or endothelial cell 
capture, so as to endothelialise the graft post-implantation.  
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1.9 Aims of This PhD Thesis  
The aims of this PhD is to produce a ‘self-endothelialising’ synthetic non-
biodegradable vascular graft, using a material previously already developed in the 
laboratory, POSS-PCU. This is a polycarbonate urea urethane (PCU) which is 
attached to a nanoparticle, polyhedral oligomeric silsesquioxane (POSS) and has 
shown promise as compliant vascular graft material. However, in large animal 
studies, this POSS-PCU polymer has shown that there is a lack of endothelialisation 
despite out-performing standard ePTFE grafts when implanted as a carotid 
interposition graft in a sheep model(39). 
Thus the aim of this Thesis is to explore different methodologies in how to 
physically and chemically alter the luminal surface of the material so as to encourage 
endothelial cells to adhere on the surface. This is in addition to studying and looking 
in depth the endothelial cell interaction with the surface and also with other cell 
types, when present. 
1.10 Hypothesis of This PhD Thesis 
The hypothesis of this Thesis is based on the manufacture of a polymer, POSS-PCU, 
which can be used as a small diameter vascular graft material and its subsequent 
modification to achieve this.  
Firstly, it was thought that it is possible to produce all the components of POSS-PCU 
in-house from raw materials and thereby reducing the productions costs of the 
polymer. Furthermore, as this is a graft material which will be eventually used for 
implantation in humans, toxicity testing will be required to prove that this is a 
possibility. It has also been noted that despite improvements of this material over 
those in current clinical use, there were still properties of the material which could be 
improved. One of these properties was the patency rates of these vascular grafts 
which can be achieved by fine-tuning the luminal surface of these grafts. This Thesis 
aims to use different techniques to either promote a ‘non-stick’ surface or to achieve 
endothelialisation so that patency rates can be improved.  
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From previous work(40-42) by other authors, it has been shown that it is possible to 
modify surface topography and chemistry to improve endothelial cells adhesion. The 
hypothesis of this Thesis is that this is possible on POSS-PCU polymer and thereby 
this will this will enhance the process of endothelialisation as it will make it an 
environment on which endothelial cells are able to adhere. This can be achieved by 
fine-tuning both the surface chemistry and topography of the polymer surface. 
Endothelial cells are known to also interact with surface topography and it is thought 
that cell adhesion especially will be improved with the introduction of surface 
topography in both the microscale and nanoscale. However, in addition to this, 
surface chemistry also plays a crucial role and this will be measured in terms of 
water contact angle. The importance of these surface properties will be explained in 
the upcoming Chapters of this Thesis.   
1.11  Chapter Description 
Chapter 1 – This Chapter looks at the in-house production of the nanoparticle, POSS, 
and the use of this nanoparticle to modify the surface chemistry of the polymer itself 
Chapter 2 – This Chapter uses plasma treatment to alter the surface of the POSS-
PCU polymer and looks at its effect on endothelial cell biology 
Chapter 3 – This Chapter combines nanopatterning with the plasma treatment on the 
POSS-PCU polymer and again looks at the effect on endothelial cell biology 
Chapter 4 – This Chapter focuses on the effect that nanotopography has specifically 
on endothelial cell adhesion 
Chapter 5 – This Chapter looks at the effect of co-culture endothelial cells with 
mesenchymal stem cells on topography and whether this would have a potential 
effect on calcification 
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Chapter 2 Materials and Methods 
This chapter contains the materials and methods of the experiments which were 
commonly conducted throughout the different chapters of this thesis. The majority of 
the experiments were conducted between two laboratories, Division of Surgery and 
Interventional Science (Royal Free Campus), University College London and Centre 
for Cell Engineering, University of Glasgow. The methodology of these experiments 
were taken in combination from both these laboratories’ protocols. 
2.1 Cell Culture of Human Umbilical Vein Endothelial Cells 
Human Umbilical Vein Endothelial Cells (HUVECs) were sourced from both Life 
Technologies (Paisley, United Kingdom) and Promocell (Heidelberg, Germany). For 
the initial experiments, they were sourced from Life Technologies and for these 
experiments, the media used was M200 and Low Serum Growth Serum (LSGS) 
(both from Life Technologies).  
The decision to source them from Promocell was undertaken as the experiments went 
on due to the ability to have utter traceability for the cell source and also to have a 
common cell source for all the cells.  
The passage for all experiments undertaken with HUVECs were between P3 – P7.  
The cells were all incubated in an incubator with 5% Co2/ 20% O2. 
2.2 Conditioning Cell Culture of HUVECs for Co-Culture Experiments 
HUVECs from Promocell were placed in conditioning media for at least 24 to 48 
hours and check using normal microscopy, prior to co-culture experiments. The 
HUVEC conditioning media were made as M199 medium (Gibco), 10% inactivated 
Fetal Bovine Serum (Gibco), 2% Penicillin-Streptomycin (Gibco), 0.03mg/ml 
Endothelial Cell Growth Supplement (Sigma Aldrich) and 0.1mg/mL of Heparin 
(Sigma Aldrich). The cells were then incubated. This protocol is modified for our 
laboratories from Bidarra et al(43).     
 48 
2.3 Cell Culture of Mesenchymal Stem Cells (MSCs) 
Mesenchymal stem cells were sourced commercially from Promocell. Basal media 
was made up in Dulbecco’s Modified Eagle’s Medium (DMEM) medium (Gibco), 
10% inactivated Fetal Bovine Serum (Gibco), 2% Antibiotic Mix (Penicillin-
Streptomycin, Fungizone and L-Glutamine) (Life Technologies), 1% Essential 
Amino Acids (Life Technologies) and 1% Sodium Pyruvate (Life Technologies). 
MSCs were used at as low passage as possible (ideally below P3) as there is a high 
risk of differentiation of the MSCs at a higher passage.  
2.4 Cell Culture of Co-Culture of MSCs and HUVECs 
The media for made of a ratio of 50:50 of the HUVEC conditioning media and MSC 
basal media. This has been taken from the optimized protocol from Bidarra et al(43). 
2.5 Fabrication of POSS-PCU 
Preparation of the POSS-PCU polymer has been reported extensively. In brief, 
polycarbonate diol and transcyclohexanechlorohydrinisobutyl-POSS were added to a 
reaction vessel then heated to 130˚C while being stirred under nitrogen gas. The 
reactants were then cooled before 4, 40 -methylenebis (phenyl isocyanate) (MDI) 
was added and all components reacted for 30 minutes under nitrogen gas. 
This reaction then forms a prepolymer before dimethylacetamide (DMAC) was 
added to convert this prepolymer into a solution. This solution was then cooled 
before the chain extender, ethylenediamine, was added dropwise until the reaction 
was completed. The chain stopper, 1-butanol, was then used to prevent further 
unwanted polymerisation. All of the reagents were supplied by Sigma Aldrich 
(Dorset, UK) and used as provided with the exception of POSS, which was supplied 
by Hybrid Plastics Inc (Mississippi, USA). 
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2.6 Fabrication of Nanopatterned Surfaces on POSS-PCU 
The fabrication of the both the micropatterned and nanopatterned surfaces were 
undertaken at the James Watt Nanofabrication Centre (JWNC) Cleanroom, 
University of Glasgow.  
 
Figure 2-1 This is a step-wise diagram which shows how photolithography and electron beam 
lithography (a) are used to produce micro- and nano-sized features, respectively. B) shows how 
soft lithography can be used to produce the surface features onto the POSS-PCU polymer and c) 
shows the SEM of a silicon master, and in this case, this is the NSQ nanopattern 
 
Photolithography was used to micro-sized features and electron-beam lithography is 
used to create nano-sized features. The diagram above shows a step-wise process in 
which these substrates are fabricated. Once a silicon master is fabricated, soft 
lithography is used to produce the features on the POSS-PCU polymer. This is 
conducted by pouring the polymeric solution onto the silicon master and then placed 
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in an oven at 65°C for a minimum of two hours until all the solvent DMAC 
(Dimethylacetamide) has evaporated. The resulting polymeric film is then removed.  
2.7 Preparation of Polycarbonate Surfaces for Cell Seeding 
The polycarbonate substrates are plasma-treated prior to sterilizing with 70% Ethanol 
for 20 minutes. The substrates are then washed with HEPES-Saline generously. Cell 
seeders (under patent at University of Glasgow) are also sterilized in the same 
fashion. The cell seeders are carefully placed on top of the substrates and placed in 6-
well plates (Corning). 400µL of media and cells for seeding is pipetted carefully on 
the cell seeder. The cells are allowed to adhere (2 hours for MSCs and 4 hours for 
HUVECs) in an incubator. Adherence of the cells are checked using microscopy 
prior to removing cell seeders carefully and flooding with excess media. 
Confirmation of cell adherence was by visualizing cell morphology as having a ‘flat 
and spread-out’ appearance on the surfaces compared with a ‘rounded’ appearance as 
non-adherence.  
2.8 Immunofluorescence 
Samples were fixed in 4% formaldehyde for 15 minutes at 37˚C then washed before 
placing in permeabilising buffer and blocking in 1% (w/v) bovine serum 
albumin/PBS. Samples were then stained with anti-vinculin antibody (1:150) 
(Sigma) in 1% (w/v) BSA/PBS or anti endothelial nitric oxide synthase (eNOS) 
antibody (1:50), in conjunction with rhodamine/phalloidin (1:500), and incubated at 
37˚C for 1 hour. Samples were subsequently washed 3 times for 5 minutes (0.5% 
Tween-20 in PBS) and then the secondary antibody, which was biotinylated, was 
added (Vector Laboratories) at 1:50 in 1%(w/v) BSA/PBS. Samples were then 
incubated for 1 hour at 37˚C. After further washing, FITC-conjugated streptavidin 
(1:50, Vector Laboratories) was added and incubated for a further 30 minutes at 4 ˚C. 
Samples were given a final wash before mounting using Vectashield with DAPI 
nuclear stain (Vector Laboratories). 
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2.9 Live/Dead Staining 
Live/Dead staining was undertaken using the Live/Dead Viability/ Cytotoxicity kit 
for mammalian cell (L-3224, Invitrogen) from Life Technologies. In short, calcein 
AM and ethidium homodimer-1 were made up to concentrations of 2 mM and 4 mM, 
respectively, using phosphate buffered saline (PBS). These solutions were incubated 
with the samples for 30 minutes at 37˚C, before washing samples with PBS and then 
analysing with a fluorescence microscope (Zeiss Axiovert M200). 
2.10 Coomasie Blue Staining 
Coomasie Blue staining was undertaken to look at cell morphology. The Coomasie 
Blue solution is composed of 0.2% Coomasie Blue, 46.5% Methanol, 7% Acetic 
Acid and 46.8% Water. The Coomasie Blue solution is filtered post-preparation 
(using 0.2µm filters) prior to applying the solution to the samples for 2 minutes. The 
solution is then removed and the samples are washed thoroughly with deionized 
water. The samples are then dried prior to visualizing under a microscope.    
2.11 Scanning Electron Microscopy (SEM) Preparation 
For visualising substrates, sample preparation was undertaken by drying and 
sputtering coating with gold at a thickness of 20nm. The samples are then visualized 
under vacuum by a scanning electron microscope. 
2.12 Atomic Force Microscopy 
Substrate samples were dried and then super-glued onto glass slides to make sure 
that the samples do not move and interfere with the sensitivity of the instrument (JPK 
Nanowizard 3, JPK). Analysis of the results was completed using Nanoscope®. 
2.13 Statistical Analysis 
When there are three or more samples with normally distributed data one-way 
analysis of variance (ANOVA) is used to compare the means of the samples to see if 
they come from the same population. To test that the samples contain normally 
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distributed data, normality tests have been applied such as D’Agostino’s K-squared 
Test.  
Non-parametric data have been analysed with both Kruskal Wallis and Mann-
Whitney tests. Mann-Whitney has been used with there has been only two samples of 
data and Kruskal-Wallis when there are three or more samples. 
Calculation using these statistical tests have been facilitated with the statistical 
program, Prism® (GraphPad Software Inc., California).      
2.14 Conclusion 
More specific methodology for the specific chapters will be found in the ‘Materials 
and Methods’ of the Chapters themselves.  
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Chapter 3 Surface Focus: Manufacture and Optimisation of POSS 
Nanoparticle 
3.1 Introduction 
Commercially available vascular grafts are made of polytetrafluoroethylene (PTFE) 
and polyethylene terephthalate (PET, Dacron®). Dacron® was first developed by 
two chemists in Manchester in 1941, JR Whinfield and JT Dickinson. In vascular 
surgery, this material was made famous by Dr DeBakey in 1952 who made the first 
Dacron® tube graft for aortic reconstruction on his wife’s sewing machine. To this 
day, Dacron® is the most used material for aortic replacement and large diameter 
lower extremity bypass surgery. PTFE, on the other hand, was developed by DuPont 
in 1938 and marketed under the trademark Teflon (DuPont) in 1945. WL Gore and 
Associates further developed a more compliant and porous version for biomedical 
applications naming it expanded PTFE (ePTFE)(6). These two materials have 
therefore been the mainstay of vascular bypass surgery. In a recent Cochrane 
Review(8), there were 4 studies comparing PTFE with Dacron® for above knee 
bypass applications and there were no significant differences in primary patency seen 
in 24 months. For below knee bypasses, there is very limited evidence and one of the 
main studies by Post et al, showed there is a trend towards improved primary 
patency rates for PTFE compared to Dacron® and significance was reached at 24 
months(7).  
Radial compliance is thought to be an important feature of vascular grafts, more so 
then material strength. This meant that an ideal material would have to be able to 
incorporate this feature and therefore, polyurethane polymers were investigated as 
they had a highly elastic nature and other beneficial properties of being 
biocompatible, compliant and non-toxic. These properties provide an interesting 
alternative to Dacron® and PTFE.     
Polyurethanes (PU) are essentially copolymers of flexible macrodiols (soft segments) 
combined with sequences of diisocyanates and short diols (hard segments). 
Unfortunately, depending on the soft-segment of the polyurethane that is being used, 
there can be potential caveats of danger due to long term stability of the material in 
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vivo. This is due to biodegradation and therefore pose a hazardous risk in vascular 
implants, (i.e. pseudoaneurysm formation). The choice of soft-segment in the 
polymer usually governs this property of the polymer meaning that choice of 
poly(ester) polyurethane will hydrolyse and poly(ether) polyurethane will 
oxidise(10). More recently, for the use of vascular grafts, polycarbonate urea 
urethane has been investigated and been marketed as Cardiotech® but these grafts 
have shown an abnormally high rate of thrombosis (unpublished data) and have been 
withdrawn from the market. Therefore, there is a need for improvements to be made 
to polyurethane-based polymers to overcome these short-comings.Compared with 
other materials such as metals and ceramics, polymers generally have lower moduli 
and strength. It was discovered that the mechanical properties of polymers  can be 
reinforced by incorporating nano-size inorganic particles (defined as having at least 
one dimension in the range 1-100nm) within the polymeric chain(44). This allows 
the polymer to be efficiently improved whilst maintaining its inherently low density 
and high ductility. The idea is to build the nanoparticle into part of the polymeric 
chain, and this can either be as a pendant group or a terminal group, forming a 
polymer nanocomposite. One such nanoparticle which has played an important role 
in the development of polymer nanocomposites is the POSS nanoparticle, in recent 
years.   
Polysilsesquioxanes are represented by the formula (RSiO1.5)n, and can be regarded 
as organic-inorganic hybrid materials at a molecular level. A subtype of these are 
known as polyhedral oligomeric silsesquioxane (POSS) and these possess a cubic 
rigid (T8) structure represented by the formula R8Si8O12 where the central inorganic 
core (Si8O12) is functionalized with organic moieties (R) at each of the 8 corners. The 
R-group may be a hydrogen-atom or an inorganic functional group (e.g. akyl, 
alkylene, hydroxyl, epoxide or acrylate). These are usually formed from hydrolysis 
and condensation reactions of chloro- or alkoxysilanes. Historically, they can include 
long reaction times, months in some cases, with very low yields. Intense research by 
Edwards Air Force research facilities have meant that these particles could be 
produced in many different forms and at yields conducive for commercial use(45). 
However recent improvements in their manufacture means that there have since been 
shorter reaction times allowing commercial manufacture of some of these particles to 
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include high yield. In recent years, a commercial company Hybrid Plastics® have 
become the main suppliers for these nanoparticles in many different forms on a 
commercial basis.  
 
Figure 3-1 Figure to show A) the chemical structure of the full cage POSS nanoparticle and B) 
the 3D structure of the POSS cage 
There are some important general features of POSS which allow for their use as a 
nanoparticle of choice(46): 
1. Their nanoscale dimensions 
2. Unreactive R groups, usually organic for stability, solubility and 
compatibility 
3. One or more reactive X-groups (may be the same as R for further 
modification, grafting or polymerisation) 
4. Well-defined, three dimensional structure with different R and R1 groups for 
introduction into polymers and composite materials 
5. Thermally and chemically robust structure 
The incorporation of POSS nanoparticle into the formulation of the polymer can be 
achieved and produces a hybrid nanocomposite polymer. This can be conducted by 
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blending the POSS into a polymer matrix, by covalently bonding POSS into a 
polymer or by using POSS as a pendant group of a polymer. These three methods 
have been extensively studied by many different research groups. The incorporation 
of POSS with the polymer chain has been shown to improve the mechanical 
properties and enhance the stability of the polymer(47). Other beneficial effects 
include fire retardant, oxidation resistant and surface hardening which would be 
important in more industrial applications(48).  
Covalent bonding allows for the POSS nanocage to be incorporated as a terminal 
group within the polymeric chain. To be able to achieve this, a reactive pendant 
group needs to be available in the POSS-nanocage to allow this to happen. Different 
structures of the POSS-nanocage are available and demonstrate the versatility of the 
molecule. The POSS-trisilanol is available as partially condensed cage version of the 
complete POSS-nanocage. This allows for the required reactive group to be ‘corner-
capped’ onto the POSS nanocage and therefore allow further reactions to take place.  
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Figure 3-2 Diagram to show the proposed step-wise methodology of producing POSS-
functionalised with a chlorohydrin group which can then be chemically attached to a polymeric 
chain 
 
A proposed methodology for the generation of a POSS which allows incorporation 
into a polymeric chain was designed.  
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Figure 3-3 This figure shows the chemical structure of the UCL patented POSS-PCU vascular 
graft material. Note the POSS nanocage is at the end of the polymeric chain. 
 The ideology for the fabrication of the POSS nanoparticle is to tailor-make one 
which is compatible for incorporation into the polycarbonate urea urethane backbone 
of the polymer. This POSS nanoparticle will play an important role in improving the 
mechanical properties of the polymer itself. This is an important feature in the 
development of vascular grafts, especially with the further development of 
polyurethane-based vascular grafts.  
In addition, the POSS nanoparticle itself can enhance the bulk properties of the 
material itself and can also play an important role in the surface properties of the 
material. The ability to fabricate the POSS nanoparticle itself allows for a more 
tailored approach to the development of a vascular graft. This means that desirable 
properties can be elucidated by the covalent positioning of the nanoparticle to the 
polymeric chain.   
The tailored approach of fabrication of a vascular graft is important as the properties 
of the material can be tailored to suit the purpose of the application. The use of 
dispersion of different POSS nanoparticles with different chemical moieties so as to 
change the bulk properties of the polymer itself is a patented technique of Hybrid 
Plastics Inc, but holds an important use for changing certain properties of the 
polymer. Certain POSS chemical moieties such as one incorporating a flouro-group 
can render the polymer hydrophobic as well as chemically inert.  
A medical device has important implications in the commercial market as well as the 
clinical arena. However, new start-ups and spin-offs with innovative ideas are rarely 
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given opportunities from large corporations. This is due to a heavy saturation in the 
medical devices of products which clinicians feel adequately provide and meet 
current clinical needs. On top of this, health committees such as National Institute for 
Health and Care Excellence (NICE) and individual primary care trusts in the UK 
demand proof of superiority of the product over current established treatments with 
clinical evidence and also evaluations of health economics. Figures from the US 
FDA (Food and Drug Association) show that there are more applications for 
extension of the roles of current devices or improvements, rather than completely 
new products or devices. Large manufacturers of medical devices have confessed 
that they do not spend on R&D services anymore and money is spent on ‘buying’ up 
the new generation of products. This has important implications for small companies 
and spin-offs as access to venture capital is now lower. Research councils do have 
funding available for bringing new medical devices to market, however, although 
there is money for research and development, a sense of trepidation is still felt for 
clinical trials of medical  devices. This is due to the high risk of failure of the device 
and subsequent ‘fall-out’ such as insurance pay-outs if the damage caused to the 
subject is high, as well as other heavy financial implications if there was device 
failure.  
Therefore, this shift in mentality has meant that there is a significant decline in large 
vascular graft manufacturers such as WL Gore Cook Medical taking on novel 
innovations such as the POSS-PCU vascular grafts without at least a good clinical 
outcome. Despite a recent Wellcome Trust grant to fund the clinical trials for this 
novel material as a vascular access graft, material sourcing is still a problem and high 
costs, especially with agreements from Hybrid Plastics for the source of their 
nanoparticle. The ability to manufacture the nanoparticle in-house would help with 
the production costs of the POSS-PCU vascular graft.    
3.2 Hypothesis 
The hypothesis for this chapter is: 
1. The POSS nanoparticle can be synthesised in our local laboratories 
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a. Partially condensed POSS- trisilanol can be synthesised via a hydrolytic 
reaction 
b. POSS trisilanol is functionalised by the introduction of an epoxy-group 
c. POSS-isobutyl-chlorohydrin nanoparticle is then produced in which it has a 
reactive group with which to incorporate into our polycarbonate urea urethane 
polymer for fabrication into a vascular graft 
2. This POSS nanoparticle can be incorporated into our polycarbonate urea 
urethane polymer4. Reduction in costs overall for an in-house system compared 
with purchasing the POSS nanoparticle 
5. This POSS nanoparticle has also the ability to initiate subtle chemical 
changes onto the surface of the polymer and therefore alter the surface to make the 
surface more cytophilic 
3.3 Materials and Methods 
3.3.1 Synthesis of partial-cage of (i-C4H9)8Si8O12 from 
Isobutyltrimethoxysilane 
Isobutyltrimethoxysilane (523.3 mmol) was added to LiOH˳H2O (238.3 mmol) 
which has been dissolved in deionised H2O (444 mmol), acetone and methanol 
mixture (88/12 ratio). This is then left to stir and refluxed at 50˚C for at least 18 
hours (a). At the end of the reaction time, the mixture is then quenched with 1N HCl 
and then stirred vigorously for 2 hours at room temperature (b). A white precipitate 
will appear and precipitate out of solution, during this time the solution will also turn 
yellow in colour. At the end of the 2 hours continuous stirring, the white precipitate 
is separated from the solution using filter paper (c).   
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The resulting solid is then washed liberally with acetonitrile and then the product is 
left to air dry overnight. The product yield was found to be 88%.  
3.3.2 ‘Corner-Cap’ Reaction 
POSS-Trisilanol (2.52 mmol) was combined with trimethoxy-2,7-oxabicyclohept-3-
ethylsilane (2.6mmol), deionised H2O (3.6mmol), tetraethylammonium hydroxide 
(0.24mmol) in a solution of THF in a flat-bottom flask. This is left to stir at room 
temperature overnight to allow the reaction to occur.  
Following this, half the THF was left to evaporate in a fume cupboard for 8 hours 
and excess methanol is added to precipitate out the product. A white product will 
appear and this is then filtered out of solution. This is then washed in Ethanol and the 
product left to dry overnight in an evaporating dish.  
a b 
c 
Product allowed 
to dry overnight 
Figure 3-4 Diagram to show the preparation of the partial cage POSS (i-C4H9)8Si8O12 from 
Isobutyltrimethoxysilane 
 63 
3.3.3 Formation of POSS-Chlorohydrin 
Epoxy-POSS is taken added to CHCl3 to dissolve it. Concentrated hydrochloric acid 
(37%) was then added and vigorous stirring for 30 minutes. Two miscible layers are 
seen with the top layer being HCl and CHCl3. Using a separating column, the CHCl3 
is filtered off and kept. Sodium Bicarbonate is placed in excess to neutralise any 
remnants of HCl acid. The resulting mixture is then centrifuged with Na2CO3 at 
3000rpm for 1 minute. The liquid is then poured off leaving the salt at the bottom. 
The liquid is then allowed to evaporate, leaving a crystalline solid to form, this being 
POSS-Chlorohydrin.     
3.3.4 Solid State NMR 
The POSS to be analysed was dissolved in deuterated chloroform (CDCl3) into a 
5mm NMR tube (Norell®). This was then processed in a Bruker NMR detector.    
3.3.5 Melting Point 
The solid sample to be tested was placed with a thermometer in a small test tube 
surrounded externally with glycerol. The glycerol is slowly heated and the moment 
the solid sample melts, this is taken to be the melting temperature.  
3.3.6 Fournier Transmission Infrared (FTIR) Spectroscopy 
The crystal is cleaned with Propanol and allowed to air dry before using. The 
crystallised product is placed on the detector and secured before the scan. A 
‘fingerprint’ of the spectrum is then generated.  
3.3.7 Thin Layer Chromatography (TLC) 
A potassium permanganate (KMnO4) solution was made up, consisting of 1.5g 
KMnO4, 1.25ml of 10% NaOH, 10g NaHCO3 in 200ml deionised H2O. This solution 
was well mixed and ready to use. Vertical linear development was used to carry out 
the TLC. A solvent solution is made up for the solvent tank. From experience, it was 
found that a mixture of 20% ethyl acetate and 80% cyclohexane was the optimal 
solution. Silica gel plates (glass or aluminium) were used and a horizontal line drawn 
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at the base of the plate to indicate the starting point of the applied samples. A 
microcapillary tube (5µl) are used to place discrete spots on the starting line, after 
each application the spot is allowed to dry before application of another. The plate is 
then placed in the solvent tank and the capillary forces allow the mobile phase of the 
solvent to run up through the front of the plate. Once the mobile phase of the solvent 
passes the sample line, the chromatographic process is initiation. The elution comes 
to an end the moment the mobile phase of the solvent is close to the upper side of the 
chromatography plate. At this point, the TLC plate is removed from the solvent tank 
and a line is used to make the border of the mobile phase of the solvent. The TLC 
plate is then allowed to air-dry before drops of KMnO4 solution is placed over the 
plate, covering the surface. This is allowed to dry before heating gently to expose the 
sample constituent’s spots. 
In TLC, the movement of a compound is known as the Rf value or retardation factor. 
The Rf of a compound is described as the distance the compound is eluted (Lcompound), 
divided by the distance from the application line to the mobile phase front (Lmobile 
phase). Although the Rf value can be calculated, it was thought that in this Thesis, this 
was not necessary as the focus is more on the comparison of two products rather than 
the synthesis of a new product which needs further analysis. 
3.3.8 POSS-PCU Polymer solution manufacture 
Preparation of the POSS-PCU polymer has been reported extensively. In brief, 
polycarbonate diol and transcyclohexanechlorohydrinisobutyl-POSS were added to a 
reaction vessel then heated to 130˚C while being stirred under nitrogen gas. The 
reactants were then cooled before 4, 40 -methylenebis(phenyl isocyanate) (MDI) was 
added and all components reacted for 30 minutes under nitrogen gas. 
This reaction then forms a prepolymer before dimethylacetamide (DMAC) was 
added to convert this prepolymer into a solution. This solution was then cooled 
before the chain extender, ethylenediamine, was added dropwise until the reaction 
was completed. The chain stopper, 1-butanol, was then used to prevent further 
unwanted polymerisation. All of the reagents were supplied by Sigma Aldrich 
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(Dorset, UK) and used as provided with the exception of POSS, which was supplied 
by Hybrid Plastics Inc (Mississippi, USA). 
3.3.9 POSS Dispersion  
2% (of the polymer weight) of POSS nanoparticle is first dissolved in DMAC before 
adding to the polymeric solution of POSS-PCU and making the final solution to 15% 
solids content. The hard segment of the polymer remains at 28%.   
3.3.10 Soft Lithography 
Once the POSS nanoparticle has been incorporated into the polymer as part of a 
polymer solution (18-22% solids content). A cast version of this polymer can be 
fabricated using soft lithography. This is done by pouring the polymer solution onto 
a substrate (such as a glass slide) and then this is placed into a vented oven at 65°C 
for a minimum of 2 hours, until the solvent (dimethylacetamide (DMAC)) has 
evaporated. The cast polymer is then removed from the substrate.  
3.3.11 Contact Angle Measurement 
Contact angle measurements were taken using the Kruss Drop Shape Analysis 
DSA100. Contact angles are usually evaluated under static or dynamic conditions. In 
this case, this is conducted by measuring the static contact angle (CA, θ) of the water 
droplet over three interphases, gLV, gSV and gSL, where it is liquid/ vapour (LV), 
solid/ vapour (SV) and solid/ liquid SL).   
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Figure 3-5 Diagram to show the measurement of contact angles using the sessile drop method. 
The wettability of the surfaces is evaluated regarding the static and dynamic behavior of the 
droplet itself and therefore in the static stage, this is evaluated over three different interphases 
in contact with the contact angle. Under dynamic conditions, this is related to the sliding angle 
(α) which is the inclination angle of the surface which causes the water droplet to roll off. 
3.3.12 Live/ Dead Staining 
This has been described in the Material and Methods Chapter. In brief, Live/Dead 
staining was undertaken using the Live/Dead Viability/ Cytotoxicity kit for 
mammalian cell (L-3224, Invitrogen) from Life Technologies. In short, calcein AM 
and ethidium homodimer-1 were made up to concentrations of 2 mM and 4 mM, 
respectively, using phosphate buffered saline (PBS). These solutions were incubated 
with the samples for 30 minutes at 37˚C, before washing samples with phosphate 
buffer solution (PBS) and then analysing with a fluorescence microscope (Zeiss 
Axiovert M200). 
3.3.13 Alamar Blue® Cell Viability  
Alamar Blue® reagent was purchased from Thermo Fisher Scientific and used as 
supplied. HUVECs are cultured in 6-well plates, with some containing POSS-PCU 
polymer and some acting as control (no POSS-PCU) and cultured for 24 hours 
initially. Cell media was removed from the cell samples and then gently washed with 
copious amounts of sterile PBS. Then a known amount of fresh cell media was then 
placed in the well. 10% of the cell media volume of Alamar Blue® was then placed 
each of the sample wells. There should be a cell-free well with only cell media and 
Alamar Blue. This will act as a baseline for standardising. The cells are then wrapped 
in foil and then placed back into the incubator at 37ºC for 4 hours. At the end of the 
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incubation period, the cells are removed from the incubator and 3 x 100µl media 
samples are removed from each well and each 100µl sample is then allocated a well 
in a 96-well plate. These samples are then analysed using a microplate reader. The 
media and Alamar Blue® solutions are then removed from each of the wells. The 
cells are, once again, washed with copious amounts of PBS before replacing with 
fresh media. The cells are then replaced back into the incubator. This process is 
repeated every 24 hours for 4 days.    
 
3.4 Results 
Each of the stages of the reaction was compared with commercially available 
products from Hybrid Plastics®, such as POSS-Trisilanol and POSS-Epoxide.   
3.4.1 Synthesis of POSS-Chlorohydrin 
The synthesis of POSS-Trisilanol is known to be a base-catalysed hydrolytic 
condensation reaction in which the presence of a base, which in this case is Lithium 
Hydroxide (LiOH), of i-BuSi(OMe)3. Interestingly, the availability of i-BuSi(OMe)3 
is widespread as it is a bulk chemical used in the construction industry, as a 
crosslinking agent for silicones and for use as a waterproofing agent in the 
manufacture of concrete.  
The direct synthesis of trisilanol from i-C4H9Si(OMe)3 through a selective base-
catalysed hydrolysis of i-C4H9Si(OMe)3. If the conditions are not exact for the 
formation of the trisilanol, T-gel is formed. T-gels are gelled silsesquioxanes and in 
this case, it is a white waxy material and of sticky consistency. The formation of T-
gel is usually noted on quenching of the reaction with 1N HCl. The formation of T-
gel is noted to be present if the conditions of the reaction are not correct.  
The conditions at which to form the POSS-Trisilanol was found to be very dependent 
on temperature, conditions of the solvent, quenching, reaction time and product 
formation was very dependent on these conditions. If product was produced this was 
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in the form of a white, fluffy material which did not gel on extended stirring and did 
not dissolve on washing with acetonitrile.  
The ‘corner cap’ reaction follows on from the first reaction to ‘functionalise’ the 
partial POSS cage so that there is an epoxy group attached. And after this, the epoxy 
group needs to be ‘ring-opened’ which leads to the POSS-chlorohydrin. In the three 
steps as detailed above this can be achieved and the following results are presented 
as such.  
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Figure 3-6 Comparative FTIR diagrams of the products produced at each stage of the chemical 
synthesis where a) is POSS Trisilanol, b) is POSS Epoxy and c) is POSS Chlorohydrin. 
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The FTIR spectrum of the UCL POSS-Trisilanol (UCL1) is comparable to Hybrid 
Plastics® POSS Trisilanol (HP1). It can be seen the intensity of the UCL1 product is 
higher than HP1. This is due to the crystalline nature of the material and the more 
crystalline the final product is the higher the intensity. This shows that UCL1 is more 
crystalline than the commercially available HP1. This pattern is also seen in the both 
the POSS-Epoxy and POSS-Chlorohydrin steps. The intensity of the FTIR is higher 
the more crystalline the product is. Therefore, the POSS-Epoxy from Hybrid Plastics 
appear to be more crystalline then the UCL POSS-Epoxy. But this is reversed again 
for the final POSS product, which is the POSS-Chlorohydrin.  
The FTIR spectrum shows the characteristic peaks at 1120cm-1 which are known for 
the Si-O-Si bond and also another peak at 1030cm-1 indicating the Si-O-Si 
framework(49). This is a very strong indication for the presence of the POSS 
nanocage.  
In all the FTIR spectrums, the UCL-POSS that is produced is comparable to the 
commercially available HP-POSS at each step of the process as seen by the FTIR 
‘fingerprints.’  
1H NMR and 13C NMR shows how matching the spectrums of UCL POSS-
Chlorohydrin to HP POSS-Chlorohydrin indicating the same material has been 
produced. Again, this is an identical ‘finger-print’ of the two products which have 
been produced.   
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Figure 3-7 NMR spectra showing the comparison of POSS-PCU produced commercial (HP-
POSS) and that produced in-house (UCL-POSS) where a) UCL-POSS proton NMR, b) HP-
POSS Proton NMR, c) UCL-POSS 13C NMR spectra and d) HP-POSS 13C NMR spectra 
  
Melting points for both the UCL-POSS and HP-POSS were found to be both at 
123°C. This indicates that the products produced at the end of the synthesis is 
comparable. If any significant impurities are present, this will usually lower the 
melting point.  
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Figure 3-8 This figure shows the exposure of a thin layer chromatography (TLC) plate highlight 
the different POSS products, where A is mixture of Hybrid Plastics POSS- Chlorohydrin and 
UCL POSS- Chlorohydrin, B is Hybrid Plastics POSS-Chlorohydrin only and C is UCL POSS-
Chlorohydrin only. A mixture of the two POSS samples is used to further confirm that the two 
products are the same. The green arrow indicates the presence of the POSS cage which is seen 
across all three products. 
Thin layer chromatography (TLC) also shows further confirmation of the product 
which has been produced, UCL-POSS. On the TLC plates it was seen that the 
fingerprints of the products are nearly the same. The main product which is the 
POSS cage is the most dominant product which is produced and can be seen to be the 
same product moving the same distance across the TLC plate. There are also smaller 
amounts of mostly, similar side-products which have been produced. However as can 
be seen the ‘fingerprints’ of HP-POSS and UCL-POSS seen on the TLC plate is not 
exactly the same and this is thought to be due to different impurities and will require 
further purification processes which will ensure a purer product is produced.   
3.4.2 Testing the Toxicity of POSS-Chlorohydrin associated POSS-PCU 
polymer 
Toxicity testing was undertaken to ensure that the incorporation of the POSS 
nanoparticle does not affect the normal growth of the endothelial cells. This was 
conducted using Live/ Dead staining which will stain ‘live’ cells green and ‘dead’ 
cells red. In conjunction with the Live/ Dead staining Alamar Blue® staining was 
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also undertaken to illustrate that endothelial cell metabolism has not changed in the 
presence of the polymer.  
This testing was undertaken in an environment in which human umbilical vein 
endothelial cells (HUVECs) are known to proliferate and this is on tissue culture 
plastic. This experiment was conducted on tissue culture plastic (TCP) in which 
HUVECs are known to grow. A piece of cast 1cm x 1cm POSS-PCU polymer, 
polymer in which the solvent has been evaporated, was placed also in the TCP well 
with the HUVECs. For the Live/ Dead staining, the results were analysed after 48 
hours whereas for the Alamar Blue® the time-point was after 4 days so as to give a 
better growth chart.  
The results show that after 48 hours, in both the wells with POSS-PCU or without 
POSS-PCU (control), the majority of the cells were still alive and there were really 
few dead cells. It is also possible to note that the natural morphology of endothelial 
cells was retained in both conditions, with and without POSS-PCU being present.  
The Alamar Blue® results show that there is a similar growth rate or proliferation of 
the HUVECs with or without the presence of POSS-PCU in the wells. This was 
conducted over 4 days and intensity readings were taken every day to establish a 
pattern. It was possible to see that there is a positive growth pattern over the four 
days and there was no statistical significance between with or without POSS-PCU at 
each of the days. This indicates that the presence of POSS-PCU does not impede 
HUVEC proliferation and that POSS-PCU is non-toxic and biocompatible.        
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Figure 3-9 Toxicity studies conducted to show HUVECs survival in the presence of POSS-PCU 
and when compared with normal conditions (control). The top diagram shows Live/Dead assay 
of the live cells (green) and dead cells (red) using fluorescence microscopy after 48 hours. The 
bottom graph shows comparison intensity when using Alamar Blue ® to measure the metabolic 
activity of the HUVECs in the presence of POSS-PCU and without. There is no statistical 
difference between the two conditions on any of the days (n = 12) 
  
3.4.3 Surface Modification of POSS-PCU using POSS nanoparticles 
Once the POSS nanoparticle has been reacted within the polymer, this leaves the 
POSS-PCU polymer to be relatively unreactive. Therefore, the addition of further 
nanoparticles was mixed in with the polymer in an attempt to allow subtle 
modification of the polymeric surface. This is based on previous observations that 
the POSS nanoparticle tends to migrate to the surface in aggregates.  
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 AFM and SEM images confirmed the migration of the nanoparticles to the surface 
and these nanoparticles tend to promote a hydrophobic property to the surface.  
Therefore, it was thought that in excess further nanoparticles can induce more of a 
definitive change to the surface properties of the polymer. Two different types of 
POSS nanoparticles were dispersed within the polymeric solution and casted till the 
evaporation of the DMAC. These were Fluoro-POSS and POSS-Chlorohydrin and 
these were dispersed at a concentration of 2% excess of the solids percentage of the 
polymeric solution. This was compared with POSS-PCU and also polyurethane 
without the POSS nanoparticle, polycarbonate urea urethane (PCU).   
 
Figure 3-10 Shows the chemical structures of a) Fluoro-POSS and b) POSS Chlorohydrin. C) 
shows the 3D rendition of the surface topography of POSS-PCU with the POSS-nanoparticle 
aggregating on the surface using and d) phase image of the same area with AFM. 
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The contact angle for these modified polymers were measured and compared with 
the current polymer in use, polytetrafluoroethylene (PTFE).  
   
Figure 3-11 a) and b) shows a snapshot of the angle measurements taken for the contact angle 
measurements of the sessile water droplet on the POSS-PCU polymer and PCU polymer. The 
table below shows the contact angles for these two polymers as well as the clinical control, PTFE 
(n = 3). 
The baseline contact angles show that POSS-PCU is actually more hydrophobic than 
PTFE. However, PCU has the lowest contact angle out of the three polymers and 
therefore is more hydrophilic. In comparison with POSS-PCU, this could be due to 
the POSS nanoparticle and therefore implies that the incorporation of the 
nanoparticle confers an increase of contact angle of around 30°. 
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Figure 3-12 The two graphs illustrate the similarities between the original polymer, POSS-PCU 
and PCU, and the modification of excess POSS nanoparticle. The contact angles of each 
polymer is recorded in the table below (n = 3). 
There is no statistical significant difference between all the contact angles, even on 
the additional dispersion of POSS nanoparticles and the known ones which are meant 
to be hydrophobic. This indicates that on the addition of excess POSS nanoparticles 
the chemistry of these nanoparticles is very important as well as the polymer 
chemistry to predict what is going to happen. In this case, it appears that despite the 
POSS nanoparticles which have been chosen for their perceived hydrophobic 
properties, on addition of these nanoparticles to the polymers, there is no appreciable 
difference in the contact angles.  
FTIR analysis of both the top and the bottom of the cast polymer sheet were analysed 
to see if there were any predictable migration to the surface of the POSS 
nanoparticle.  
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Figure 3-13 FTIR spectrums taken of both the top and bottom of cast polymers where the 
spectrums are a) POSS-PCU, b) POSS-PCU with 2% POSS-Chlorohydrin, c) POSS-PCU with 
2% Fluoro-POSS, d) PCU, e) PCU with 2% POSS-Chlorohydrin and f) PCU with 2% Fluoro-
POSS. The arrows indicate the extra peaks of the POSS nanoparticle at 1100 cm-1 wavelength 
 The FTIR spectrums taken of the cast polymers with the different dispersions show 
that in POSS-PCU there is no difference to the chemical fingerprint whether there is 
excess POSS-Chlorohydrin or Fluoro-POSS dispersed within the polymeric solution 
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before being casted. However, with the PCU, there are extra peaks seen at 1100cm-1, 
mostly seen on the topside of the cast polymer and not on the bottom-side of the 
polymer. This shows that the POSS nanoparticle might be migrating to the surface of 
the polymer during its fabrication using soft lithography.   
3.4.4  Costs 
The commercial costs to source POSS-Chlorohydrin from Hybrid Plastics Inc.  has 
been quoted to us as £3157 / kg. The costs calculated to produce POSS at UCL was 
£885/kg. This is assuming that the raw materials were sourced from Fluroochem Ltd 
where the advertised prices for Isobutyltrimethoxysilane is £20/100g and for 
Epoxycyclohexylethyltrimethoxysilane is £18/25g. These costings are accurate as of 
2013.  
However due to licensing agreements between Hybrid Plastics and UCLB, the 
negotiated costs of 1kg of POSS-Chlorohydrin is much higher than this. Therefore, 
the reduction in costs, if POSS can be produced in-house, will be phenomenal and 
make the final product more commercially viable.   
3.5 Discussion 
These results have shown that it is, indeed, possible to produce the POSS 
nanoparticle required to produce POSS-PCU polymer in-house. This is an important 
step in the production and commercialisation process of the POSS-PCU polymer as it 
allows a degree of independence in the supply of the nanoparticle. However, this is 
obviously very dependent on the status of patents and will require consultation with 
patent lawyers, especially if the manufacture is to be taken into a commercial setting. 
Further optimisation will be required to get the product into a setting which is 
appropriate to production which attains regulatory standards such as ISO especially 
if it is to be part of a medically implanted device.   
The use of a base-catalyzed hydrolytic condensation reaction for POSS synthesis is 
well-known but it should be known that if the conditions are incorrect, it can often 
lead to intractable resins (T-gel) rather than discrete molecular clusters. Under these 
favourable conditions the formation of a POSS framework is typically observed with 
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thermodynamic control. This is due to the cleavage of the Si-O-Si linkages which are 
facile(50).  
The formation of the trisilanol is thought to occur via the stabilisation of a lithium 
salt, lithium silanolate or trisilanolate for staibility during the base-catalysed reaction. 
Upon quenching with acid (1N HCl), the trisilanol is freed and production of the 
partial cage is possible.  
The ‘corner-capping’ of trisilanols have been investigated and is a very useful 
reaction as it involves functionalising the silsesquioxane cage structure. These 
functional groups are important as they can be carefully selected to allow a desired 
chemical group to be ‘corner-capped’ onto the silsesquioxane cage structure. 
Common reactions have involved the use of chloride salts but this requires high 
amounts of solvent and the waste products were large precipitates of chloride salts 
with a potential environmental impact. Good yields were difficult without these 
consequences and long reaction times.  
When compared to the commercially available products, it is obvious that the 
possibility to produce the POSS-chlorohydrin in-house is possible. However, the 
purity levels of this POSS-chlorohydrin is difficult to assess due to the lack of 
professional chemical synthesis equipment in our own laboratories. Furthermore, to 
enhance the purification of the final product of the POSS nanoparticle is still an 
ongoing project. Melting point indicates that the POSS-chlorohydrin produced in this 
project has similar purity levels to those available commercially as both the melting 
points were the same. As mentioned before, melting points can decrease the melting 
point of a product and although the UCL-POSS which has been produced has similar 
melting point to the reference product, HP-POSS, TLC reveals that there are 
impurities in the both the products. It might be that the purity level in both products 
are the same or similar but due to manufacture techniques differing this would mean 
that there are different impurities present. Unfortunately, the ability to quantify this 
to that required at a commercial level is not possible currently as is the ability to 
further purify the product to a satisfactory level.  
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An advantage of being able to produce POSS-chlorohydrin in-house would be the 
huge reduction in manufacturing costs. This Chapter has shown that this is a 
potential but the system still requires optimization and purification of the final 
product. In addition to this, the process would need further consultation with patent 
lawyers to make sure that producing POSS-chlorohydrin on a commercial basis 
would not interfere with any existing patents currently held by Hybrid Plastics.   
The incorporation of the POSS nanoparticle has been shown to be especially 
beneficial in improving the mechanical properties of the polycarbonate urea urethane 
polymer over polycarbonate urea urethane polymer by itself. It has been suggested 
that POSS incorporation in the polymers reduce chain mobility and this is the reason 
for the improvement in the results of both mechanical and thermal properties(50). In 
the case of POSS-PCU, the POSS nanoparticle is at the end of the polymeric chain. 
Polyurethanes are partial crystalline structures due to the amorphous soft segment 
and crystalline hard segment, and this is also the case of POSS-PCU. The resulting 
polymer produced is relatively inactive.   
 One of the downfalls of the POSS-PCU polymer is its inability to harbor an 
endothelial layer in the luminal surface(39), which has been confirmed in large 
animal studies. The endothelial layer in a luminal surface of a vascular graft has been 
shown to have important implications as discussed previously, however a surface 
which is shown to be completely repellant against any cells or protein material is also 
desirable. This means that no biological material is allowed to settle on the surface of 
the polymer. By achieving a superhydrophobic state (CA >150°), this allows for a 
surface that is not conducive to any protein adsorption, and hence platelet adhesion. 
Focused surface modification of the polymeric surface without affecting the polymer 
bulk is desirable as bulk mechanical properties can be retained. Previous attempts to 
do this with expanded PTFE (ePTFE) have been reported as a failure(51).  
Although cells have not been able to directly adhere to POSS-PCU, we do know that 
the polymer is non-toxic to them. As shown, experiments have shown that the 
polymer is able to be in the same vicinity as the endothelial cells and this does not 
affect the growth of the endothelial cells. This suggests that the POSS-PCU polymer 
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does not emit any toxic substances which would otherwise affect cell death and this 
is especially important in the presence of endothelial cells in which the primary aim 
is to grow cells eventually on the polymer itself.   
Alamar Blue® is a very useful reagent as it allows evaluation of the metabolism of 
live cells and does not require the cells to fixed or destroyed for analysis. It uses 
resazurin which is a non-toxic and cell permeable compound. In its native state it is a 
blue colour and does not fluoresce. However, upon entering the cell, it is converted 
to resorufin, by reduction. Resorufin is a compound which is red in colour and highly 
fluorescent and thereby detectable using a plate-reader and allows for intensity 
readings. Although it is possible to conduct a quantitative evaluation of the amount 
of resazurin reduced, it was decided that in this case it was not necessary. This 
experiment is intended to be used as comparison data and therefore the comparison 
in fluorescence intensity was considered adequate.  
Both Alamar Blue® and Live/ Dead staining have shown that POSS-PCU polymer 
is, indeed, a biocompatible polymer and does not require any further modifications 
from that point-of-view. However, it does need to have a surface which is conducive 
for direct cell adherence and proliferation, leading to the aim of this Thesis.  
Initially, there were two ‘trains of thought’ in modifying the POSS-PCU polymeric 
surface. The first one, as mentioned, was to enhance the surface so that cells are able 
to adhere and proliferate on the surface, especially endothelial cells. Currently, this 
would require lowering of the surface contact angle to make the surface more 
hydrophilic so that cells are able to grow. The second train of thought was to ‘tune’ 
the luminal surface of the vascular graft to the other end of the spectrum. This 
involves making the surface super-hydrophobic (contact angles > 150º) instead of 
hydrophilic, meaning that water droplets would just roll off it and would not be able 
to ‘wet’ the surface at all. This would also mean that cells, platelets and proteins 
would not be able to adhere on the surface and the vascular graft would function as a 
tube, but one that would have a non-adherent luminal surface. Initial attempts were 
made towards making the surface hydrophobic using the intrinsic nanoparticle, 
POSS. This focused in finding different functional and chemical groups which were 
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known to promote hydrophobicity. After noticing that the nanoparticles aggregate on 
the surface of the POSS-PCU polymer, it was hypothesised that excess of 
nanoparticles can be used to induce subtle changes in the chemistry of the polymer 
especially the surface without affecting the bulk properties. The Fluoro-POSS was 
selected due to the known hydrophobic nature of fluorine groups within the chemical 
structure. POSS-chlorohydrin was also selected as it was a known hydrophobic 
molecule as well as being a nanoparticle that we have already in abundance in our 
laboratory to test out this hypothesis.  
Despite the known hydrophobic properties of these nanoparticles, it would seem that 
there is a lack of change in the overall surface contact angle of the surface of the cast 
polymer. It is thought that the reason for this is due to the individual chemical 
structure of the POSS nanoparticle involved and is likely due to the caged structure 
which does not allow water molecules to penetrate. For unmodified POSS-PCU 
polymer, the aggregation of the POSS nanoparticle on the surface is due to the 
fabrication technique employed. For fabrication of the cast polymer, this is usually 
placed on a glass substrate and the surface of the glass is hydrophilic in nature. This 
hydrophilicity means that the hydrophobic nanoparticles will orientate themselves as 
far away from the hydrophilic glass substrate as possible and therefore this means 
that they will aggregate on the surface furthest away from the glass surface.  
In POSS-PCU, the presence of excess POSS nanoparticle (either in the form of 
Fluoro-POSS or POSS-Chlorohydrin) did not make any difference to the CA of the 
cast polymer as previously thought. It is thought that as the POSS nanoparticle is 
incorporated as part of the POSS-PCU polymer, their presence allowed excess POSS 
to penetrate the bulk of the polymer, as it was already anchored within the polymer, 
allowing an interplay between ‘free’ POSS and ‘anchored’ POSS. In reverse, PCU 
polymer is more hydrophilic than POSS-PCU as there is no POSS nanoparticle as 
part of the polymer. This hydrophilicity means that it will force the ‘free’ POSS to 
migrate to the surface, away from the hydrophilic nature of the PCU. This effect is 
reminiscent of phase separation. This is why the FTIR shows large peaks of POSS 
nanoparticles on the top of the polymer surface. However, despite these aggregations 
of POSS nanoparticles on the surface there is still no discernable change in the CA.     
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The use of CA to measure the subtle surface changes is an important technique as 
this will give us quite a sensitive indication of the hydrophobic or hydrophilic nature 
of the surface. This allows a sensitive methodology of fine-tuning the surface till a 
desirable CA is reached to which further testing can be initiated and functions as a 
sensitive indicator.  
A vascular graft was released by Vascutek Ltd (Renfrewshire, UK), FluoropassivTM, 
which was essentially a knitted polyester skeleton with the surface having been 
treated with a proprietary fluoropolymer solution before gelatin impregnation(52). In 
animal models, the addition of this fluoropolymer exhibited reduced thrombogenicity 
and suture hole bleeding(53). However, when this graft was moved to clinical 
evaluation, Robinson(54) et al found that when compared with ePTFE vascular 
grafts, FluoropassivTM functioned less effectively as a vascular graft. The primary 
patencies at 6 months were found to be 50% for FluoropassivTM compared with 71% 
for ePTFE. In addition, it was found that 36% of the enrolled patients with 
FluoropassivTM vascular grafts developed graft thrombosis compared with 8.8% of 
those with ePTFE grafts. FluoropassivTM uses a similar reasoning to what was 
attempted in this Chapter. The idea is to increase the surface to a hydrophobic level 
in which cells and platelets are not able to adhere. The use of POSS nanoparticles to 
disperse within the polymeric solution did not seem to have as strong an effect as 
was intended and combined with the clinical efforts of the FluoropassivTM vascular 
graft, it may appear that this line of investigation may be futile.  
3.6 Conclusion 
 This chapter shows that it is possible to produce the POSS-Chlorohydrin 
nanoparticle in the laboratory and incorporate it within a polyurethane-based 
polymer, polycarbonate urea urethane (PCU). However once the polymer that is 
produced, POSS-PCU, is quite hydrophobic in nature. Endothelialisation of its 
unmodified form, has already shown it to impossible in preclinical studies. 
Therefore, further modification of the polymer will be required at this point, either to 
increase the hydrophilicity or the hydrophobicity of the polymer. Surface 
modification to increase the hydrophobicity of the polymer using nanoparticles 
dispersed within it, did not change the surface contact angle an appreciable amount. 
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When compared with the recent clinical attempts to increase hydrophobicity of the 
luminal surface, it was concluded that increasing the hydrophilicity of the surface 
may be a better strategy.    
3.7 Further Work 
As mentioned already, although it is possible to prove that the POSS-chlorohydrin 
molecule is a particle that can be synthesized in-house, there is still much work to be 
conducted in which POSS-chlorohydrin can also be produced on a commercial scale. 
This will involve optimisation, formal assessment of the purity levels of the product 
and also scale-up of the production line. Unfortunately, the current laboratory in 
which this initial work is conducted in, is not suitable for this further work and would 
require further dedicated chemistry laboratories with associated specialist chemistry 
help. Ideally, if funding was available, a specialist chemical synthesis company 
would be consulted in bringing this work to such a place. 
Production of this nanoparticle will then need to be formally tested for 
biocompatibility and its ability to be made into the POSS-PCU polymer with the 
same results as those obtained using the POSS-Chlorohydrin produced commercially 
from Hybrid Plastics. Although we have tested the biocompatibility of POSS-PCU in 
this Chapter, the POSS-PCU was made using POSS from Hybrid Plastics and not the 
POSS made in-house. Therefore, this does need to be investigated further and, again, 
in a more formal environment which will take into account ISO standards.  
Further work needs following this Chapter needs to also focus on endothelialisation. 
This will require a method which involves surface modification technique which 
does not destroy the bulk properties of the POSS-PCU polymer. Physical and 
chemical techniques are usually preferable over biological techniques. This is mainly 
due to the fact that biological techniques tend to have further problems regarding 
storage, cell culture, cell/ protein sourcing, for example, and tend to require specialist 
facilities to be made available on-site. Therefore, further Chapters in this Thesis will 
concentrate on further surface modification techniques to encourage 
endothelialisation.    
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Chapter 4 Surface Modulation of the POSS-PCU Polymer: Plasma 
Treatment 
4.1 Introduction 
Surface modulation of the vascular graft surface allows for a more focused approach 
when designing a vascular graft more conducive to endothelialisation. It has long 
been acknowledged that the main factors allowing an endothelial cell layer to line the 
luminal surface of a vascular graft, are surface chemistry and topography. Despite 
several new materials undergoing extensive investigation for use as an implantable 
medical device such as a vascular graft, it has been difficult to achieve both an 
endothelialised surface as well as a durable polymer with mechanical properties 
suited for a vascular graft. Therefore, a methodology which allows for modulation of 
both factors as well as allowing independent adjustment from each other is a 
desirable effect.  
In the fabrication of vascular grafts, it is essential to understand that the luminal 
surface of the graft has a very close interaction with the blood and haemodynamic 
flow. Therefore, the design of this surface has to be non-thrombogenic, non-
inflammatory and endothelial-cell ‘friendly’, to name a few things. The ‘holy grail’ 
of vascular surgery is known to be the ability to produce of an endothelial cell layer 
on the luminal surface of the graft. This endothelial layer ensures the patency of the 
grafts as there is an important haemostatic balance to be achieved here by the 
endothelial cells themselves. In addition to this, this endothelial layer must also be 
able to withstand the high pressures and haemodynamic flow encountered within 
arterial vessels without delaminating. Clinical research conducted by Zilla et al(38) 
has added weight to the need for endothelialisation. They found that when 
endothelial cells were seeded onto PTFE grafts, long-term patency rates were 
superior when compared to non-endothelialised PTFE grafts. Despite the viability of 
this process already proven by these clinical trials, unfortunately this methodology is 
limited to specialized cell culture facilities, university hospitals or tertiary hospitals 
and where the cell culture facilities are close to the operating theatres. Pre-seeding of 
these endothelial cells also limits the usage of this technique for emergency and 
urgent operations.  
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‘Off the shelf’ vascular grafts which are self-endothelialising are therefore 
considered to be the ideal solution to the problem. This means that the proposed 
vascular graft would be accessible to all different types of scenarios, emergency and 
elective cases. Once the graft is implanted, it would be able to recruit endothelial 
cells from neighbouring vessels to endothelialise itself. This would preclude the need 
for prior endothelial cell seeding and allows this graft to be used even in emergent 
situations. A reliable and reproducible fabrication methodology is required to 
achieve this. However, although this is not a new idea, previous observations have 
shown that inward endothelial cell growth is limited to 2-3 cm at best and therefore 
continued efforts to make this work have waned in recent years. 
One of the more popular strategies used to induce endothelialisation has been to 
incorporate protein and peptide molecules into the luminal surface of the vascular 
graft. Many methods have been used such as grafting, coating and anchoring but 
none have really progressed to a clinical setting beyond preclinical trials. For 
proteins, sourcing would be very difficult as there are problems with testing of 
transmittable diseases, high costs, ethical approval and also difficult FDA approval. 
Peptides would potentially also run into the same problems, although short-chain 
peptides such as REDV and RGD(55) have been produced in the laboratory without 
too much problem, but their production in bulk, amounts to huge costs, which is yet 
another problem. There are still discussions as to whether there are potential 
complications resulting in downstream effects of the ‘attached’ proteins and peptides 
and whether a systemic reaction may be a problem.  
Within the body, endothelial cells reside in an extracellular matrix within the luminal 
surface of the vessel, which provides physical, chemical and biological cues to allow 
it to function and reaction to different stimuli. To attempt a full reconstruction of the 
extracellular matrix is beyond the capability of our current technology at this 
point(37). However, it has been identified that altering some of the more gross 
aspects such as surface chemistry and topography can help benefit cell adhesion and 
function onto some synthetic biocompatible materials. These materials can be 
designed to have bulk properties which have similar mechanical and compliance 
features to that of a native arterial vessel. Polyurethane has been a biocompatible 
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synthetic polymer of choice in the recent years and as mentioned in the previous 
chapters, problems in long-term degradation through oxidation and hydrolysis have 
mainly been fixed by the addition of the POSS nanoparticle. The addition of this 
POSS nanoparticle has also improved the mechanical and compliance properties of 
the polymer(44). However, endothelialisation is still a problem as demonstrated in 
large animal studies(39). Therefore, other strategies to allow endothelialisation to 
happen without compromising on the bulk properties of the material is further 
investigated. One of the strategies of this type of modification was to alter the 
luminal surface chemistry of the POSS-PCU polymer, using plasma treatment.   
Plasma treatment offers a reproducible methodology to alter the surface chemistry of 
the surface of a material without affecting the bulk properties of the material itself. 
Plasma is referred to as the 4th state of matter and was coined by Langmuir in 
1928(56). Plasma is composed of partially ionized gas and can be defined as particle 
system in which a mix of free electrons, ions and radicals, composed of neutral 
particles (atoms and molecules). Some of these may be in the excited state and return 
to ground state by photon emission. This accounts for the light emission visualized. 
Electrons can also be free meaning that positive and negative charges move 
independently of each other. This plasma state is usually activated by radio-
frequency or electrons from a hot discharge.   
Plasma is divided into two distinct categories, equilibrium (thermal) and non-
equilibrium (non-thermal). In our usage, non-equilibrium is used most commonly, as 
high temperatures can have a detrimental effect on polymers. Plasma is highly 
reactive and therefore there are three main categories of plasma reactions: 
• Plasma polymerization 
• Plasma treatment  
• Plasma etching 
These are not mutually exclusive and can happen in unison and therefore this, 
overall, ends in a lack of control over the final product, which can present as a 
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disadvantage of the technique. However, at low enough power (wattages) and careful 
monitoring and planning, it is possible to control certain aspects of the plasma.  
Although wet chemical treatment of a surface can also induce a chemical 
modification within the surface, the undesirable effects of a wet chemical treatment 
include causing partial degradation and scissions of the polymers at the surface. This 
can lead to loss of mechanical strength of the overall bulk polymer and lead to faster 
degradation. Whereas plasma treatment has the ability to modify the surface of the 
polymer regardless of the geometrical configuration as well as being a solvent-free 
method and no toxic solvents are required to induce a chemical change. This 
chemical change allows the hydrophilicity to be induced onto the surface of a 
polymer and therefore encourage cytophilicity. 
There are many different ways to induce a state of plasma and one of the most 
common ways is to use a radio-frequency discharge. The plasma is excited and 
sustained by high-frequency electromagnetic waves. When the frequency of the 
electromagnetic wave is increased, the ions and the electrons can no longer reach the 
electrode surface during the acceleration phase of the exciting external field. This 
means that at these radiofrequencies, the interaction between power supply and the 
plasma generated are really displacement currents rather than actual currents. This 
adds the extra advantage that any impurities at the electrodes can be avoided.  
Theories have been produced to take into account the surface energy and the surface 
roughness when measuring the contact angle. The three main models are Young’s 
model, Wenzel’s model and Cassie-Baxter’s (CB) model(57).  
Young’s model is based on the contact of the sessile drop on a flat, homogenous, 
rigid and inert surface. Unfortunately, in reality, surfaces are not completely flat, 
rigid, homogenous and inert as assumed in this theory and therefore this may be a 
more simplistic way to look at contact angles.  
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Where cosθ0 is the contact angle and γSV, γSL and γLV represent surface-vapour, solid-
liquid and liquid-vapour interphase. 
Wenzel’s theory is described by the equation below: 
 
Where θW is the apparent contact angle which corresponds to the stable equilibrium 
state (Wenzel’s theory), r is the surface roughness ratio and θO is Young’s contact 
angle. This equation takes into account of the surface morphology and roughness on 
the contact angle. This assumes that the water penetrates into the grooves and 
irregularities of the surface structures.  
CB theory is based on the equation: 
 
Where θCB is the contact angle calculated by CB theory, rf is the roughness ratio of 
the wet surface area, f is the fraction of solid surface area wet by the liquid and θ0 is 
Young’s contact angle. This equation takes into account the surface morphology and 
roughness much like Wenzel’s theory but it assumes that water is unable to penetrate 
right into the grooves or irregularities of the surface structures and there are ‘air 
bubbles’ stuck inside these grooves.   
In theory, there is probably an intermediate state that exists between the Wenzel’s 
and CB theory.  
However, these theories help to understand the actual current state when the sessile 
drop lands on the surface of the material and the measurements are taken for the 
WCA. 
Polymers that do not possess polar groups or chemically reactive groups, have a low 
surface energy (and are therefore hydrophobic) with minimal polar contribution. 
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These polymers have been shown to have a higher affinity for platelets(58). Plasma-
assisted oxidations produced in low-pressure glow discharges ensures that all inert 
polymer surfaces can be oxidized easily (except for fluorinated polymers like PTFE), 
with well-controlled oxidation and no thermal exposure of polymers.  
Oxygen introduction by low-pressure plasma treatment is associated with the 
formation of O-polar groups, which is reflected in increasing of surface energy and 
its polar contribution. Using plasma oxidation treatment, chemical surface 
modification can be used to incorporate additional ‘-OH’ and ‘-COOH’ groups 
which has been seen to lower the WCA of the surface. This has been shown by 
previous groups to enhance hydrophilicity of the surface and therefore encouraging 
cytophilicity. The successful incorporation of these chemical groups can be easily 
checked by the measurement of contact angle. It is the polarity of these chemical 
groups that will increase the wettability of the surface and therefore allow cells to 
adhere to the surface of the polymer without damaging the bulk properties of the 
polymer.  
POSS-PCU has been developed as a polymeric scaffold for the main purpose of a 
vascular graft. Previous data has shown that POSS-PCU is a polymer which has been 
found to be biocompatible(39), anti-thrombogenic(59) and compliant(60), but with a 
surface which is does not endothelialise(39). This indicates that further surface 
optimization needs to be conducted so that it will also incorporate endothelialisation. 
Therefore, the idea is to modify the surface of the polymer without affecting the bulk 
properties using plasma treatment and rendering the surface of the polymer to 
become bioactive. It is hoped that the bioactive surface would be able to produce a 
surface which will encourage endothelialisation, in particular ‘self-
endothelialisation’ potential.  
The inherent chemical properties of POSS-PCU means that it is an inert polymer 
which has no polar groups on its surface when it is in its cast form. This means that 
there is low surface energy present and therefore the WCA measured indicate high 
hydrophobic measurements. Therefore, the introduction of oxygen using plasma 
treatment allows the introduction of O-polar groups and thereby lowering of the 
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WCA. It has been shown that cells are more adhesive on surfaces which are 
moderately hydrophilic rather than super-hydrophilic, and therefore the subsequent 
lowering of WCA will render the surface hydrophilic.    
 
Figure 4-1 Figure to show the step-wise effect of O2 plasma treatment on POSS-PCU polymer, 
a) and when O2 plasma is initially applied b), and when chemical groups start to form on the 
surface c). D) shows the chemical structure of the POSS-PCU polymer itself. 
This Chapter therefore has focused on testing whether the use of plasma-treatment 
would be an option of producing surfaces which can encourage this 
endothelialisation.    
4.2 Aims    
The aim of this Chapter is to: 
• Establish that the water contact angles of POSS-PCU can be lowered 
successfully using oxygen plasma treatment 
• Demonstrate that on altering the surface, the surface of POSS-PCU is now 
able to allow endothelial cells to adhere 
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4.3 Materials and Methods 
4.3.1 POSS-PCU Preparation 
Polycarbonate diol and transcyclohexanechlorohydrinisobutyl-POSS were added to a 
reaction vessel then heated to 130˚C while being stirred under nitrogen gas. The 
reactants were then cooled before 4, 40 -methylenebis(phenyl isocyanate) (MDI) was 
added and all components reacted for 30 minutes under nitrogen gas. 
This reaction then forms a pre-polymer before dimethylacetamide (DMAC) was 
added to convert this pre-polymer into a solution. This solution was then cooled 
before the chain extender, ethylenediamine, was added dropwise until the reaction 
was completed. The chain stopper, 1-butanol, was then used to prevent further 
unwanted polymerisation. All of the reagents were supplied by Sigma Aldrich 
(Dorset, UK) and used as provided with the exception of POSS, which was supplied 
by Hybrid Plastics Inc (Mississippi, USA). 
4.3.2 Control Polycarbonate Urea Urethane Preparation 
Dry polycarbonate polyol of 2000 molecular weight was placed in a 250ml reaction 
flask, equipped with a mechanical stirrer and nitrogen inlet. The polyol was heated to 
60°C and then flake MDI was added and reacted with the polyol, under nitrogen gas, 
at 70-80°C for 90 minutes in order to form a pre-polymer. Anhydrous 
Dimethyacetamide (DMAC) was then added slowly to the pre-polymer to form a 
solution; the solution is then cooled to 40°C. Chain extension of the pre-polymer was 
carried in a dropwise fashion with the addition of chain extenders, ethylenediamine 
and diethylamine in dry DMAC. After completion of the chain extension, 1-butanol 
in DMAC was added to the polymer solution. Again, all reagents were purchased 
from Sigma Aldrich (Dorset, UK) and used as supplied.  
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4.3.3 Plasma Treatment of POSS-PCU 
The polymer solution of POSS-PCU is aliquoted into eppendorfs and centrifuged at 
3000 rotations per minute (rpm) for 60 seconds. The top layer of the solution is then 
poured onto the different surfaces and placed in an oven at 65˚C for a minimum of 2 
hours so that the DMAC is able to evaporate leaving behind a thin film. These films 
are peeled off from the master surface. These films are plasma treated in a 
Cleanroom (James Watt Nanofabrication Centre, University of Glasgow) using a 
plasma cleaner (Gala Prep 5 Instrumente) using different power and times.  
The rest of the films are then sterilized in 70% Ethanol for 10 minutes and then 
washing with PBS for three times. These films are then cut into 1cm x 1cm squares 
and place in low adhesion 24 well plates (Corning).  
HUVECs are seeded at a seeding density of 1 x 105/ cm2 and these are then incubated 
for 5 days. The samples are then analysed using a variety of methods.  
4.3.4 Live/Dead Staining 
This method is to look at cell survival on the different treatments of the polymer. 
Live/Dead staining was undertaken using the Live/Dead Viability/ Cytotoxicity kit 
for mammalian cell (L-3224, Invitrogen) from Life Technologies. In short, calcein 
AM and ethidium homodimer-1 were made up to concentrations of 2 mM and 4 mM, 
respectively, using phosphate buffered saline (PBS). These solutions were incubated 
with the day 5 samples for 30 minutes at 37˚C, before washing samples with PBS 
then analysing with a fluorescence microscope (Zeiss Axiovert M200). 
4.3.5 Immunofluorescence 
Samples were fixed in 4% formaldehyde for 15 minutes at 37˚C then washed before 
placing in permeabilising buffer and blocking in 1% (w/v) bovine serum 
albumin/PBS. Samples were then stained with anti-vinculin antibody (1:150) 
(Sigma) in 1% (w/v) BSA/PBS or anti endothelial nitric oxide synthase (eNOS) 
antibody (1:50), in conjunction with rhodamine/phalloidin (1:500), and incubated at 
37˚C for 1 hour. Samples were subsequently washed 3 times for 5 minutes (0.5% 
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Tween-20 in PBS) and then the secondary antibody, which was biotinylated, was 
added (Vector Laboratories) at 1:50 in 1%(w/v) BSA/PBS. Samples were then 
incubated for 1 hour at 37˚C. After further washing, FITC-conjugated streptavidin 
(1:50, Vector Laboratories) was added and incubated for a further 30 minutes at 4 ˚C. 
Samples were given a final wash before mounting using Vectashield with DAPI 
nuclear stain (Vector Laboratories). 
4.3.6 Coomasie Blue Staining 
Day 5 samples were fixed using 4% formaldehyde then stained with Coomassie blue 
(0.2% Coomassie blue w/v in 46.5% methanol, 7% acetic acid, 46.5% water) for 2 
minutes. Samples were subsequently washed with de-ionised water before being 
visualised using optical microscopy. 
4.3.7 Cell Number Count 
Cell numbers were measured after 5 days of culture by taking fluorescence 
microscope images, at a magnification of x20, of cells stained with DAPI. Cell nuclei 
were counted as an indicator of cell number. Images were taken at random locations 
on the substrates; ten locations were imaged on each film, and a minimum of six 
films were assessed for each treatment type. 
4.3.8 In Cell Western 
In- Cell Western has been increasingly used in recent times over the more traditional 
Western Blot technique. ICW uses the near-infrared (NIR) fluorophore-conjugated 
antibodies and employ a similar technique to immunofluorescent methodology. NIR 
fluorophores extended the linear range of detection and potentially can improve 
sensitivity of detection(55).   
Cells are fixed using 4% formaldehyde and then placed in permeabilising buffer 
before blocked in 1% milk power/ PBS solution. Samples were then incubated with 
primary antibody (anti-eNOS or anti-P-mysoin) at a concentration of 1:50 for 2 hours 
at 37˚C. The samples are then washed and then a fluorescent-labelled secondary 
antibody at a concentration of 1:1000 is than added with Cell Stain (CellTag 700 
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Stain, Li-cor, Cambridge, UK) for normalisation. This is left at room temperature for 
1 hour on a shaker. The secondary antibody is than washed off. The samples are then 
analysed using Odyssey Sa (Li-Cor, Cambridge, UK) plate reader and the results 
were analysed.  
4.3.9 Statistical Analysis 
The statistical testing of the results from these experiments were conducted using the 
statistical program, Prism®.  
Statistical analyses were carried out on the data as follows; WCA data sets and cell 
number on the different substrates were compared using a Kruskal-Wallis one-way 
analysis of variance (non-parametric) test. In-Cell Western data used the Mann-
Whitney test to compare each topography individually with the other topographies.   
4.4 Results                                                           
4.4.1 Plasma Treatment 
Plasma treatment was conducted in a cleanroom (James Watt Nanofabrication 
Centre, University of Glasgow, UK). This was to ensure that the plasma treatment 
was conducted in an atmosphere which would discourage any impurities or 
unwanted deposition. It is important to point out here that the plasma cleaner used, 
required 2 vacuum ‘pump-downs’ to ensure that there are no impurities and also to 
make sure that the vacuum atmosphere activates the plasma. The first pump-down 
ensures that any atmospheric impurities are removed from the plasma treatment 
chamber and the second pump-down is to get the appropriate vacuum level to 
activate the plasma. This is an important consideration as previous experience has 
found that there was impure deposition on the polymer when the plasma was 
conducted under just one ‘pump-down’ and when the infiltration was of atmospheric 
air rather than pure oxygen.  
The results show that increasing power for a fixed period of time, led to the reduction 
of WCA in a step-wise predictable manner. However, this was not seen when 
treatment times were increased and this was thought to be related to the plasma 
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treatment power reaching a natural equilibrium with the surface chemistry and 
polymer chains.  
Therefore, it was decided that increasing power for a fixed period of time (60s) was 
adequate to allow for the step-wise decrease in WCA.  
 
 
Figure 4-2 Where a) is a simplified diagram to illustrate the concept of the plasma chamber and 
b) shows the step-wise drop in water contact angle (°) when increasing the power (watts) of the 
plasma treatment (inset: sessile water contact angle measurement) 
It was important at this point to check the degradability of the plasma treatment as 
the plasma treatment is not a permanent effect as the surface tends to revert back to 
its untreated state, an effect known as ‘aging.’ Establishing a rough baseline for this 
was important as this research project takes place over two institutions (University 
College London and University of Glasgow) and therefore substrates need to be 
transferred from one institution to the other and it should not have ‘aged’ during the 
transfer process.  
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Figure 4-3 This figure shows the consistent contact angles obtained d) over a seven-day period 
after plasma treatment and the different images of at Day 1 a), Day 5 b) and Day 7 c) showing 
that there are no changes of the contact angle and therefore no degradation in the initial 7 days 
post plasma treatment (n = 3) 
Over the period of 1 week since the plasma treatment there is no significant changes 
seen in the contact angles. This indicates that over the period of one week there is not 
much change to contact angles of the plasma treated surfaces and therefore these 
samples can keep for a minimum of one-week post-treatment without any significant 
changes in contact angle.  
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4.4.2 Live/ Dead Staining 
Live/Dead staining is a technique that allows visualization of cell survival on the 
POSS-PCU polymer. This experiment is used to confirm that the chemical surface 
modification of the bulk polymer has not caused the surface to be toxic to cells and 
detrimental to cell growth. This staining technique takes into account that 
characteristics for a live cell requires there to be a ubiquitous intracellular esterase 
activity and an intact cell membrane. The green-fluorescent calcein AM indicates 
intracellular esterase activity and the red-fluorescent ethidium homodimer-1 
indicates the lack of plasma membrane integrity. Therefore, these work in 
conjunction to produce a fluorescent image which shows the live (green) and dead 
(red) cells.   
 
 
 
It was seen that at all the plasma treatment levels there were minimal amounts of 
dead cells (red) and the majority of the cells appear to be highlighted green meaning 
that they are still alive. This indicates that overall plasma treatment, whichever the 
level of treatment, is not detrimental or toxic to endothelial cells. It should be noted 
that the cells show a similar morphology as that known for endothelial cells whereas 
the dead cells are rounded and lack any of the known endothelial morphology, 
however, it was also noticed that although the cells were highlighted in green (and 
therefore alive) there were a few more rounded cells seen in the lower treatment 
levels (40w at 60s). This was an indication that the cells were not as healthy as those 
that appeared more spread.      
a) b) c) 
Figure 4-4 Live/ Dead staining for the different plasma-treatment levels, where a) 40W at 60s, 
b) 60W at 60s and c) 80W at 60s. (Scale bar: 20 μm) This shows that the plasma treatment is 
not toxic to the endothelial cells and illustrates that despite the plasma treatment, 
biocompatibility of the POSS-PCU polymer is retained 
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However, it can be seen that on some of the surfaces there were more cells seen 
growing than on some of the other surfaces although it was not possible to quantify 
this and this is more of a qualitative result. This technique highlights that the 
chemical modifications of POSS-PCU do not affect the cytocompatibility of the 
POSS-PCU polymer.  
4.4.3 Coomasie Blue Staining 
Using Coomasie Blue as a cell-stain, the morphology of the HUVECs on the 
different plasma-treated POSS-PCU (40W at 60s, 60W at 60s and 80W at 60s) were 
examined under normal microscopy.  At the lower treatment levels (40W at 60s), the 
HUVECs look rounded, less well spread on the polymer and less in abundance, 
which was also noticed on the Live/Dead staining. This indicates that at these 
plasma-treatment levels, the surface chemistry is still not optimized for HUVEC 
adhesion. However, with the increasing plasma-treatment, it is possible to see that 
the HUVEC morphology starts to change by becoming more spread on the surface of 
the POSS-PCU and there are more of them in abundance. The higher plasma-
treatment allows more HUVEC adhesion and therefore coincides with a lower 
contact angle. Again, as this is not a quantitative measure but gives another 
qualitative result which also correlates with the Live/Dead staining. 
 
Figure 4-5 This figure shows the morphology of the HUVECs using Coomasie Blue staining on 
the POSS-PCU polymer post-plasma treatment of a) 40W for 60s, b) 60W for 60s and c) 80W 
for 60s and the increased spreading of the HUVEC cells with the increasing plasma treatments 
(Scale Bar: 20µm) 
4.4.4 Cell Number 
To estimate the number of cells proliferating on the surface of the plasma-modified 
POSS-PCU surface, a simple technique of highlighting the nucleus of the cell using 
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DAPI (4’6 diamidino-2-phenylindole) was used. DAPI is a well-known fluorescent 
stain that binds to the A-T rich region of DNA and therefore highlights the nuclei 
when viewed under fluorescent or confocal microscopy. As DAPI can pass through 
the nuclear membrane intact, it can be used as a ‘live’ or fixed cell stain, although the 
concentrations required for ‘live’ staining tend to be higher. 
 
 
Figure 4-6 Box plot showing cell numbers on plasma modified POSS-PCU films and unmodified 
POSS-PCU (0) and PCU films. Significant differences calculated using One-Way Anova are 
highlighted on the graph as follows: **** (p<.0001), *** (p<.001), ** (p<.01) 
  
The controls that were used act as a comparative marker were polycarbonate 
urethane (PCU) which is without essentially polycarbonate urea urethane without the 
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POSS nanoparticle. The plasma samples were also compared with untreated POSS-
PCU polymer to demonstrate the difference in cell number.  
As it was seen, progressive higher plasma treatments showed a corresponding 
increase in cell number on the polymer. This is of particular importance as it proves 
that plasma-treatment has a definite improvement in cell number compared over 
untreated POSS-PCU and also PCU.  Interestingly, there is statistical difference 
between all the plasma treatments except for 60W and 80W (for 60 seconds), 
indicating this may be the optimal treatment range.  
4.4.5 Immunofluorescence 
 
Figure 4-7 Immunofluorescence of the HUVECs again highlight the normal morphology of the 
cells on the different plasma-treated polymer where a) 40W for 60s, b) 60W for 60s and c) 80W 
for 60s, where actin is red, vinculin is green and the nuclei is blue. (Scale bar: 10μm) 
Immunofluorescence was conducted after 5 days of culture of HUVECs on the 
different plasma-treated POSS-PCU substrates. Immunofluorescence tagged one of 
the focal adhesion proteins, vinculin to look for signs of cell adhesion, as well as 
actin filaments and nuclei-staining.  
The results of this immunostaining show that although it is possible to see the 
intracellular vinculin being present, it is less apparent to see the actual formation of 
the focal adhesions at the periphery of the cell. Again, the HUVECs are seen to 
spread out more in the POSS-PCU substrates with the higher plasma-treatment 
levels, whereas at the lower treatment levels these are much more rounded in 
morphology.  
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4.4.6 In Cell Western 
The use of the newer technique named In-Cell Western (ICW) over the more 
traditional Western Blot analysis means that there is the ability of a high throughput 
analysis and an easily quantifiable methodology.  
 
 
Figure 4-8 This figure shows the use of In Cell Western (ICW) to quantify the amount of eNOS 
expression and the image on the left shows the near-infrared fluorophores tagged to eNOS 
(green channel) and the cell stain (red channel) and when it is merged. The intensity of this is 
then measured giving a quantifiable measurement on the different channels. ICW looks at 
quantifying the intensity of these fluorophores and therefore giving the graph on the right, 
where the eNOS expression is quantified on the different plasma-treated POSS-PCU polymer: * 
(p<0.05) (n = 4) 
 
These results looked at the expression of eNOS (endothelial nitric oxide synthase) 
which would indicate the function of the endothelial cells on the plasma treated 
POSS-PCU at the end of 5 days. These results show that on untreated planar POSS-
PCU there is really very little expression of eNOS but with increasing plasma 
treatments there is increased eNOS expression until it experiences a drop at the 
treatment level of 120W at 60s. This indicates that this might be the limit of the 
beneficial effects of the plasma treatment in terms of the expression of eNOS and 
therefore endothelial cells function.  
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Figure 4-9 This graph shows the P-myosin expression by the HUVECs on the different plasma 
treatments compared with planar untreated POSS-PCU surface. * p<0.05 (n = 4) 
 P-myosin expression by the endothelial cells was measured on the different plasma-
treated POSS-PCU surfaces after 5 days of cell culture. It was seen that there was 
only a significant difference in p-myosin expression when plasma-treatment levels 
reached 80W for 60s. However increased power in the plasma treatment levels only 
served to have a decreased in P-myosin expression levels, thereby indicating that the 
optimal plasma treatment level would be 80W for 60s.  
4.5 Discussion 
Plasma treatment is an established physical surface modification technique which has 
been used in changing the surface chemistry of materials. This technique allows the 
modification of the surface of the substrates without jeopardizing the bulk properties 
of the material. The addition of hydroxyl (-OH) and carboxyl (-COOH) using pure 
oxygen plasma is known to decrease the surface water contact angle. This is an 
added advantage as this renders the surface of the substrate more conducive to cell 
growth (increased cytophilicity). It has been shown that different cells on different 
substrates will require different optimal contact angles and although it is possible to 
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predict the range of contact angles which are required, it will require further testing 
to confirm this prediction as not all cells behave uniformly.  
A technical aspect of the plasma treatment is that the treatment itself needs to be 
conducted under vacuum and not under atmospheric pressure. This is due to the 
plasma discharge being more stable with the consequent plasma reactions being 
easier to control. This was even more evident during these experiments, as it was 
found that when a proper vacuum was not applied, the contact angles that were 
produced were not consistent. Plasma treatment of the substrates under atmospheric 
pressure would be a more desirable option as this means that there will be less 
technical equipment required, however practically, it was found that deposition of 
impurities was also problem when not conducted under a vacuum.  
Another technical aspect of the plasma treatment is that moisture of the substrate 
does increase the resistivity of the substrate to plasma treatment(61). This can be a 
problem to ensuring that the plasma treatment is effective. It has been described by 
Nissan(62, 63) the three potential ways in which moisture can affect plasma 
treatment: 
1. Low moisture content – means that the hydrogen bonds (H-bonds) can 
potentially dissociate individually into water molecules and then become absorbed 
into the structure of the polymer 
2. Intermediate moisture content – a number of H-bonds can break in a group at 
the same time as diffusion of additional water molecules. A H-bond breakage, due to 
the presence of other water molecules, has a knock-on effect on other neighbouring 
bonds to break simultaneously. 
3. High moisture content – the water molecules interact with one another and 
resulting in a high number of broken H-bonds.  
The molecular structure of the polymeric substrate can be altered, including the 
physical properties and therefore the plasma treatment can alter the substrate 
completely. Bearing this in mind and thinking about the fabrication of the coagulated 
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form of POSS-PCU (extrusion into water), it was thought that this form of POSS-
PCU would not be suitable for plasma treatment, especially plasma treatment in the 
most controllable form.  
Therefore, the cast polymeric version of POSS-PCU was chosen as the moisture can 
be evaporated away and dried in the oven, as compared with the coagulated form of 
POSS-PCU which is hygroscopic. This was an important consideration when 
choosing a version of POSS-PCU to undergo plasma treatment to test the different 
surface modification techniques. A consideration for fabrication of a future vascular 
graft would be that the luminal surface of the vascular would be laminated with the 
cast version of the POSS-PCU whereas the bulk of the graft would be made of the 
coagulated version of POSS-PCU. Although this may impact slightly on the 
compliance of the POSS-PCU.     
In this chapter, it can be seen that a step-wise lowering of contact angles can be seen 
with increasing levels of plasma treatment. This is a very important observation as it 
means that by using plasma treatment it is possible to lower the contact angle to a 
level in which a suitable biological response was seen. Furthermore, this shows that 
the use of plasma treatment conditions can elicit this controllable chemical 
modification in POSS-PCU polymer but without also changing the chemically toxic.   
HUVEC adhesion is noted on the plasma treated samples and it can be seen that with 
the increasing treatments there are more cells seen adhering to the polymer at the end 
of 5 days of incubation, especially compared to non-treated POSS-PCU surfaces and 
even just polycarbonate urea urethane (PCU) surfaces. This is encouraging as it 
means that there is a predictable effect when trying to improve HUVEC adhesion 
onto the POSS-PCU substrates especially in lowering the surface WCA. There is no 
statistical significance seen of the cell count at the plasma treatment levels of 60W 
and 80W at 60s and this is an indication that at these treatment levels, this lowers the 
WCA to a level in which cells are optimally adhered and proliferating.  
Increasing plasma-treatment has also shown a change in the cell morphology of the 
cells adhered to the surface of the POSS-PCU polymer. The HUVECs are seen to be 
spread out and become less rounded with increasing plasma-treatments indicating a 
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healthier cell morphology with these treatments. By the Live/Dead staining, this also 
indicates that the cells are healthy and that by altering the surface chemistry of the 
POSS-PCU polymer, there are no toxic effects rendered to the cells after 5 days of 
cell culture. This observation is crucial as changes to surface chemistry can also 
confer detrimental effects to the cells and therefore lead to cell death. This is also an 
important test of the biocompatibility nature of the chemical changes and indicates a 
safe environment for cells. These results are also correlated by those seen in the 
Coomasie Blue staining.  
Cell count using DAPI staining provided some interesting results. As mentioned 
previously, DAPI binds to the AT region of double-stranded DNA. When it is bound, 
DAPI has an absorption maximum at a wavelength of 358nm and its emission 
maximum is at 461nm which is blue. This means that when using fluorescence 
microscopy, it is possible to excite it using ultraviolet (UV) light. The cell count 
demonstrated that plasma treated POSS-PCU had beneficial effects over untreated 
POSS-PCU and even the control polymer of PCU. It also indicates that the optimal 
range of plasma treatment would be in the region of 60W at 60s and 80W at 60s.  
Disappointingly, the immunofluorescence does not indicate more focal adhesion 
formation and it is thought that although the cells are adhering to the surface, this 
may not be wholly adequate and requires another physical change in the surface 
environment to allow better adhesion. This is a crucial observation as it implies that 
when under haemodynamic flow, the cells would not be able to survive and any cell 
sheets would ultimately delaminate especially under the pressures in normal arterial 
flow. Delamination of an endothelial cell sheet, when normal haemodynamic 
pressures are applied, is a crucial problem discovered by many researchers in the 
1980’s and early 1990’s, leading to more crucial examination of cellular adhesion 
properties under static conditions prior to application of haemodynamic pressures as 
a test of the original theories. Untreated PTFE and Dacron® vascular grafts after 24 
hours under flow conditions have been found to have only 4%(64) and 3.4%(65) 
respectively, of seeded cells remaining on the original graft. This is obviously an 
important consideration and under static conditions, it is thought that cell adhesion 
should be optimized prior to testing under normal haemodynamic flow.  
 109 
In Cell Western (ICW) results looking at the function of the HUVECs on the treated 
POSS-PCU surfaces compared with the untreated POSS-PCU surfaces have shown 
that function is maintained. Expression of eNOS is an important indicator of 
HUVEC function. Functional eNOS is found to be primarily associated with the 
plasma membrane and is highly regulated by multiple extracellular stimuli and the 
nitric oxide (NO) that is produced is a labile, cytotoxic messenger molecule with 
primarily paracrine function. However, the detection of the presence of eNOS is a 
sensitive indicator of function of the HUVECs on the POSS-PCU polymer. This is 
importance as there is the potential for the HUVECs to enter into a senescent phase. 
NO is produced from the conversion of L-arginine to L-citrulline by eNOS. In 
endothelial cells, the isoform that exists is responsible for endothelium-derived NO 
production. Under certain conditions, human endothelial cells enter senescent, with 
eNOS activity being reduced in the process(66). The results show that this is not an 
issue and function of the HUVECs are maintained despite the chemical changes of 
the surface.  
The ICW results have also shown an interesting pattern of results and even at higher 
plasma treatments, beyond the original boundary of 80W for 60s, it was seen that for 
endothelial function, 100W for 60s, might be the optimal plasma treatment level for 
the expression of eNOS, especially since a sharp drop is seen at 120W for 60s. This 
is in slight conflict with the cell count results which suggest that the optimal plasma 
treatment level might actually be in the range of 60-80W for 60s. It is thought that a 
fine balance has to be reached for further evaluation of this plasma treatment level 
and whether it is the treatment effect at this level or whether it is the consistent CA 
level reached. This is because the power levels on different plasma cleaners can also 
be another variable in the experiment (ie. plasma treatment levels can vary between 
different plasma machines). 
Overall the process of ICW, it was found to give quantitative results which is a 
benefit over the more traditional Western Blot technique which is considered to only 
produce semi-quantitative assay results(67). The use of ICW gives high throughput 
quantitative results and does not require the labour-intensive and technically 
demanding steps of the more traditional Western Blot.   
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Therefore, this technique was also employed to investigate the presence of P-myosin 
expression by the HUVECs on the different plasma treatments of POSS-PCU. Non-
muscle myosin II (NMII) is essentially comprised of 3 pairs of peptides(68). These 
are two heavy chains of 230kDa, two 20kDa regulatory light chains (RLCs) that 
regulate NMII activity and two further 17kDa essentially known as light chains 
(ELCs) that work to stabilize the light chain structures. NMII is important as it is 
known to be fundamental in processes such as cell adhesion, cell migration and cell 
division. NMII uses actin-cross linkage and contractile functions for these purposes. 
The active form of NMII is usually expressed as the phosphorylated form, and the 
phosphorylated version of this abbreviated P-myosin. The phosphorylation of NMII 
is a complex subject and involves a number of different kinases which initiate this 
process, which is beyond the scope of this PhD. 
As NMII regulates cell adhesion and also polarity in cell migration by dynamic 
remodeling of the actin cytoskeleton and the environmental interaction. In particular, 
NMII is essential for the assembly and disassembly of nascent adhesions inside the 
lamillipodium. There is an important integrin-actin linkage which translates the 
effect of NMII to adhesions and will mediate adhesion formation and maturation. 
This means that in the activated form NMII plays an essential role in mediating cell 
adhesion and therefore the investigation of P-myosin (the activated form of NMII) 
would give a useful direct indication of cell adhesion on the substrate. Interestingly 
again the results support that that at treatment levels of 80W for 60s, the presence of 
P-myosin is at the maximal and any further plasma treatment seems to have a 
negative effect on this. This is interesting as it supports that cell count is the highest 
at this treatment level as well.    
Consistently over the experiments conducted in this Chapter, it has been shown that 
the unmodified POSS-PCU has performed significantly worse than the plasma-
modified POSS-PCU. Interestingly, the results have also shown that the optimal 
range for treatment appears to be around 80W for 60s on the POSS-PCU polymer. 
This treatment level appears to maintain endothelial cell proliferation, cell adhesion 
and function under all the investigated parameters. This important finding indicates 
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that this would be an acceptable plasma treatment level for the POSS-PCU polymer 
to create a surface which is conducive to endothelial cell adhesion.   
These results are a vast improvement over that of untreated POSS-PCU in an in vitro 
setting and potentially also in an in vivo setting as seen in the sheep model(39) where 
no endothelialisation was seen at the end of the 9-month implantation period. This is 
an important consideration as it shows, in this chapter, that the use of plasma 
treatment is already part of the way to producing a biologically active surface 
although further work is required for further optimization of this. This is an 
important step into producing a POSS-nanocomposite polymer with a bioactive 
surface and proving that this physical method of surface modification, plasma 
treatment, is an essential methodology for this. However, although the results do 
show that plasma treatment is an essential first step in producing a surface in which 
endothelial cells are able to adhere and grow on and maintain their function, these 
results also show that perhaps further surface modification is required to further 
optimize HUVEC adhesion on the plasma treated POSS-PCU surfaces. 
 
4.6 Conclusion 
This Chapter has shown that it is possible to change the surface chemistry of the 
POSS-PCU polymer in a controlled manner to a contact angle which is conducive to 
cell, especially HUVEC growth. There is no toxicity of the POSS-PCU chemical 
changes to the cells, indicating that the chemical changes don’t affect the 
biocompatible nature of the polymer. The function of the HUVECs are maintained 
through expression of eNOS. Optimal treatment levels have been indicated to be 60-
80W for 60s although slightly higher treatment levels (100W at 60s) have also been 
seen to not impair the function of the HUVECs. Plasma treatment is indeed a viable 
option into surface modification of POSS-PCU without changing the bulk properties 
of the polymer. The ability to confirm this biologically active surface is an important 
finding towards creating POSS-PCU surfaces with bioactive surfaces especially in 
which self-endothelialisation is possible   
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However, although there is P-myosin expression, with an optimal plasma treatment 
level at 80W for 60s, it would appear that expression of vinculin is not detected as 
strongly on the immunofluorescence and begs the question of whether the cells are 
not as strongly adhered to the surfaces as we would have liked.  
4.7 Further Work 
Despite the first step in this work as being a positive finding in that POSS-PCU 
surfaces can be made bioactive, further optimization is still required. As cell 
adhesion has not been seen to be as evident due to the lack of focal adhesion 
formation found in the immunofluorescence, it has been suggested that a further 
physical factor might come into play which may also allow the formation of focal 
adhesion machinery. This other physical factor that is also known to have an effect is 
surface topography, and comes into a synergistic relationship with surface 
chemistry(42, 69). In vitro, many studies have shown that endogenous proteins are 
the first to be rapidly adsorbed onto the surface of a material, and it is these proteins 
which provide the structural framework on which further cell adhesion can begin. 
This effect has been extensively studied since the 1960s by Vroman(70) (and hence 
this is dubbed ‘Vroman’s effect’). The Vroman’s effect is also dependent on surface 
chemistry as well as topography(71). This shows that surface topography probably 
will need to work synergistically with surface chemistry to enhance cell adhesion and 
growth.  
Recent studies have shown that cells are responsive to micro and nanoscale 
topography. Harrison(72) in 1911 noted that cells were able to align themselves 
according to surface topography. However, until recent technological advances, the 
ability to study cell behavior on surface topography has not been possible. However, 
as we have seen in this chapter that surface chemical modification is possible but 
there may be extra factors which may contribute to cellular adhesion and this may be 
surface topography. Further work will concentrate on adding controlled surface 
topography to the plasma treated surface of POSS-PCU. In combination, it is hoped 
that this will provide both further cell adhesion and proliferative surfaces. 
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Chapter 5 Surface modulation of POSS-PCU: Surface topography 
5.1 Introduction 
The development and research of vascular grafts have driven many researchers to 
either improve on current materials in clinical use (such as PTFE and Dacron®) or to 
develop new materials. The investigation of POSS-PCU as a potential novel vascular 
graft material has shown some very promising results. The mechanical and 
compliance properties of the material is shown to be similar to native vessel when 
compared with PTFE(60). Unfortunately, this material does not endothelialise and 
this has both been confirmed in both in vitro(73) and in vivo(39) experiments. 
Therefore, the ability to retain the beneficial bulk properties of POSS-PCU but still 
allowing the fine-tuning of the luminal surface of the vascular graft, produces a 
desirable aspect of research.  
In the last Chapter, the experiments have shown that plasma treatment does have a 
positive effect on endothelial cell adhesion and function on the surface-modified 
POSS-PCU. However, it is not certain that this is the complete solution as ‘strong’ 
endothelial cell adhesion is still questionable, due to the lack of vinculin seen 
forming as ‘localised’ focal adhesions on the immunofluorescence images. This 
raises the question of the adequacy of the endothelial cell adhesion. Therefore, it is 
concluded that other physical factors must come into play and that altering surface 
hydrophilicity (through chemistry) alone was not enough. Another physical factor 
that would play a synergistic role with surface chemistry would be surface 
topography.   
Harrison first noticed in 1919 that cells were adaptive to surface topographical 
features(72). This was an interesting observation but unfortunately research on it has 
since come to a standstill from then to only recently due to the lack of technological 
advance allowing the creation of surface topographical features in which to study the 
cells on the topography. From the moment, Richard Feynman(74) mentioned that 
‘there was plenty of room at the bottom’ in his infamous speech to Drexler coining 
the term of ‘nanotechnology’, this has meant that the scientific research has allowed 
fine-precision tuning to the nanoscale.  
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Cells have been seen to react with surface topography both in the micro- and 
nanoscale and both will have an impact on cell behaviour. It is thought that the cell 
as a whole is more likely to react to topography in the microscale but nano-sized 
topographies will have further impact on entities which are in the same size, namely 
cell receptors. Topography provides a biomimetic physical-cue to cells which is 
similarly found on the topography-rich surfaces of basement membranes found in 
vivo(75). Cells in vivo are known to reside on surfaces with physical cues (and not 
just flat surfaces) and this has been observed. These cues come in the form of pillars, 
pits, fibres, channels, pores, etc. and can be uniformly or randomly textured.  
However technological advances in the semiconductor industry has meant that 
surface features can be created in the micro- and nanoscale and used to study the 
biological responses to it. Although, it is not possible to create all the complex 
intricacies of what is in vivo, it is possible to create surfaces with simple repetitive 
features and therefore study cellular behaviour on these features.  This has led to a 
flurry of research activity to investigate the extent in which surface topography can 
be used to control and modify cell behaviour.  
5.1.1 Fabrication Techniques 
There have been many different fabrication techniques which have been adopted to 
develop features in the micro- and nanoscale. Lithographic techniques have been 
mainly used due to the reproducibility and the high-precision of the features which 
are created. This Chapter will focus on the fabrication techniques which are relevant 
to this PhD. In this PhD, the most used fabrication technique has been lithographic 
techniques to create micro- and nanostructures for our experiments. 
Lithography is essentially a technique which is used in the transfer of a pattern onto a 
substrate by means of an etching process(76). Resist lithography makes use of an 
irradiation source on which a photosensitive polymer material (photoresist) is utilised 
to perform the pattern transfer. The process starts with coating a substrate (usually a 
silicon wafer) with the photoresist in liquid form. This is ‘soft-baked’ at a low 
enough temperature to evaporate the solvent off which is in the photoresist but not 
high enough to cause other chemical reactions, and in addition this helps improve 
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resist-substrate adhesion. This photoresist can then be exposed to a variety of light 
sources (i.e. Ultraviolet (UV) light, X-rays, electron-beam) depending on the 
lithographic method. Exposure to this light source initiates a photochemical process 
in which the resist will alter the physical and chemical properties of the exposed 
areas for differentiation into a subsequent image development process. The solubility 
of the subsequent film can be modified such as increasing the solubility of the 
exposed areas (yielding a positive image post-development) or decreasing the 
solubility to yield a negative tone image. Post-development, surfaces with negative 
tone images can be ‘hard baked’ to further strengthen the cross-linking process and 
improve mechanical stability of the patterns. 
Standard photolithography uses a mask for its patterning potential but there are 
limitations to the resolution of the feature sizes that can be produced. Although it is 
possible to make submicron features and there have been many published techniques 
which have illustrated this, these techniques are pushing the boundaries of the 
technique and may not be reproducible from laboratory to laboratory. For example, it 
is possible to use extreme UV light (wavelengths from 124nm to 10nm) and X-rays 
(wavelengths from 10nm to 0.01nm) as the light source as the feature size possible is 
correlated by the wavelength of the source. However, conventional lenses are not 
transparent to extreme UV and are unable to focus X-rays and the energies of these 
radiations will damage most materials used in masks and lenses(77).   
Therefore, for sub-micron features, it was more desirable to use lithography 
techniques based on focused beams such as e-beam lithography (EBL) and focused 
ion beam (FIB). EBL uses a focused beam of electrons directly onto the photoresist 
to produce patterns. It is possible to produce feature sizes down to 10nm and even 
lower, using both EBL and FIB. However, the throughput of EBL can be limited and 
the costs to produce small areas of patterns can be very high. A further drawback of 
EBL is the proximity effect caused by the scattering of the electrons in the resist. 
This backscattering impacts on the final resolution and contrast of the features 
produced(78). Although FIB is also a possibility for producing patterns and they 
have the potential of producing thin films (such as epitaxial films) and metal organic 
chemical-vapour deposition and sputter deposition, there are unfortunately 
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disadvantages to the technique. The process of milling and imaging can cause direct 
damage to the material and there is concern that doping with Gallium ions can also 
add to this damage. Unfortunately, this damage makes this technique unsuitable to 
development of biomedical devices which require more local biological effects, such 
as endothelialisation, to take place and such entities would be sensitive to surface 
damage. There is concern that with FIB being a maskless technique, direct-write 
using the high-energy beam onto the surface can potentially damage the surface 
releasing toxic elements which can also affect cell growth.       
This forms the basis of many lithographic techniques on which subsequent 
improvements have been made to produce the smallest feature sizes possible. 
Photoresists themselves play an important part of the lithographic process and in the 
manufacture of biomedical devices, this is an important consideration as the 
photoresists themselves have to be non-toxic.  There are a number of photoresists 
available for this purpose, for use under conditions which require a biocompatible 
and non-toxic photoresist. Photoresists such as SU-8 have been deemed to fulfil 
these requirements and therefore have been used for this purpose.  
5.1.2 ‘Disordered’ and ‘Ordered’ Surface Topography 
Since the fabrication techniques can be utilised to produce a wide range of 
topographies, two types of topographical design differences must be established. 
This is mainly ‘ordered’ and ‘disordered’ surface topography.  
Disordered topography can be easily fabricated with techniques such as 
electrospinning(37) or polymer de-mixing(41). With advancements in 
electrospinning, this has meant that fibres can be produced in both the micro- and 
nanoscale. The use of electrospinning in the fabrication of vascular grafts have 
proven to be a very popular fabrication technique in the recent years. Electrospinning 
allows a facile fabrication in which surface topography can be produced on the 
luminal surface of the vascular graft. The capability of the technique has meant that a 
variety of polymers can be used for the task, ranging from synthetic to non-synthetic. 
The fibres that are produced can be used to create a variety of nano/ micron-sized 
pores to allow tissue integration and also mechanical and biological properties of the 
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vascular graft can be fine-tuned by varying the composition of the mixture or the size 
of the fibres being produced(79). This technique also benefits from being a high-
throughput manufacturing process and therefore these benefits have made it a 
process which a lot of research focus has been. However, one of the main 
disadvantages of such a technique is the non-consistent reproducibility of the 
technique, namely no two grafts will be identical meaning that exact mechanical and 
biological properties will vary. The cell seeding that is required, post scaffold 
production, also means that this will limit the use of such scaffolds in an ‘off the 
shelf’ or emergency setting. Despite the ability to control the porosity of the 
scaffolds to allow for cell integration, many studies have shown that in 
electrospinning this is still a difficulty.  
Ordered topography can be created with precision by techniques, as mentioned 
above, such as photolithography and electron beam lithography. These techniques 
allow a more controlled fabrication methodology to creating the surface topography. 
If these vascular grafts were to be manufactured commercially, this would make 
things easier for quality control as the predictability of each graft can be ensured.  
In theory, due to the ability of such topography being able to elicit a cellular 
response, it is therefore possible to produce a surface topography in which the 
vascular graft could have ‘self-endothelialisation’ potential post-implantation. This 
would allow these vascular grafts to be used in an ‘off the shelf’ setting.  
5.1.3 Cell Engineering 
With the advances of the lithographic techniques, this has allowed the study of cell 
behaviour on various topographies. Surface topography has mainly been fabricated 
in two-dimension (2D) but with newer techniques of fabrication such as two-photon 
polymerisation(80), fabrication techniques have also developed into 3D culture.   
For biological applications, the requirements of the topographies(81) are that they 
should be the following: 
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• Occur over a large surface area so that the results are repeatable and also 
‘patterning’ of medical devices will require high throughput production than 
currently conducted in some techniques 
• Easily accessible and low-cost so that the production of the patterns is not 
limited to specialised equipment 
• Reproducible patterns so that there is a consistency in the results that are 
produced time and time again 
Endothelial cells, like many other cell types, react to biophysical cues from the tissue 
microenvironment and these modulate cell function on a different level from 
biochemical cues. With a particular focus on vascular endothelial cells, these cells 
reside in the basement membrane, which is a specialised extracellular matrix (ECM) 
providing complex 3D biophysical cues to the endothelial cells. These cues can be in 
the submicron (100-1000nm) and nanoscale (1-100nm) range and therefore being 
able to provide these cues can provide an interesting dimension to the research. 
One topography of interest, and on which this Chapter will be focused on, is known 
as the NSQ (Near Square). This is an interesting topography which is essentially 
nanopits with diameter of 120nm, 100nm deep with an average of 300nm centre-to-
centre spacing but slightly displaced with an offset of ±50nm. The reason for the 
interest is that NSQ has been found to push mesenchymal stem cells (MSCs) to 
differentiate into an osteogenic lineage when cultured on this topography(42). 
Interestingly when compared with a more ordered topography this is not seen, 
suggesting that the role that topography plays is essential in determining the lineage 
of stem cells.  
There is further suggestion that cell adhesion may be promoted on this NSQ 
topography creating large focal adhesions, which forms a part of the differentiation 
process(82, 83). However, although the importance of the role of the NSQ 
topography has been investigated for MSCs, this has not been fully explored for 
HUVECs. The NSQ topography will therefore form an important part of this 
Chapter. It is postulated that the large focal adhesions which NSQ can cause the cells 
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to form, can help endothelial cells to adopt a similar morphology and encourage 
better adhesion to the substrate, allowing the endothelial cells to withstand pressures 
and stresses that are seen in the vascular vessels.  
In addition to this, micro-topography has also been a focus of study and it is not sure 
which scale of topography would have a good effect on endothelial cell adhesion. 
Previous work has suggested that endothelial cells response to micro-topography 
especially grooves and are able to align themselves onto the grooves.     
Cell Type Substrate Pattern Dimensions 
and Pitch 
Static/ 
Shear 
Flow 
Culture? 
Description Year/ 
Ref 
Human 
microvascular 
endothelial 
cells (HMECs) 
Type I 
Collagen 
films 
Microgrooves Parallel 
channels with 
groove and 
ridge widths of 
650nm with 
300nm depth, 
500nm with 
250nm depth 
and 332.5nm 
with 200nm 
depth 
Shear flow Cell culture 
studies show that 
nanopattern did 
not affect 
endothelial cell 
proliferation and 
had minimal 
effect on cell 
alignment but 
significantly 
enhances cell 
retention under 
flow-shear 
conditions. 
2009(40) 
Bovine aortic 
endothelial 
cells (BAECs) 
PDMS Microgrooves Symmetric 
patterns: 5x5, 
3x3, 2x2 
Asymmetric 
patterns: 5x2. 
Widths of 
ridges and 
channels 5 and 
2µm. 
Separation 
500µm 
Shear flow Width dimension 
of 3D 
microgroove 
guides direction 
of endothelial 
cell migration in 
absence of flow. 
Critical groove 
width for cell 
migration is 
2µm. 
Microgrooves 
guide orientation 
of actin stress 
2008(84) 
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fibres parallel to 
grooves after 
exposure to flow 
(moderate and 
high shear) for at 
least 4 hours. 
 
BAECs Micro-
patterned 
ECM by 
injection of 
collagen 1 
into PDMS 
mold 
Microchannels Width 15, 30 
and 60µm  
Static ECs on 15µm 
collagen strips 
had 30% less 
adhesion area 
and lower shape 
index, had fewer 
but polarised 
focal adhesions 
and migrated 
faster.  
2001(85) 
Figure 5-1 Table to show a selection of publications in which grooves have been used to identify 
in both static and shear flow conditions and a brief description of the findings. [Adapted from 
Table 2 in (37)] 
Endothelial cells in the presence of either microgrooves or channels tend to induce 
cell alignment along the grooves, however recent published results on this have 
shown conflicting results in the exact dimensions of microgrooves which induce a 
consistent cell alignment. This is likely due to a non-consistent use of cell type, or 
substrate and therefore consistent results cannot be extrapolated. However, because 
of this discrepancy in the results, individual results using a consistent cell type and 
substrate would probably elucidate a more consistent conclusion. 
In addition to this, microgrooves have also been seen to promote endothelial cell 
migration by giving the cells ‘contact guidance’. This would have an additional 
beneficial effect when designing the luminal surface of vascular grafts as this would 
potentially encourage the inward migration of endothelial cells from neighbouring 
native vessel. Prior to the use of topography, there has been other interest in using 
different methodologies of in situ endothelialisation, however, as Professor Zilla 
pointed out, there has only ever been 1-2cm inward growth of endothelium and 
therefore this technique was largely abandoned(86). However, the possibility of 
using ‘contact guidance’ by designing the surface with topographical cues on the 
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luminal surface of the vascular grafts offers an alternative methodology and merits 
further investigation.  
Thus with this in mind, in this Chapter, endothelial cell behaviour on topographical 
cues will be observed and analysed. 
5.2 Aims and Hypothesis 
The aims of this Chapter is to investigate the addition of surface topography in both 
the micro- and nanoscale onto the POSS-PCU polymer. The aims of this Chapter: 
• Show that both micro- and nanoscale patterns can be replicated in POSS-
PCU polymer with high fidelity 
• The patterns do not cause any detrimental effect on biological cells 
• These patterns in synergy with plasma treatment can provide a more 
biologically active surface than just with plasma treatment alone 
5.3 Materials and Methods 
5.3.1 Photolithography and Electron Beam Lithography 
These processes were conducted in a Cleanroom at the James Watt Nanofabrication 
Centre (JWNC) at the University of Glasgow, United Kingdom.  
Photolithography was conducted according to previous published methods. The 
technique was used to produce microscale grooves of 12.5µm wide grooves with 
25µm pitch and 700nm groove depths.   
Electron-beam lithography was conducted, again, as per previously published 
methods(87). The master substrate was fabricated using EBL (Vistec VB6 UHR 
EWF Electron Beam Lithography Tool) to form arrays of 120nm diameter pits of 
100nm depth and 300nm pitch in a square arrangement with an offset with a random 
displacement of ±50nm.    
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Both substrates produced from the two techniques were then treated by reactive ion-
etching to produce the intended features. These techniques have been briefly 
described in Chapter 2 (Materials and Methods).  
These substrates were kindly produced by the post-doctoral research associates and 
technicians under the guidance of Professor Nikolaj Gadegaard at the JWNC. 
5.3.2 Soft Lithography 
The shims that were generated by both EBL and photolithography were used as the 
substrates for soft lithography for pattern transfer. This involves placing the POSS-
PCU polymeric solution on to the substrates and then placing in an oven set at 60°C 
for a minimum of 2 hours, until all the DMAC solvent has been evaporated off. The 
polymer films are then allowed to cool before peeling off from the substrate.  
5.3.3 Plasma Treatment and Contact-Angle Measurement 
The POSS-PCU films were then plasma-treated in a barrel-type plasma asher 
(Plasma Prep 5 GaLa Instrumente) with pure O2 at different powers for different time 
points. This was conducted under Cleanroom conditions at the JWNC to lower the 
risk of deposition of any other impurities on the substrate as previously found. Post-
treatment with plasma, contact angles were measured to check the effectiveness of 
the treatment. This was conducted with an in-house built apparatus.   
5.3.4 Scanning Electron Microscope (SEM) and Atomic Force Microscopy 
(AFM) 
The POSS-PCU films were sputter-coated with gold at a thickness of 2nm before 
being visualised with a SEM, a Carl Zeiss Sigma Variable Pressure Analytical SEM 
with Oxford Microanalysis (Germany). This was conducted to check the fidelity of 
the replication of the patterns on the POSS-PCU films.   
The POSS-PCU samples were stuck onto glass-slides with super-glue for analysis 
with AFM (JPK Nanowizard 3). This was again conducted to check the replication 
fidelity of the replication of the patterns on the substrate and to check the roughness 
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of the surface. Surface analysis was conducted using Data Processing Software from 
JPK. This includes the calculation of roughness values (RMS). RMS is defined as the 
standard deviation of the elevation, z values, within the given area is calculated from 
the following equation: 
 
Where zave is the average of the z values within the given area, z, is the z value for a 
given point, and N is the number of points within the given area(88). This equation 
can be converted using AFM-associated software so that RMS values can be 
generated. 
    
5.3.5 4’,6-diamidino-2-phenylindole (DAPI) Cell Count 
Cell numbers were measured after 5 days of culture. The cells were then fixed in 4% 
formaldehyde for 15 minutes at 37°C and then washed in PBS. DAPI (Vectoshield 
DAPI, Vector Laboratories) were placed, as per instructions on the substrates. Using 
fluorescence microscopy (Zeiss Axiovert M200), ten randomly selected images were 
taken at 10 different locations of each of the films at a magnification of x20, of cells 
stained with DAPI. Cell nuclei was counted as an indication of cell number. A 
minimum of 4 films were assessed for each treatment and topography.  
5.3.6 Coomasie Blue Staining 
The samples were after 5 days of culture and then fixed using 4% formaldehyde 
before Coomasie Blue (0.2% Coomasie Blue w/v in 46.8% methanol, 7% acetic acid, 
46.5% water) was added for 2 minutes. This is then removed and the samples are 
then washed with de-ionised water and dried before visualising with an optical 
microscope.  
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5.3.7 Immunofluorescence of the HUVECs on the POSS-PCU Films 
Day 5 samples were fixed in 4% formaldehyde for 15 minutes at 37°C and then 
washed before placing in a permeabilising buffer and then blocking with 1% (w/v) 
bovine serum albumin/ PBS mixture. Samples were then stained with anti-vinculin 
antibody (1:150) (Sigma) in 1% (w/v) BSA/PBS or anti-endothelial nitric oxide 
synthase (eNOS) antibody (1:50), in conjunction with rhodamine/ phalloidin (1:500), 
and incubated at 37°C for 1 hour. Samples were subsequently washed for 3 times at 
5 minutes each (0.5% Tween-20 in PBS) and then the secondary antibody, which is 
biotinylated, is added (Vector Laboratories) at 1:50 in 1% (w/v) BSA/PBS. Samples 
were then incubated for 1 hour at 37°C. After further washing, FITC-conjugated 
streptavidin (1:50, Vector Laboratories) was added and incubated for a further 30 
minutes at 4°C. Samples were given a final wash before mounting using Vectashield 
with DAPI nuclear stain (Vector Laboratories). Samples were then imaged using a 
fluorescence microscope (Zeiss Axiovert M200).   
5.3.8 In-Cell Western for eNOS and P-myosin of HUVECs on the POSS-PCU 
Films  
Once again at the appropriate time-point of cell culture, the cells on the POSS-PCU 
films are firstly fixed in 4% formaldehyde at 3°7C for 5 minutes. The cells are then 
placed in a permeabilisation buffer at 4°C for 5 minutes, before being blocked (milk 
powder/ PBS) for 1 hour at room temperature. The primary antibody is then added at 
a concentration of 1:50 (anti-eNOS and anti-P-myosin) and incubated at 37°C for 2 
hours. These are then washed with 0.1% Tween/ PBS and then fluorescent-labelled 
secondary antibody (Licor, Cambridge, UK) at a concentration of 1:1000 with also 
CellStain (CellTag 700 Stain, Licor, Cambridge, UK) at a concentration of 1:500, 
and then left at room temperature for 1 hour. The secondary antibody is then 
removed and the films washed using 0.1% Tween/PBS. The results are then analysed 
using an automatable infrared imager with a 2-channel imaging system (Odyssey Sa, 
Licor, Cambridge, UK). 
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5.3.9 Statistical Analysis 
Statistical Analysis of the results were conducted using Prism (GraphPad Software, 
La Jolla, USA).  
The statistical tests that were conducted were as follows: roughness values between 
sample types were compared using Mann-Whitney (non-parametric) tests, 
differences in cell number between samples (both plasma treated planar substrates 
and topographically altered substrates) were compared using Kruskal-Wallis (non-
parametric) tests. 
 
5.4 Results 
The results in the previous Chapter has shown that plasma treatment is able to lower 
the contact angle of the POSS-PCU in a step-wise fashion. This Chapter looks at 
whether surface topography and chemistry can synergistically encourage endothelial 
cell growth.  
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5.4.1 Replication Fidelity 
 
Figure 5-2 A) This figure shows scanning electron microscopy images of planar, microgroove 
and nanopit POSS-PCU surfaces before plasma treatment, insets show higher magnification 
images of the topographies; nanopit inset was imaged after plasma treatment for 60s at 80W. B) 
AFM scans of planar (upper two images) and nanopit (lower two images) POSS-PCU films 
before (left hand side images) and after (right hand side images) plasma treatment. C) Box-plot 
showing roughness values of planar and nanopit POSS-PCU films. 
 
It is possible to see that using soft lithography, the replication fidelity of the patterns 
is intact and this can be confirmed on both AFM and SEM. Visually it is possible to 
see that on SEM that the microgrooves and nanopits features have been retained. As 
there is a great concern that at high plasma treatments, there is a possibility that 
nanopatterns would be destroyed due to the high energy bombardment of the 
molecules on the surface of the polymer, AFM was used to measure roughness 
values (RMS). There is no statistical significant difference between pre- and post-
treatment with plasma. This means that the current highest level treatment of plasma 
at 80W for 60s is safe even in the presence of nanopatterns, or in our case, the 
nanopits. In addition, again, it is possible to see again the POSS aggregations on the 
surface of the films. It is decided as this is an inherent part of the POSS-PCU 
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polymer itself, it was not anything that can be changed but as both the micro- and 
nanofeatures are easily discernible between the aggregates, it was deemed that these 
aggregations would not disrupt the effect on the cell by the surface topography. As 
this is an inherent property of the POSS-PCU polymer, it is assumed that the 
distribution of POSS aggregates will be the same throughout the polymer and will 
not be affected by the treatment.  
5.4.2 DAPI Cell Count and Coomasie Blue 
The DAPI cell count has shown that the optimal plasma treatment level (80W for 
60s) has no significant effect on the number of cells after 5 days of cell culture on the 
different topographies, namely planar, nanopit (NP) and microgroove (MG). This 
experiment was repeat three times.  
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Figure 5-3  This figure recaps from the previous chapter about the cell number (a) and from 
this original graph, it can be seen that plasma treatment levels of 80W for 60S has the highest 
cell count and extrapolating this treatment level as the optimal treatment, cells were cultured on 
the different topographies using this plasma treatment (b) with no significance differences found 
(p>0.05). C) Upper image shows a scan of Coomasie Blue staining on the different topographies 
and the lower is a fluorescent image is Live/Dead staining (green = Live, red = Dead) of cells on 
a nanopit substrate with plasma treatment (80W for 60s). (n = 4)  
Coomasie Blue results show that after 5-day culture patchy endothelial cell growth 
can be seen. Live/Dead staining also indicates that the cells are still alive on the 
topographies. These results suggest that these surface topographies do not have any 
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detrimental effect on the on cell growth and proliferation and there is evidence of 
‘patchy’ endothelialisation after 5 days of cell culture.  
5.4.3 Immunofluorescence of HUVECs of POSS-PCU 
These immunofluorescent images show that endothelial cell morphology is 
maintained on the different topographies and it is possible to form endothelial cell 
sheets on these plasma-treated surfaces. The HUVECs look elongated at the lower 
magnification (x20) and spread out which is typical of normal endothelial cell 
morphology on a surface which is suitable for them to adhere and proliferate on.   
 131 
 
Figure 5-4 Cell morphology and function on topographically patterned POSS-PCU films. 
Fluorescent micrographs show nuclei (blue) and actin (red). Specific proteins, namely vinculin 
(highlights focal adhesions at cell periphery) and nitric oxide synthase (marker of endothelial 
cell function) are highlighted in a) and b) respectively. Grey arrows in a) in the lower right 
image highlight focal adhesions. Images were enhanced using contrast/ brightness controls with 
the exception of the insets in b) which show the unmodified images of eNOS expression using 
identical microscope settings.  
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These fluorescent images highlight the healthy morphology of the endothelial cells. 
However interestingly, focal adhesion formation was only seen on endothelial cells 
growing on NP topography compared with the microgroove and planar topography. 
This seems to suggest that there is a subtlety in the nanoscale topography which 
enhances the focal adhesion formation.  
In addition, the fluorescent images also confirm that despite the topographical 
changes to the surface of the polymer, this does not impair the function of 
endothelial cells on the surface. It is possible to see eNOS expression on the three 
different surfaces at the highest plasma treatment level of 80W for 60s. This is a very 
important indication of function of the HUVECs on the different topographically and 
plasma-modified surfaces.    
 
5.4.4 In Cell Western Quantification of Endothelial Cell Function  
The measurement of endothelial nitric oxide synthase (eNOS) is a useful indicator of 
endothelial cell function and due to this, it is useful to get a quantitative indication as 
to the function of the endothelial cells, which was conducted using In-Cell Western. 
This comparison was done using MG (microgrooves) as samples of this topography 
can be fabricated in bulk quantity easier than with the nanoscale topography. This 
would give an indication as to whether topography in the microscale makes any 
difference to endothelial function.   
It was seen that there was a statistical significance only at treatment levels of 80W at 
60s and 100W at 60s compared with untreated planar, therefore suggesting that at 
these treatment levels in the presence of micro-topography are optimal for 
endothelial function. Interestingly, at the treatment level of 120W at 60s, this eNOS 
expression falls indicating that at this point, endothelial function is disrupted. 
However, although the other treatment levels (40W and 60W at 60s) did not receive 
a level of statistical significance, there is a step-wise pattern to the increase of eNOS 
production on the MG surfaces.  
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Figure 5-5 Graph showing eNOS expression at 5 days after cell culture on microgroove and 
plasma-treated POSS-PCU surfaces using In Cell Western. There is a statistical significance in 
eNOS expression at 80W and 100W at 60s plasma treatment levels on the micron grooved 
POSS-PCU substrates (* p<0.05) (n = 4) 
  
5.4.5 In Cell Western Quantification of P-Myosin Expression  
A further measurement of HUVEC adhesion to substrate was to look at P-myosin 
expression. Again, due to fabrication enablement, microscale topography was used at 
different plasma treatment levels.  
There was no clear indication that on any of the plasma treatment levels had any 
effect on P-myosin expression and no obvious pattern was discernible from the 
results. There was also no statistical significance between any of the treatment levels.  
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Figure 5-6 This graph showing P-myosin expression after 5 days on incrementally increasing 
plasma treatment on POSS-PCU substrates with microgrooves. There is no statistical 
significance at any of the plasma-treatment levels on the micro-grooved surfaces. (n=6)  
5.5 Discussion 
The use of a combined methodology, in the form of surface chemistry and 
topography to help with endothelial cell adhesion is explored in this Chapter. 
Previously, it has been shown that it is possible to use plasma treatment to lower the 
water contact angle (WCA) of the POSS-PCU films so that endothelial cells are able 
to grow and adhere on the surfaces of POSS-PCU films. However, it was not certain 
that the endothelial cells were greatly adhered to the surfaces as there did not seem to 
be any focal adhesion formation seen in the immunofluorescence images. 
Endothelial cells need to be able to withstand the high pressures and haemodynamic 
flow especially in arterial flow and thus the importance of good cell adhesion to the 
surface needs to be proved. Therefore, it was essential to be able to prove the 
adherence of the endothelial cells on the POSS-PCU films in a static environment 
prior to application of haemodynamic flow conditions.  
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In addition to surface chemistry, the use of surface topography is essential to 
providing cues for cells to differentiate, adhere, proliferate etc. The vascular 
basement membrane provides biochemical as well as these physical cues. The 
biochemical components of the basement membrane have been characterised 
previously and include a mixture of elastin, collagen IV, heparin-sulfate 
proteoglycans, laminin and nidogen/ enactin. Recently Liliensiek et al(75) also 
characterised the endothelial basement membrane nanotopography in rhesus 
macaque monkeys. This experiment was conducted so that it would give a guide to 
tissue engineers as to the topography required for vascular tissue engineering. Their 
decision to perform this study on nonhuman primates rather than on humans was to 
eliminate confounding variables introduced by human variability such as donor age 
and state of health. In addition to this, the time from harvest from human cadaveric 
tissues to fixation can vary and therefore dictate the state of the tissues. Interestingly, 
they found that the basement membrane in a carotid artery was made up of a 
combination of nanopores and nanofibres. These features would provide a 
combination tactile physical cues for the endothelial cells to respond to. Currently 
limitations of technology limit use to produce substrates with exact topographical 
features of that of the basement membrane seen. In addition, these features were seen 
to be in the nanoscale and illustrates the importance of feature sizes in the nano-
range.  
Due to the features in the basement membrane being in the nanorange, it is important 
to have a fabrication technique which is able to produce feature sizes in this scale 
range. EBL is a technique which allows the production of these features at this size 
and allows a precise production of these features in the nanoscale region. The ability 
to produce nanopits using this technique has provided a first step in investigating 
endothelial cell behaviour on the NSQ substrates.   
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Figure 5-7  This figure shows three SEM images to illustrate how to create a topography similar 
to that found in native basement membranes and using the current technology that we have. A) 
is an SEM image adapted from (70) which shows the carotid basement membrane of a rhesus 
macaque (Scale bar: 600nm). B) is an SEM (conducted using a field electron source (Hitachi 
S4700)) the silicon shim that has been produced from electron beam lithography in an attempt 
to reproduce the nanopores seen in A) in a slight disordered fashion. C) is an SEM image of the 
POSS-PCU polymer with after soft lithography has imprinted the nanofeatures of the shim onto 
the polymer. Although this is not an exact replica of the basement seen in the SEM due to the 
limitations of the current technology, the nanopores can be replicated to a certain extent and 
then molded into the POSS-PCU polymer with good fidelity. 
 
It is therefore important to first confirm the ability to replicate the micro- and 
nanotopography on the POSS-PCU polymer and also the fidelity of this replication 
within the polymer. It was seen that the use of soft lithography, solvent-based 
evaporation, meant that the microgrooves and nanopits were replicated into the 
polymer with high fidelity when visualised under SEM and AFM. Interestingly in the 
SEMs, it is possible to also see white surface aggregates. This is thought to be POSS 
nanoparticle aggregates which migrate to the surface. However, this was taken as an 
inherent component of the polymer and did not seem to affect or distract from the 
surface topographical features.  
Plasma treatment has also been known to have etching properties and this can be 
detrimental in the presence of surface topography especially in the nanoscale. The 
surface topographical changes, using plasma treatment is usually variable and non-
controllable but require high energy particles to bombard the surface of the polymer 
to achieve this. If the energy is high enough, this will disrupt and change the surface 
topography and any ‘intentional’ surface topography such as the nanopits would 
render them obsolete. Therefore, AFM was used to confirm that the plasma treatment 
required to treat the surfaces were also not going to cause problems for the surface 
topography. The optimal plasma treated surfaces (80w for 60s) with the nanopits 
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were therefore used for this analysis. The surface roughness (RMS) of the surfaces 
were then used to analyse this. AFM is used as the methodology gives 3 dimensional 
(3D) measurements on the roughness values over other methods such as Stylus 
Profilers.  
The roughness values showed that there is no difference pre- and post-plasma 
treatment and therefore this is a good indication that the current plasma treatment on 
the polymer surfaces does not destroy the surface topographies, allowing a 
combination of the surface modifications to be used.  
Interestingly, the surface topographical features did not seem to have any definitive 
effect over planar in cell count, regardless of MG or NSQ. This suggests that there is 
possibly a lesser role for topography, in terms of cell proliferation. However, after 5 
days of culture, there appears to be ‘patchy’ endothelial cell sheets on the POSS-
PCU polymer (as shown by Coomasie Blue). This illustrates that at a longer time-
point the polymer films would eventually be covered with endothelial cell sheets, 
and indicates a more positive role, but this may occur over longer time-points. These 
results seem to indicate that the role of topography may be lesser on endothelial cell 
proliferation, but more on cellular adhesion to the substrate.    
There is always a danger that the wrong topography would causes apoptosis in the 
endothelial cells and therefore elicit cell death. Live/ Dead staining has showed that 
the cells are still healthy on all the topographies after 5 days of cell culture. This 
further shows that these surface alterations do not seem to have any detrimental 
effect on the endothelial cells. Endothelial cell function is also retained as shown by 
the presence of eNOS.  
Further explanation on the role of eNOS is due at this point. Nitric oxide synthase is 
an enzyme found primarily in endothelial tissue and it produces the vasoprotective 
molecule nitric oxide (NO). eNOS is the isoform of this group of enzymes in the 
vasculature and is responsible for the majority of the NO produced in this tissue. NO 
is responsible for a plethora of vasoprotective functions and to name a few(89): 
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• Vasodilatory effects by activating soluble guanylyl cyclase and increasing 
cyclic guanosine monophosphate (cGMP) in smooth muscle cells 
• Potent inhibitor of platelet aggregation when released into the vessel lumen 
• It can inhibit leukocyte activation by interfering with the leukocyte adhesion 
molecule CD11/ CD18 by forming a bond with the endothelial cell surface or by 
suppressing CD11/ CD18 expression on leukocytes. Indirectly, as white cell 
adhesion is an early event on the onset of atherosclerosis, there is therefore a 
preventative role for NO in atherosclerosis formation 
• NO inhibits DNA synthesis, mitogenesis and proliferation of vascular smooth 
muscle cells  
Therefore, eNOS provides a positive indication of the function of endothelial cells 
and this does not seem to have been deterred by the plasma treatments or surface 
topographical modifications. The importance of eNOS for the survival of the small 
diameter vascular graft can be seen by the functions listed above. Thus its presence 
as well as is function is essential. 
The results produced in this Chapter regarding the function of the endothelial cell is 
retained on the plasma treated surfaces on the MG substrates. Although the graph 
shows a similar pattern to that found in Chapter 4, in which increasing plasma 
treatment will increase the eNOS expression, there is less significance found in the 
lower treatment levels. There might be an indication that the presence of the MG 
would have a slight negative effect on the endothelial cells.  
In the presence of grooves, cells have been shown to align along the grooves by 
contact guidance. Contact guidance is the interaction between microscale and 
nanoscale features and the cellular response and is usually coordinated by organized 
ECM proteins. However, the interest in contact guidance is due to the important role 
it has in the migration of individual cells or groups of cells or tissues. It forms an 
important component in organelle formation. The response of cell types to 
nanogratings by simultaneously aligning and elongating of the grating axis is not 
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seen by the HUVECs on the MG surfaces in this Chapter. This lack of contact 
guidance is due to the lack of optimisation of feature sizes. Larger responses to the 
surface topography is mainly seen in features with a decreased feature pitch and on 
increased depth. It is therefore thought that the current pitch size of 25µm and depth 
of 700nm is not optimised for the endothelial cell on the POSS-PCU surface. It is 
likely that the pitch size is too large and not providing enough tactile feedback to the 
cell to allow contact guidance. Further investigating would require investigating 
HUVEC reaction to other pitch sizes until HUVEC alignment due to contact 
guidance is seen.  
 Together the results so far seem to show the importance of surface plasma treatment 
over the use of surface topography as a main tool for enhancing endothelial cell 
growth. It was important to further determine if there is really a role of the 
modification of surface topography to enhance endothelial cell growth.  
Subtle topographical cues, such as nanopits, have been known to either positively or 
negatively induce the recruitment of adhesion proteins enhancing endothelial cell 
adhesion. The ECM is linked to the cell cytoskeleton by focal adhesions, 
multiprotein complexes that are formed which bind to the integrin family 
transmembrane receptors to extracellular ligands. These are recruited and work 
together in a complex system within the cell so that it is able to respond to its 
surroundings. Famous SEM images taken by Teixeira(90) et al illustrate a human 
corneal epithelial cell reacting to its surrounding surface topography. When they are 
cultured on flat silicon oxide surfaces, they are of rounded morphology. The 
morphology changes when they are cultured on nanogratings of 70nm wide ridges 
with a 400nm pitch and it can be seen that they are elongated and aligned in the 
direction of the nanogratings (Figure 5.9). This illustrates the cells reacting to the 
topography by contact guidance.  
The ability of the cellular machinery to explore both the micro- and nanoscale 
environment has therefore both complex sensory and feedback mechanisms that 
connect the sensory (input) and operational (output) modules, as described by 
Geiger(91) et al. These complex interactions start by the activation of integrins by 
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the external stimuli provided by the ECM, and which are then converted to 
biochemical stimuli back to the cell. Integrin-mediated adhesions are multiprotein 
complexes that provide this link from the ECM to the actin cytoskeleton. The 
biological activities of the adhesion components are diverse and include several actin 
regulators that affect the organization of the attached cytoskeleton. The adhesome 
integrin network is complex and composed of many components. There have been 
projects which has sought to identify all the different components of the adhesome 
integrin network(92).   
 
There are complex mechanisms that underpin a cell’s reaction to its surroundings. 
Although there are still complexities of these mechanisms that is not entirely 
completely understood, it is quite important to know the known aspects of it when 
investigating cellular behaviour.  
Detecting the presence of vinculin gives a good indication as to the presence of one 
of the main focal adhesion proteins. Vinculin does not bind directly to integrins but 
plays a key role in the assembly of focal adhesions by indirectly connecting talin and 
α-actinin to the actin. Vinculin is found ubiquitously in the cytoplasm but when it is 
activated to become part of the focal adhesion machinery, it is seen as contact points 
(1µm) at the periphery of the cell. These point contacts are complexes which are 
localised at the edges of the lamellipodia(93). The importance of vinculin is due to 
its ability to act as a regulator of mechanical stress as well as acting as a mechano-
coupling protein. It provides a physical connection between the exterior environment 
and the inferior actomyosin cytoskeleton. Despite vinculin’s inability to bind directly 
to integrins, there are linker proteins which are present such a talin and paxillin, 
which act to bind integrins to the focal adhesions proteins(93). 
Furthermore, the detection of the presence of focal adhesions on the NSQ substrates 
on the immunofluorescence images indicate that the nanopits are producing a tactile 
stimulus in which the HUVECs are responding to and producing focal adhesions 
which are detectable. Unfortunately, with the planar and MG samples this is not seen 
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and indicates that there is not enough external stimulus to either produce such an 
effect or the HUVECs are not as adhered as strongly to these surfaces.   
The detection of P-myosin expression on the MG surfaces using ICW has shown that 
the addition of the topography on the plasma-treated POSS-PCU does not have an 
effect. In addition, there is a suggestion that the presence of the MG surfaces may 
have a negative effect on the cells despite the plasma treatment effect and thereby 
obliterating the positive effects of the plasma treatments. This is due to the loss of the 
step-wise increase of P-myosin expression as seen previously on the plasma-treated 
only POSS-PCU surfaces. This will need further investigation as the mechanism for 
this is not understood at this stage.    
 One of the limitations of this Chapter is that the eNOS and P-myosin expression was 
not further investigated on the NSQ surfaces. This was due to a variety of reasons 
which included that the fabrication of enough thin films of NSQ made of POSS-PCU 
was time-intensive due to the lack of multiple masters (one master can only fabricate 
one film per surface and take 2-4 hours and will take at least a week of continuous 
fabrication to make enough for one experiment). The presence of eNOS had already 
been confirmed in the immunofluorescence images of the HUVECs on NSQ and 
would give us indirect information about the presence of eNOS and since the 
fabrication methodology is easier with MG, this was the pattern that was 
investigated.  
5.6 Conclusion 
This Chapter has shown that plasma-treatment of the POSS-PCU films remain a very 
important methodology to making the surfaces cytophilic and the addition of surface 
topography has demonstrated mainly subtle changes. However, it is important to note 
that the ability to produce both micro- and nanoscale topography is possible on the 
POSS-PCU surfaces co-currently with plasma-treatment. The addition of the 
topographical features does not have a detrimental effect on the endothelial cells. 
However, on comparison of the different surfaces, NSQ (nanopits) seem to have a 
positive effect on cellular adhesion over planar and MG surfaces. 
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5.7 Further Work 
As this Chapter has shown that very subtle changes in the surface topography will 
elicit very subtle changes in the adhering cell. There is the subtle detection of focal 
contact points forming in the endothelial cell periphery when cultured on the NSQ 
surfaces but it is not entirely clear the significance of it. It is therefore thought that, it 
would be crucial at this point to investigate the effect on topography on the HUVECs 
themselves. The nanopit topography is an important topography as mentioned due to 
its resemblance to that that seen in vascular vessels and since this is the topography 
which has elicited a response from the HUVECs.  
Further work would also include investigating eNOS and P-myosin expression by the 
HUVECs after 5 days of cell culture on the nanopit surfaces and to observe whether 
there is a difference to the expression levels on the MG and planar plasma-treated 
surfaces. This will help to further elucidate and confirm the positive effects of NSQ 
topography over the other two.  
As endothelial adhesion on surfaces is a very important factor when designing 
bioactive and cell-responsive surfaces especially for vascular grafts, further research 
will go into the investigation of endothelial cell behaviour on the different 
topographies. It is assumed that if it is possible to distinguish a particular topography 
that endothelial cells will respond by large focal adhesions, then this topography can 
play an important part in the further development of vascular grafts. This is an 
important study as optimal endothelial cell adhesion on the surface is crucial so as to 
avoid delamination especially when haemodynamic and pressure stress flows factors 
are applied.  
In addition to this, MG surfaces of different pitch sizes require further investigation. 
As mentioned, it is not clear as to the reason for the lack of endothelial cell 
alignment and also the loss of step-wise P-myosin expression (when seen on just 
plasma-treated surfaces). However, this will require further investigation and further 
optimisation of the pitch sizes. Combinatorial and high throughput screening 
methodologies allow for this to be conducted in a speedy way. Preliminary work on 
substrates produced by Reynolds(94) et al of culturing HUVECs on the surfaces 
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have shown that at the smaller pitch sizes of the grooves, the HUVECs start to align, 
thereby indicating that at these sizes the grooves provide an optimal contact guidance 
for the HUVECs to adhere and align themselves to, and raising migration 
possibilities. In contrast, the HUVECs on the larger pitch sizes appear small and 
round and do not align themselves on the grooves, thereby also indicating a more 
‘unhealthy’ HUVEC morphology. This is consistent with our earlier findings that at 
the higher pitch sizes (in our case, 25µm pitch) the HUVECs do not align. This may 
also account for our observation that there is no consistent P-myosin expression 
despite the plasma treatment. These preliminary results allow for a very interesting 
avenue of future work.   
 
 
Figure 5-8 The middle diagram is adapted from (94) and illustrates POSS-PCU film with a 
micro-gradient of grooves (pitch of grooves from 8µm to 100µm with shallow groove depth of 
10nm increasing to 1µm along the 10mm grooves) transferred on it using soft lithography and a 
polycarbonate master. The films are then plasma-treated at 80W for 60s. The top two images 
are SEMs of the POSS-PCU substrate at different points to illustrate the smaller grooves (left) 
and the bigger grooves (right). The bottom images show Human Umbilical Vein Endothelial 
Cells (HUVECs) stained with Coomasie Blue stain of the same areas as the SEM images. The 
yellow arrows on the left image show the HUVECs which have aligned along the smaller 
grooves and this is in contrast with the HUVECs on the flat surface which have more spread 
and rounded morphology. The image on the bottom right show that on the larger pitch sizes the 
HUVECs are small and rounded in morphology which may indicate that they are unhealthy on 
this surface.    
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Chapter 6 Endothelial Cell Adhesion to Nanotopography 
 
6.1 Introduction 
Endothelial cell response to topography has been seen to play more of a subtle role 
than originally thought from the previous Chapters. This Chapter is more focused on 
finding if there is an actual response of endothelial cells to the topography, especially 
in terms of endothelial cell adhesion. Although there has been previous work on a 
number of different substrates and topographies, looking at endothelial cell response 
to topographical changes, there is still uncertainty of endothelial cell behaviour on 
the nanopits especially on polycarbonate substrates. 
6.1.1 Endothelial Cell Adhesion 
Endothelial cell adhesion has been an intensely studied topic. Vascular endothelial 
cells have to be able to withstand haemodynamic stress flow and although this is an 
important aspect of research, it is essential to prove that the endothelial cells are able 
to adhere under static conditions before testing them under stress flow conditions. 
Historically when endothelial cells were seeded onto vascular grafts, the endothelial 
cell sheets would delaminate on application of stress flow conditions, even at mild 
stress flow conditions. Although surface protein coatings such as fibronectin and 
gelatin have been applied onto the luminal surface of the vascular grafts to enhance 
adhesion and to help resist detachment on the application of flow, initial studies have 
found this not to very useful.   
Publication Author Year Summary 
Kinetics of Endothelial Cell Seeding JE Rosenman 1985 They looked at endothelial cell harvesting cell 
technique as well as seeding onto untreated ePTFE 
grafts and then implanted straight into canine carotid 
interposition. Loss of 70.2% in the first 30 mins were 
noted. 2nd phase was 30 mins to 24 hours and there 
was a slow steady loss of adherent endothelial cells. 
Enhanced strength of endothelial 
attachment on polyester elastomer and 
polytetrafluoroethylene graft surfaces 
KA Kesler 1986 This study compared fibronectin coated surfaces on 
PET and PTFE compared with uncoated and found that 
cell adhesion was better on fibronectin coated surfaces 
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Table 6-1 Table to show some of the historical publications(64, 65, 95, 96) looking at promoting 
endothelial cell adhesion and correlation that the strength of adhesion prior to application of 
flow played an important part. These publications illustrate the problem of delamination even 
in the presence of proteins which promote cell adhesion onto the substrates.  
 
Rosenman(64) et al carried out one of the first comprehensive studies looking at the 
extent of endothelial cell delamination at the application of flow.  On untreated but 
endothelial cell seeded PTFE surfaces, once implanted as carotid interposition grafts 
in a canine model, within 30 minutes there is a 70.2% delamination of endothelial 
cells, once the clamps were removed. This is an important finding that untreated 
PTFE surfaces are not enough to retain endothelial cells especially under 
haemodynamic stress flow. From these studies and those mentioned in the table 
above, it was obvious that the luminal surface of the vascular grafts plays an 
essential role in endothelial cell retention and therefore strategies to research the 
‘optimal’ surface conditions have seen been underway.   
As previously mentioned there is a complex interplay involved in cellular adhesion 
involving integrins and focal adhesion proteins. One of the main aims of this Chapter 
is to further investigate the role of nanopits in endothelial cell adhesion and whether 
there is a positive role of nanopits in it.   
6.1.2 Nanopit Topography (NSQ and SQ) 
Previous publications and research conducted at the University of Glasgow have 
shown that MSC behaviour can be manipulated using surface topography especially 
with fibronectin substrate  and but only marginally better under flow conditions 
than uncoated surfaces. 
Effect of fibronectin-coating on 
endothelial cell kinetics in PTFE grafts 
GR 
Ramalanjaona 
1986 This looked at pre-coating PTFE surfaces with 
fibronectin and then either pre-clotting with M199 or 
whole blood. They found that there was a significant 
retention of ECs after flow was applied. It was found 
that initial EC adherence was 46.7% and after 24 hours 
of flow there was 21.3% adherence. Uncoated was 
19.8% to 3.4%. 
Endothelial cell adhesion to vascular 
prosthetic surfaces 
D Gourevitch 1988 These seeded ECs from human saphenous vein and 
also human omentum. Maximal adhesion was noted on 
1% gelatin and also cold insoluble globulin coated on 
Dacron graft material. The maximal adhesion on 
gelatin was 73.4%. 
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by two topographies of interest. One such topography has already been investigated 
in the previous Chapter and this is the NSQ topography(42). In the previous Chapter 
it can been seen that there might have been subtle focal adhesions formation by the 
endothelial cells on this topography. These subtle changes may provoke an 
endothelial response for recruitment of stronger adhesional factors but the exact role 
these changes play is still not clear. Furthermore, another interesting topography is 
SQ which is also a nanopit-based topography. This topography has been found to 
promote the maintenance of mesenchymal stem cells(97). Both topographies consist 
of nanopits of 120nm in diameter and 100nm in depth arranged in a square lattice. 
For the SQ, the centre-to-centre spacing of the pits is 300nm and for the NSQ, each 
pit has an offset of up to 50nm in the X and Y direction. These topographies came to 
attention due to their ability to have an effect on MSC maintenance and 
differentiation with just the slightest alteration. NSQ is a surface that promotes high 
intracellular tension and osteogenesis(42) and SQ is a surface that promotes self-
renewal(97). However, as the majority work has been conducted on MSCs, it is not 
clear if a similar effect will be seen in endothelial cells.  
Nanopit topography has been identified in vascular tissue and may provide an 
extremely important external stimulus for endothelial cells(75). Furthermore, pitted 
topographies have been shown to have differing effects on cellular adhesion and 
requires more investigation especially when there is a potential it can play a crucial 
role in the vascular system. Highly ordered nanopit topography has previously been 
shown to reduce focal adhesion formation by directly affecting filodopia formation. 
This study however also highlights that focal adhesions are formed in the inter-pit 
region and not on the pit itself. Therefore, it is modification of the inter-pit region 
which would affect the focal adhesion rather than the presence of the pit itself. It has 
also been shown that by increasing the size of the inter-pit region in a slight 
disordered fashion, such as an offset, could encourage the formation of more focal 
adhesions in the inter-pit area and therefore increase cellular adhesion. Focal 
adhesion formation on nanopit topology has been investigated by studying MSC 
behaviour on the topography.  
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Therefore, this forms an important avenue of investigation by looking at the response 
of HUVECs to both ordered and slight disordered nanopit topography and to 
compare it to that of the more studied, MSC response. 
6.1.3 Injection Moulding 
Replication-based techniques such as hot embossing has been used for a long time to 
produce many devices such as microfluidic channels but unfortunately long heating 
and cooling times make these techniques undesirable.  
Injection moulding has been a fabrication technique used industrially for many years 
with the ability to produce sub-micron features. This can be seen in the manufacture 
of Blu-Ray DVDs by commercial injection moulders which can produce features 
below 150nm in seconds. Thereby injection moulding is a desirable high throughput 
methodology and is largely employed in commercial manufacture. Traditionally 
single mould tools (the template for the injection moulder) are expensive and time-
consuming to produce and can only be used for a specific purpose. However new 
design of mould tools allows for the surface features to be varied by introducing a 
‘slot’ system in which a different inlay can be inserted at the mould/ melt interface. 
This has been used frequently in commercial settings as this means that a single 
mould tool can be modified with changing of the inlay and this allows for different 
surface features to be manufactured. The inlays are usually made of nickel which can 
withstand the high temperatures and pressures generated within the injection 
moulding system. Other materials such as silicon dioxide, which would be useful as 
inlays when producing micro- and nanoscale features, are not able to withstand these 
high pressures and would shatter, especially if they are as brittle as silicon.  
The nickel inlay is manufactured by electron beam lithography (EBL) or 
photolithography, as mentioned in the last Chapter, to have the desired features. The 
injection moulder works in a cyclic way, in which the polymer is typically heated to 
100°C above the glass transition temperature (Tg) before it is rapidly injected into 
the mould cavity. This is kept at a much lower temperature (typically 30-50°C below 
the Tg of the polymer). The polymer of choice in our case, is polycarbonate. The 
polycarbonate used for injection moulding needs to be a thermoplastic to allow for 
 149 
moulding. Polycarbonate is used as it is well-known to be a biocompatible polymer 
which has been used for a variety of medical devices including renal dialysis 
membranes. In addition, it has also been used successfully in a wide range of 
experiments by Professors Dalby and Gadegaard’s groups and therefore proves as a 
‘standard.’  
6.1.4 Nanotopography and Vascular Grafts 
As mentioned before, it is hoped that the addition of surface topography would prove 
to be an important additional design for the luminal surface of vascular grafts. 
Surface topography provides an external physical cue for the endothelial cells to 
migrate and adhere on surfaces. It is therefore postulated that these observations 
could be harnessed to produce surfaces which are ‘tailored’ for endothelialisation. As 
these surfaces have the ability to recruit, activate and cause changes to cell 
behaviour, they have been promoted as ‘intelligent’ surfaces. In the case of vascular 
grafts, recruitment of neighbouring endothelial cells from native vessels by inward 
migration is a desirable concept and it is hoped that the use of nanotopography will 
improve on current observations which show this inward migration is limited by 2-
3cm past the anastomosis(86). 
There have been various recent attempts to utilise nanotopography within a small 
diameter vascular graft. One of the main attempts have been by Zorlutuna(98) et al 
in which they produced a two-sided nanopatterned vascular graft made of collagen I. 
The nanopatterns were parallel channels of equal grooves and ridges with width of 
650nm and 300nm depth. Vascular smooth muscle cells (VSMCs) were seeded on 
the outside and human internal thoracic artery endothelial cells (HITAEC) were 
seeded in the internal lumen. The nanopatterns were seen to successfully orientate 
the VSMCs on the external surface of the vascular grafts, giving mechanical strength 
to the graft, and the HITAECs were seen to produce an endothelial layer within the 
luminal surface of the graft. This work highlighted the fact that it is possible to use 
nanopatterns in vascular graft production. Unfortunately, it is not mentioned if this 
vascular graft is able to withstand the stress flow and pressure conditions of the 
normal arterial vessel.  
 150 
Several efforts have also been made to produce nanopatterned tubes using a variety 
of methods. Berry(99) et al employed a polymer de-mixing method using 20% 
polystyrene (PS) and poly-n-butyl methacrylate (PnBMA) to produce a luminal 
surface topography within a 0.5mm standard nylon tubing. Human endothelial cells 
were then seeded into the tubing and cell adhesion was studied. Interestingly, they 
show that the endothelial cells were reduced when compared with the control nylon 
tubes (without luminal nanotopography). The nanoislands produced by polymer de-
mixing methodology gave an average feature height of 85nm. A prior study by 
Dalby(100) et al showed that cells do interact with the topography produced by 
polymer de-mixing but there is increased cellular adhesion when the average feature 
height was <20nm and when the feature sizes were >80nm (as in Berry’s paper) cell 
adhesion is reduced. This shows cell dependency on the physical cues and the 
sensitivity they display towards it.  
These are examples of the work so far towards producing tubes with internal surface 
topography with mixed results. There is a strong indication that cells will react 
differently to different topographies and it is essential to find out which ones will 
have the biggest positive on cell adhesion. Previous work by Seunarine(101) et al 
have shown that different cells will react to different topographies and that 
endothelial cells have adhered to nanotopography especially nanopits. Therefore, 
from the last Chapter, there is some positive indication that endothelial cells may 
preferentially be adhering to surfaces with nanopit topography. However, this merits 
further investigation and further elucidation and therefore this Chapter is focused on 
further exploring endothelial cells on nanopit topography. The use of NSQ and SQ 
topographies is important there has been prior extensive investigation of these 
topographies with regards to MSCs and therefore this serves as an important 
comparison.  
6.2 Aims and Hypothesis 
The aims of this Chapter is to: 
• Optimise the growth and adhesion of HUVECs on nanopit topology 
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• Investigating HUVECs adhesion on different nanopit topology whilst being 
compared with planar surfaces 
6.3 Materials and Methods 
6.3.1 Injection Moulding of Polycarbonate (PC) Substrates 
This is a process which has been optimised by the University of Glasgow 
Engineering Department and James Watt Nanofabrication Centre and have been 
previously published(102, 103). 
A ‘near square’ (NSQ) and ‘square’ (SQ) arrangement of nanopits with a 120nm 
diameter, 100nm depth and with an average of 300nm centre-to-centre spacing with 
no off-set (SQ) or with a ±50nm offset (NSQ) are to be fabricated. These were 
initially fabricated with electron beam lithography (EBL) and dry etch. This is to 
create a nickel die or inlay in which is used in the injection moulder.  
A hydraulic injection moulder (Victory 28, Engel GmbH) is used to produce the 
polycarbonate substrates with the nickel inlay. The inlays are inserted into the mould 
tool and injection moulded with the polycarbonate (PC) (Makrolon OD 2015) which 
has been air-dried at 110°C for 3 hours under vacuum. The use of an injection 
moulder ensures higher throughput for production of the substrates.  
Again, the fabrication of the PC substrates was kindly produced by Professor Nikolaj 
Gadegaard’s Team.  
6.3.2 Plasma Treatment of the PC Substrates 
Plasma treatment of the polycarbonate substrates is a standardised procedure for 
rendering the surface of the polycarbonate substrates hydrophilic. The treatment of 
these substrates have been optimised by University of Glasgow for the use of 
mesenchymal stem cells (MSCs). The plasma treatment has mainly been in air 
plasma and therefore the protocol for this was maintained for this Chapter. The 
plasma cleaner utilised for this was the Harrick Plasma (PDC-32G, Harrick Plasma, 
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USA). This plasma cleaner only has limited settings for ‘tuning’ the power and 
therefore this uses the local standard protocol. 
6.3.3 Sterilisation and Seeding of the PC substrates 
Once the PC substrates have been treated with plasma treatment, prior to any 
biological work, sterilisation of the substrates need to be performed. In a cell culture 
hood, the substrates are first placed in two lots of 70% Ethanol solution for 10 
minutes each. They are then washed in HEPES-Saline solution generously and then 
placed in 6-well plates (Corning). Cell seeders (under patent application, University 
of Glasgow) are also sterilised in the same manner and then placed on top of the 
substrates ready for cell seeding. Endothelial cells are seeded onto the substrates on a 
cell density of 1 x105/cm2 and then left in an incubator for 4 hours to allow the 
endothelial cells to adhere. Adherence is checked using normal light microscopy and 
if the cells are spread, then the cell seeders are gently removed, and the cells and 
substrates gently placed back into the incubator.  
6.3.4 Contact Angles Measurements 
The contact angles measurements were conducted in the same way as the previous 
Chapters and this was done on an ‘in-house’ manufactured machine.   
6.3.5 In Cell Western 
Once again at the appropriate time-point of the cell culture, the cells on the POSS-
PCU films are firstly fixed in 4% formaldehyde at 3°7C for 5 minutes before being 
washed in PBS. The cells are then placed in a permeabilisation buffer at 4°C for 5 
minutes, before being blocked (milk powder/ PBS) for 1 hour at room temperature. 
The primary antibody is then added at a concentration of 1:50 (P-myosin and VE-
Cadherin) and incubated at 37°C for 2 hours. These are then washed with 0.1% 
Tween/ PBS and then fluorescent-labelled secondary antibody (Licor, Cambridge, 
UK) at a concentration of 1:1000 with also CellStain (CellTag 700 Stain, Licor, 
Cambridge, UK) at a concentration of 1:500, and then left at room temperature for 1 
hour. The secondary antibody is then removed and the films washed using 0.1% 
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Tween/PBS. The results are then analysed using an automatable infrared imager with 
a 2-channel imaging system (Odyssey Sa, Licor, Cambridge, UK). 
6.3.6 Cell Count using DAPI  
As in the previous chapters, the endothelial cells were fixed after 5 days of culture. 
The cells are placed in 4% formaldehyde solution for 15 minutes in 37°C. A few 
drops of DAPI (Vectoshield DAPI, Vector Laboratories) are placed on the substrates 
and then using fluorescence microscopy (Zeiss Axiovert M200), ten random images 
were taken at 10 different locations of each of the polycarbonate substrates at a 
magnification of x20, of cells stained with DAPI. Cell nuclei was counted as an 
indication of cell number. A minimum of 4 substrates were assessed for each 
topography.  
6.3.7 Scanning Electron Microscopy (SEM) of the HUVECs on the PC 
Substrates    
The cells were fixed in 4% glutaldehyde and then osmium tetroxide. They are then 
dehydrated through a graded alcohol series and hexamethydisilane (HDMS) and air 
dried prior to sputter coating with 20nm gold/ palladium. The images are then taken 
using a Zeiss Sigma FE-SEM. Sample processing and sample imaging were kindly 
conducted by Margaret Mullin (University of Glasgow).  
6.3.8 Statistical Analysis 
The statistical analysis for this Chapter was conducted using Prism. The data was 
analysed using the one-way Anova statistical test.  
6.4 Results 
The polycarbonate samples have been proven to be effective in the replication of 
nanopit topography and the fidelity of the replication of these patterns have been 
published previously(103).  Once these PC substrates have been fabricated by the 
injection moulder, the surfaces have to be rendered hydrophilic with a short 
treatment in the plasma chamber before further experiments can take place. There 
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have been previous protocols developed at the University of Glasgow, but these have 
mainly been developed for mesenchymal stem cell work.  
 
Figure 6-1 This figure shows a) the injection moulder [image adapted from the JWNC website] 
used to create the PC substrates and then the b) plasma cleaner used to render the PC surfaces 
hydrophilic (with the red plasma glow in the chamber to indicate the plasma treatment is taking 
place) and c) graph to shows the difference in contact angles pre- and post-treatment using 
University of Glasgow standard protocols. There is a statistical significance pre- and post-
plasma treatment (p <0.05).  (n = 3) 
  
Contact angles show that the University of Glasgow methodology pre- and post-
treatment with 45 seconds of air plasma treatment, does have a significant difference 
on the contact angles of the polycarbonate surfaces. The Glasgow protocol has been 
determined locally (unpublished data). This has been a reliable method of treatment 
of the PC surfaces so that MSCs are able to adhere and proliferate on these PC 
substrates, across the board of NSQ, SQ and planar topographies.  
However, it was noted that these treatment levels were not able to elicit the same 
response by the HUVECs and they were unable to adhere to the surfaces as the 
MSCs. Therefore, a further period of optimisation was required to re-adjust and 
lower the contact angles so that they are optimal for the HUVECs to grow. It was 
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therefore realised at this point that contact angle requirements by each cell type is 
different from each other and that cells which are ‘sensitive’ to their environment 
like HUVECs will require further optimisation protocols to be developed.     
 
Figure 6-2 This figure shows normal microscopy of Day 1 post-seeding of the HUVECs on the 
PC substrates where a) planar, b) NSQ and c) SQ surfaces where the treatment has been 10 
minutes of exposure to air plasma. The cells are noted to have adhered successfully to the 
surfaces. The graph on the right shows the significant differences (* in SQ and ** in NSQ). The 
control bar is used for comparison purposes. It should also be noted that there is a statistical 
significant difference with all the planar treatments and both SQ and NSQ topographies but 
there is no significance between the three planar treatments. [Scale bar is 10 µm] (n = 4) 
  
Increasing time in the plasma chamber was therefore used and treatment times of 2, 5 
and 10 minutes were used. Interestingly, with increasing times the planar contact 
angles seem to have reached an equilibrium and no further treatment caused any 
significant difference in the contact angles. In the SQ topography, there was a 
significant difference between all three treatment times. In the NSQ topography, 
there was significant difference between 2 and 10 minutes and 5 and 10 minutes but 
no difference between 2 and 5 minutes.  
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Figure 6-3 This figure highlights the contact angles which seem to promote endothelial cell 
adhesion on the polycarbonate substrates. On the left is a table which shows the mean of all the 
contact angles and highlighted in ‘orange’ colour are the contact angles which have consistently 
and successfully been able to grow HUVECs on.  
It was also noted that at 10 minutes of exposure to air plasma, this is a consistent 
optimal duration of treatment in which the HUVECs will adhere and proliferate on 
the surface, and this optimal contact angle appears to be different on the three 
topographies. It is thought that the treatment times are crucial to getting the surfaces 
to a level in which endothelial cells are able to adhere. As can be seen in Figure 6.3, 
the means of the contact angles in which the HUVECs are able to adhere to are 
highlighted in yellow. It is these contact angles, not the plasma treatment time of 10 
minutes, which is consistently and reliably able to produce these contact angles. The 
plasma treatment times are more reflective of the plasma cleaner itself and will need 
evaluating for every different plasma cleaner utilised (other than the one used in 
these set of experiments). Interestingly, there is a statistical significant difference 
between all the optimal contact angles, with the most hydrophobic being SQ 
followed by NSQ and then planar. It is thought that the slight increase in 
hydrophobicity in the nanotopographies is due to nanopits.   
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Figure 6-4 SEM images of the endothelial cells on the surface of the three topographies, planar, 
NSQ and SQ in both low and high magnifications. Red arrows indicate the filopodia of the 
HUVECs and these tend to be found in the leading edge of the cell. Yellow arrows indicate the 
retraction fibers of the cell found at the tail-end of the migrating cell.  
The SEM images show the HUVECs on the three topographies at both high and low 
magnifications. The morphology of the HUVECs show that they are spread out on all 
three of the topographies. Interestingly there seems to be an increase in retraction 
fibres seen on the topographies, which may indicate that the cells are migrating. 
Retraction fibres tend to be the fibres which appear longer, almost like the ‘strings 
attaching pegs to a tent.’ Filopodia is more prominent and much smaller than the 
retraction fibres and can be seen ‘sensing’ the surface topography. On the 
topographies, there are more retraction fibres seen and this can be an indication that 
cells are more likely to be migrating on the topographies over the planar surfaces. 
Despite this, it is possible to ‘capture’ a migrating endothelial cell and be able to 
identify the leading edge of the cell.  
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Figure 6-5 This figure shows the cell stain on the substrates when using ICW as a detection 
method for conducting cell counts, where a) shows the intensity of the cell stain as visualised by 
the ICW plate reader and b) the quantifiable data comparisons. C) uses DAPI count to count 
the number of nuclei on the substrates. (* p<0.05, *** p <0.0005) 
Two different methodologies were used to ascertain the cell count of the HUVECs 
on the surface of the PC substrates. The first was ICW which has been used to give a 
quantitative determination of protein expression. In the traditional Western Blots, the 
protein expression is usually compared with a housekeeping protein (such as 
GAPDH) and although these housekeeping proteins can also be utilised in ICW 
protocols, an alternative can also be performed. This is cell stain which stains the 
entire cell and therefore the intensity of the cell stain can be estimated using the ICW 
reader. The second methodology was that using the same method used previously in 
an earlier chapter, using DAPI to stain the nuclei and the use of fluorescence 
microscopy to take images. A count of the nuclei gave a quantitative estimation of 
the number of cells on the substrates.  
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Both methodologies have shown a very similar graph, thus validating both methods 
as usage for cell count comparison. It is seen that there are less HUVECs growing on 
the SQ topography and that the highest cell count or cell stain seems to be that of 
NSQ. This patterns seems to be consistent across the two methodologies. The 
HUVECs express a preference to the NSQ topography over the SQ and planar.  
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Figure 6-6 Graphs to show P-myosin expression by the HUVECs on the different topographies 
(Planar, NSQ and SQ on polycarbonate substrates) at different time points of Day 1 (top graph), 
3 (middle graph) and Day 5 (bottom graph) using In Cell Western analysis. As can be seen on 
Day 5, there starts to be seen a statistical significance in the expression of P-myosin on the NSQ 
surface (* p<0.05) (n = 4) 
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The expression of P-myosin was investigated in a variety of time-points as an 
indication of endothelial cell adhesion to the topographies. P-myosin expression is 
interestingly not seen to have any significant difference in Days 1 and 3. However on 
Day 5 there is a significant expression of P-myosin on the NSQ topography over 
planar. This shows that over the days there is increased of cell contractility of cells 
on the NSQ topography over the other topographies.  
 
Figure 6-7 Graph to show VE-Cadherin expression by HUVECs on the different topographies 
(planar, NSQ and SQ on polycarbonate substrates) after 5 days of cell culture (* p<0.05) (n=3) 
 
To further investigate HUVEC adhesion on the topographies using In-Cell Western, 
another protein expression was investigated. This was VE-Cadherin which is an 
endothelial cell-to-cell contact. After 5 days of HUVEC culture on the different 
topographies, there was a significant increase in VE-Cadherin expression on the SQ 
topography over planar. These show that for adherence on SQ topography, VE-
Cadherin seems to play a more important role than P-myosin in cell adhesion.  
6.5 Discussion 
There has been a lot of work that has been conducted on the topographies SQ and 
NSQ, due to the influence that they have on MSCs maintenance or differentiation, 
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respectively. The SQ topography has been shown to have MSC maintenance 
properties, meaning that this can have a lot of implications on future stem cell 
therapies(97). NSQ topography, pushes MSCs towards an osteogenic lineage(42). 
These topographies are very similar except for a ±50nm offset in the NSQ 
topography and are interesting as such a small difference has such different outcomes 
on MSC phenotype. Biggs et al (104) measured the size of the focal adhesions of the 
MSCs formed on both NSQ and SQ topographies and found that larger focal 
adhesions were formed on the NSQ surfaces compared with the SQ surfaces. This 
seemed to be a strong indicator for differentiation into osteogenic lineage by the 
MSCs. It is thought that if the NSQ surface topography could have a similar effect on 
endothelial cells by inducing them to form large focal adhesions, there is potential to 
enhance endothelial cell adhesion to their substrates. There is a correlation of focal 
adhesion size and effectiveness of the adhesion strength and further observations 
have also shown that these focal adhesion size are enhanced on the application of 
flow(105).  
This Chapter is an initial study on endothelial behaviour on the different 
topographies on the polycarbonate substrates and observing if there is a definitive 
effect the topographies have on the endothelial cells.  
HUVECs are known to be difficult cells to culture. In this Chapter, one of the most 
important factors that was discerned was that the HUVECs were very sensitive to the 
surface hydrophilicity. Previous ‘HUVEC-growing’ protocols do not lower the 
contact angle enough. Therefore, a further optimisation step was required to render 
the surfaces to a contact angle that was conducive to HUVEC growth. By air plasma 
treating the surfaces of the polycarbonate surfaces for 10 minutes, a contact angle 
low enough for HUVECs to grow was achieved. Interestingly, at the lower contact 
angles, the MSCs are also able to adhere to the surfaces and grow in co-culture with 
the HUVECs. This shows that the appropriate contact angle has to be reached before 
HUVECs will grow on the substrates. It is important to reiterate at this point, that the 
power treatment levels of the plasma cleaner that was used to conduct these 
experiments will not be the same for every plasma cleaner. There will be a variation 
and it is attaining the correct contact levels which seem to be the important factor 
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here. Thus for a different plasma cleaner, it is likely that a period of optimisation is 
required to confirm the contact angles generated on the substrates. 
On further examination of the contact angles on the different surfaces produced after 
10 minutes in the air plasma chamber, there is no significant difference between the 
treatments on the planar samples. However, for SQ, there is a difference between all 
the treatments and for NSQ, there is initially no difference between 2 and 5 minutes 
but there is a statistical difference between 5 and 10 minutes. This would indicate 
when trying to lower the contact angle of surface topography, higher energy plasma 
is required. This is likely due to surfaces with topography such as nanopits, higher 
energy is required to ‘bombard’ the surfaces so that the surfaces within the nanopits 
also have the contact angles lowered.   
Nanotopography provide a physical cue to the endothelial cells which will then have 
a knock-on effect for a canonical of biochemical reactions which are important. Of 
one of the cues, this would be cell adhesion features. Cell adhesion is important as it 
is the first event in a chain events leading up to successful integration of the vascular 
graft, especially endothelialisation. There are lots of cellular functions which occur 
as a result of successful cellular adhesion such as proliferation, differentiation and 
extracellular matrix deposition. This all happens as a result of an anchorage-
dependent cell which has adhered to the biomaterial surface(99).  
The SEM images indicate that the HUVECs are responding to the topography. As the 
SEM images show, there is a degree of cell movement on the different topographies 
as indicated by the presence of the leading edge and the retracting fibres. In the high 
magnification images, it is possible to see the interaction of the cell, via filopodia, 
with the surrounding nanotopography. Filopodia are important in a range of 
biological processes. It is part of the actin machinery and coexists with lamellipodia. 
Lamellipodia are protrusions on the leading cell edge of most motile cells and are 
persistent protrusions, whereas in contrast, filopodia appear to have both sensory and 
exploratory functions to steer cells, depending on cues from the environment(106). 
Therefore, filopodia are important for the feedback mechanism and determine how 
the cell reacts to the environment.  
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Previous work conducted by Tsimbouri(107) et al on the same nanotopographical 
substrates, showed that MSCs on all the materials were seen to have formed 
contractile stress fibres but this was notable more in cells on NSQ. Cell adhesion 
analysis also showed that the focal adhesions developed on SQ were significantly 
smaller than that on NSQ, which had critically larger adhesions. They also found that 
there was higher P-myosin found in the contractile MSCs on the NSQ than compared 
with planar and SQ. In the case of MSC, this is in line with previous observations 
that for MSCs progressing towards osteogenic lineage the focal adhesions required 
are larger(104). In the results from this Chapter, it can be seen that only on Day 5 
does P-myosin expression on NSQ start to be statistically significantly over the 
planar. This seems to suggest that the contractility of the cells will developed slowly 
on the surfaces and it takes a few days before the cells develop these mature focal 
adhesions.   
This seems to be consistent with the results from the cell count conducted after 5 
days of cells culture. Cells need to securely adhere onto the material surface to 
proliferate and since the cells seems most securely attached to the NSQ surface, 
which would suggest that this topography allows for successful cell proliferation. P-
myosin, as mentioned previously, is involved in the stabilisation of the myosin 
filaments which are responsible for cell contractility. Inter-pit distance appears 
crucial for the formation of focal adhesions. On the SQ topography inter-pit distance 
is the same in all aspects of the topography. However, on the NSQ topography, the 
±50nm offset in the X and Y direction, means that a range of inter-pit distances is 
observed and some of these distances will be larger than those seen in the SQ 
topography. Focal adhesions have a larger area to form in these spaces and therefore 
allows for larger focal adhesions to develop.     
VE-Cadherin belong to the family of Type II cadherins. The cadherins are cell 
adhesion molecules that mediate adhesion via homophilic, Ca2+- dependent 
interactions(108). VE-cadherin is the major determinant and regulator of endothelial 
cell contact integrity. VE-cadherin is essential to regulation of the permeability of 
blood vessel wall for cells and substances. It is thought that VE-cadherin achieves 
optimal adhesion by association with the c-terminus of the catenins, which are 
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cytoplasmic proteins. Catenins are actin binding proteins and contribute towards cell 
adhesion. Endothelial cells have both adherens and tight junctions intermingled. 
Adherens junctions participate in multiple functions including establishment and 
maintenance of cell-cell adhesion, actin cytoskeleton remodeling, intracellular 
signalling and regulation of transcription(109). 
VE-cadherins have recently been found to have a more crucial role in 
mechanotransduction of the cell cytoskeleton. Huveneers(110) et al described focal 
adherens junction between endothelial cells. They found that these junctions were 
attachments sites for radial F-actin bundles and also for junction remodeling. 
Molecules, such as thrombin, can activate these junctions, which then bind with 
vinculin in a way that is dependent on actomyosin contractility by exposing a 
specific vinculin-binding α-catenin domain. Due to this force-dependent binding of 
vinculin, the mechanical stability of the focal adherens junctions are reinforced and 
the endothelial junctions are therefore prevented from opening (less permeable). The 
association of the VE-cadherin-catenin complex can also directly transduce the 
mechanical forces to couple with other junctional proteins, PECAM and VEGFR2. 
The transfer of intercellular signals from this complex modulates Src (family of 
intracellular signaling molecules) and other intracellular signals needed for optimal 
vascular homeostasis, to maintain the correct cell attachment to the matrix and to 
regulate the blood flow, in vivo(111, 112).    
In addition, VE-cadherin has also been found to have anti-proliferative effects that 
mediate cell-contact driven inhibition of cell growth in cultured endothelial 
cells(113). VE-cadherin is significantly elevated in HUVECS cultivated on the SQ 
surface, the anti-proliferative effects of these findings were also seen in the cell 
count, with SQ surfaces having the lowest amount of cultured endothelial cells 
present. It is also interesting that the graphs do not have a similar pattern but in the 
expression of VE-cadherin, its expression on the planar and NSQ surfaces do not 
reach significance so it is not clear if this would be a factor. The anti-proliferative 
effects of VE-cadherin also seem to suggest that there is a ‘switch’ to the quiescent 
state, which is also associated with a downregulation of VEGFR2 (vascular 
endothelial growth factor receptor 2)(114).  
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From the results from this Chapter, it is unclear as to why there is a switch from a 
proliferative form for the endothelial cells when there is a switch of topographies 
form NSQ to SQ. However, it highlights the sensitivity of the cells to the 
surrounding topographies as there is only a ±50nm offset difference between the two 
topographies. It is also not clear as to whether the upregulation of VE-cadherin and 
therefore the reliance of cell-to-cell contact will also have an associated negative 
influence on the strength of the cell adhesion on SQ surfaces.  
6.6 Conclusion 
This Chapter has illustrated that there is an effect of both the NSQ and SQ 
topography on the endothelial cells, especially with regards to their proliferative 
effect and their adhesion to the surfaces. Once again, there is evidence that the 
surfaces need to be of a suitable contact angle before the endothelial cells will adhere 
on them, and in comparison, this contact angle is much lower than those required by 
MSCs to adhere to the same surfaces and reiterates the important of optimisation of 
the surface.  
 As can be seen, there is an increased in the upregulation of P-myosin on NSQ 
surfaces, which is also confirmed by other studies on MSCs, however the 
upregulation of VE-cadherin on the SQ surfaces is interesting. This seems to be 
linked to the anti-proliferative effect on the endothelial cells on the SQ surfaces and 
will require further investigation.  
6.7 Further Work 
This Chapter has highlighted a number of unanswered questions as to the adhesion of 
the HUVECS on the three surfaces, planar, SQ and NSQ. Further work would focus 
on elucidating the biology of the cell adhesion on the surfaces. This would look at 
the immunofluorescence of the presence of vinculin and if possible, measurement of 
the size of the focal adhesions formed to compare with previous work(104). It is not 
clear of the switch to VE-cadherin on the SQ surfaces and if there is a direct link to 
cell senescence and therefore measurement of endothelial cell function on the 
surfaces would provide additional information to correlate with the findings.   
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The use of the NSQ and SQ surfaces have proven important in a number of works 
which has focused on using these surfaces on orthopaedic implants and self-renewal 
of stem cells, respectively(42, 97). Therefore, this also leads to the question of 
whether circulating MSCs would prove to be troublesome if these surfaces are 
exposed in luminal flow, such as in a vascular graft, and promote osteogenesis and 
subsequently calcification(115). Calcification can lead to a number of undesired 
events in a vascular graft, such as endothelial dysfunction, increased formation of 
intimal hyperplasia and altered flow patterns and shear stress, and these can also lead 
to premature graft failure(2). If this was the case, then these topographies can prove 
to be entirely inappropriate for the use in vascular graft development.    
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Chapter 7 The Influence of Mesenchymal Stem Cells on 
Endothelial Cells in the Presence of Nanotopography 
7.1 Introduction 
Mesenchymal stem cells (MSCs) has played an important part in the evolution of 
tissue-engineering and there are many new technologies which have been developed 
from their usage. MSCs can be harvested from a number of tissue sources and they 
can co-exist with a number of tissue and cell types, of which one is endothelial cells. 
However, it is not clear if they can potentially have a detrimental effect in vascular 
tissue engineering.  
7.1.1 Mesenchymal Stem Cells (MSCs) 
Mesenchymal stem cells (MSCs) are non-haemopoeitic cells which can be isolated 
from a number of sources such as the bone marrow, umbilical cord, peripheral blood 
and adipose tissue. They have multipotent capacity meaning that they can 
differentiate into a number of cell types; including osteoblasts, chrondrocytes, 
adipocytes, myoblasts and neurons. This means that they can be used in a 
regenerative capacity and are therefore a useful resource in tissue engineering. Other 
beneficial effects of MSCs include immunosuppressive and anti-inflammatory 
effects (they do not express the Major Histocompatibility Complex (MHC) II 
complex which are used in modulation of the immune system as seen in other cell 
types)(116).  
It has proved difficult to apply a formal definition to mesenchymal stem cells as 
there are no definitive cell surface markers which distinguish them from 
haemopoeitic stem cells. However, the International Society for Cell Therapy(117) 
have proposed the following criteria for Human MSCs: 
1. Adherence to plastic (tissue culture plastic) under standard culture conditions 
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2. Expression of surface molecules CD73, CD90 and CD105 in the absence of 
CD34, CD45, HLA-DR, CD14 or CD11b, CD79a or CD19 surface molecules.  
3. A capacity to differentiate into osteoblasts, adipocytes and chrondroblasts in 
vitro.  
The beneficial effects of MSCs have been acknowledged and a number of recent 
clinical trials have used these beneficial effects of MSCs. For example, in patients 
with end-stage liver disease, autologous mesenchymal stems cells improve clinical 
indices following injection(118). There were no adverse effects noted from this trial.  
MSCs have also been found in peripheral blood. These are thought to be MSCs 
which have been mobilised from other tissues by the presence of pathologies which 
involve tissue injury and tumours. Despite this, the circulating concentrations of 
peripheral blood MSCs (PB-MSCs) are still extremely low. The concentrations of 
circulating MSCs are 1 in 108 cells comparable to MSCs from the bone marrow 
which have the frequency of 1 in 104 or 1 in 105cells(119, 120).  
MSCs have homing potential and they have been found to express chemokine 
receptors and integrins, to sites of injury and inflammation. The exact mechanisms of 
this ‘homing’ potential still requires further elucidation and this is still under great 
investigation. However, the engraftment properties of PB-MSCs are thought to be 
greater than bone marrow MSCs (BM-MSCs) and it is not clear what chemical 
factors accentuate the homing potential of the MSCs. There is also discussion as to 
whether there are actually ‘circulating’ MSCs as such or rather they are mobilised 
BM-MSCs rather than PB-MSCs which reside permanently in the peripheral 
circulation.   
 
7.1.2 Mesenchymal Stem Cells, Nanotopography and Tissue Engineering 
MSCs have a lot of potential in tissue engineering applications and this has been the 
study of many research groups. As previous mentioned, the Dalby group have found 
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that the topographies, that are used in this thesis, NSQ and SQ, provoke a reaction 
from the BM-MSCs that are cultured on them, as mentioned previously. It has been 
shown that MSCs which are differentiating have high metabolism and exhibit the 
formation of large focal adhesions on the substrates which seem to predict their 
differentiation into an osteogenic lineage(82, 107).    
For bone engineering these topographies have shown to be of immense use in the 
field of bone engineering and for orthopaedic implants due to their influence of 
MSCs. In addition, due to SQ being a topography which favours maintenance of 
MSCs, has meant that this topography could potentially be used to create a 
production line of high quality stem cell delivery. In contrast, MSCs which are not 
undergoing differentiation are not as metabolically active as those which are 
differentiating and the focal adhesion sizes formed have been seen to be much 
smaller(107).   
However, it is not certain of the effect of these particular topographies on endothelial 
cells and in particular, in co-culture conditions.  This Thesis has sought to explore 
the ways in which the topographies can affect endothelial cell behaviour especially 
adhesion and its potential on vascular grafts.  
 
7.1.3 Calcification of Vascular Grafts 
Calcification of vascular grafts is known to vascular surgeons and this has been 
reported in the past(121). A recent study by Mehta(2) et al has shown that 
calcification in vascular grafts may be an underestimated issue. They looked at 
explanted PTFE grafts and found that 68% of vascular grafts showed evidence of 
calcification either within or adjacent to the PTFE grafts. Of the vascular arterial 
grafts that were examined, they found that 82% of them were exhibiting signs of 
calcification. This calcification is important as it contributes to graft failure by 
mechanisms such as reducing compliance, increasing stiffness and thus compliance 
mismatch, predisposing to graft fracture altering the haemodynamic flow patterns 
and exacerbating the endothelial dysfunction.  
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Calcification of vascular grafts are less well appreciated with less research directed at 
them but there has been a large amount of research based on the calcification of heart 
valves. There have been a number of hypotheses on why the calcification process 
occurs and Levy(122) et al propose a mechanism in which direct adsorption of 
calcium and phosphate by the polymer leads to subsequent subsurface crystallization. 
The degraded cellular components initiate the calcification and the collagen moieties 
can also act as additional nucleation sites for calcium phosphate minerals, which are 
independent of cellular components. The mineralization process is further 
exacerbated in the presence of haemodynamic stress and turbulent flow.  
There is an active inflammatory process and foreign body reaction to the vascular 
implant occurring also at the time of implantation and in most cases, this is thought 
to be a low-grade reaction. Macrophages can be found on the surfaces of 
biomaterials and they can propagate the foreign body response, and have the ability 
to undergo phenotypic changes depending on their microenvironment. 
This highlights the problem of calcification and the importance of its effect on a 
vascular graft. As it is currently an under-estimated problem, there is call for a 
registry in which to record vascular graft failures post explantation. Such a Registry 
is being set up in Strasbourg, France, to examine the cause of vascular graft failures 
and other medical devices so that with the results, a more focused approach can be 
undertaken(123). Although this is an ongoing registry and it will take some time 
before a comprehensive list of factors which cause vascular graft failures will be 
published, it is still thought that the problem calcification is an under-estimated 
cause.  
7.1.4 Mesenchymal Stem Cells and Endothelial Cells Cross-Talk and the Link 
with Surface Topography 
Recently, there has been a number of experiments which have been conducted 
looking at the co-culture of MSCs and endothelial cells. These experiments were 
conducted in a hope of elucidating the factors which will preclude MSC 
differentiation. In co-cultures with endothelial cells, MSCs have been shown to rely 
on both diffusible factors and juxtacrine mechanism by gap junctional activity for 
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intercommunication with endothelial cells.  In fact, when cultured with MSCs, 
factors such as BMP-2 can be expressed by endothelial cells and these can induce 
osteogenic differentiation of the MSCs. In the absence of any topography, there have 
been a few studies which have confirmed these observations both in vitro and in 
vivo. In vitro, MSCs which have been co-cultured with endothelial cells have shown 
an increase in osteogenic differentiation(124). This is confirmed by similar 
observations in an in vivo animal model too where co-transplantation of EC with 
MSCs resulted in more bone formation then with MSCs alone(125).  
The effect of these ‘Dalby and Gadegaard’ topographies on endothelial cells have not 
been evaluated. Earlier Chapters of this Thesis have shown that there is some merit 
in using a nanopit topography for the growth of endothelial cells. Unfortunately, the 
configuration of these topographies have been previously shown to have definitive 
effects on MSCs, especially the NSQ which has a propensity towards osteogenic 
lineage. Theoretically, circulating MSCs could potentially ‘home’ in on these 
topographies if they have been implanted as a vascular graft and settle on the luminal 
surface, differentiate down an osteogenic lineage and then cause premature 
calcification within the vascular graft.  
7.2 Aims  
The aims of this Chapter is to investigate the: 
• Possibility of mesenchymal stem cells also being incorporated with the 
HUVECs on the nanotopographies in a co-culture 
• Adherence of the MSCs on exposed surfaces of the PC substrates 
• Possibility of the attached MSCs to differentiate into osteogenic lineage in 
the presence of HUVECs and topography, thereby causing calcification  
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7.3 Materials and Methods 
7.3.1 Fabrication of Polycarbonate (PC) substrates 
This was previously outlined in Chapter 6 of this thesis. Electron beam lithography 
were used to fabricate these polycarbonate substrates. First master substrates have to 
be produced and they were fabricated to have an array of 120nm diameter pits of 
100nm depth and 300nm pitch in a square (SQ) arrangement. The NSQ master 
substrates had a controlled disorder by changing the pits from perfectly square (SQ) 
by 50nm offset and still maintaining an average of 300nm pitch.  
Nickel dies were made directly from the patterned resist samples, followed by sputter 
coating with a thin layer (50nm) of Ni-V on the samples as these will act as an 
electrode for the subsequent electroplating process. The nickel shims are then used in 
the injection moulder for the production of polycarbonate substrates which have the 
SQ, NSQ and planar topographies.  
7.3.2 Mesenchymal Cell Culture 
MSCs were purchased from Promocell® and cultured in basal media (DMEM, 10% 
Fetal Bovine Serum (FBS), 2% antibiotic mix (containing penicillin-streptomycin, 
Fungizone® and L-glutamine), 1% Non-essential Amino Acids, 1% Sodium 
Pyruvate). They are then cultured in a humidified incubator (20%O2/ 5% CO2) until 
ready for use. The cells are all used for experiments at P1-P3.  
7.3.3 MSC/ HUVEC Co-culture 
The co-culture conditions are modified from Bidarra(43) et al. They found the 
optimal conditions for MSC/ HUVEC co-culture was at a ratio of 1:1. Therefore the 
basal media for MSC was used. However, the HUVECs were grown in endothelial 
media which was M199 (Gibco), 10% FBS (Gibco), 0.1mg/mL Heparin (Sigma), 
0.03 mg/mL of endothelial cell growth supplement (ECGS)(Sigma). The HUVECs 
are conditioned in this media for 48 hours prior to co-culture experiments which uses 
the combined media, as mentioned. The ratios for seeding of cells for these 
experiments was 1:10 (MSC: HUVEC).   
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7.3.4 Sterilising of the PC Substrates and Seeding of the Co-Culture 
Firstly, the PC substrates surfaces have to be rendered hydrophilic and this is 
conducted by 10 minutes in the plasma cleaner, as optimised in the last Chapter 
(Harrick Plasma Cleaner). This is to render the contact angles of the substrates to the 
appropriate levels as seen in the last Chapter. The PC substrates are then sterilised 
using 70% Ethanol (2 x 10 minutes) and then rinsed in HEPES-Saline. The substrates 
are then placed in 6-well plates. The cell seeders (under patent application by 
University of Glasgow) are also sterilised in the same way and placed on top of the 
substrates ready for seeding. The HUVECs are first seeded at a density of 1 x 104 
cm2 on the substrates. These are allowed to adhere for 4 hours and then extra media 
(co-culture media) added and the seeders removed. The HUVECs are then allowed to 
be cultured on the substrates for 48 hours until there is ‘patchy’ distribution on the 
substrates. This patchy distribution is confirmed by phase contrast microscopy and 
then MSCs are then seeded carefully and directly on top of the substrates by using a 
needle and syringe, and carefully returned to the incubator to allow attachment.      
7.3.5 Immunofluorescence 
The protocol for immunofluorescence is as before. Samples were fixed in 4% 
formaldehyde for 15 minutes at 37˚C then washed before placing in permeabilising 
buffer and blocking in 1% (w/v) bovine serum albumin/PBS. Samples were then 
stained with mouse anti-CD31 antibody (1:200) (Abcam) in 1% (w/v) BSA/PBS, in 
conjunction with rhodamine/phalloidin (1:500), and incubated at 37˚C for 1 hour. 
Samples were subsequently washed 3 times for 5 minutes (0.5% Tween-20 in PBS) 
and then the secondary antibody, AlexaFluor 488 Goat anti-mouse was added (Life 
Technologies) at 1:500 in 1%(w/v) BSA/PBS. Samples were then incubated for 1 
hour at 37˚C. Samples were given a final wash before mounting using Vectashield 
with DAPI nuclear stain (Vector Laboratories). 
7.3.6 Coomasie Blue Staining 
As before, a Coomasie Blue Solution (0.2% Coomasie Blue, 46.5% Methanol, 7% 
Acetic Acid, 46.5% water) was filtered and 1-2ml are placed in each well (assuming 
a 6-well plate is used). This is left for 2 minutes and then washed thoroughly with 
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deionised water. This is then dried thoroughly before visualising with an optical 
microscope.  
7.3.7 Von Kossa Staining 
The samples were fixed after 3 weeks of co-culture using 4% formaldehyde solution 
and incubated for 15 minutes at 37°C. The samples are then washed thoroughly with 
PBS. A 5% silver nitrate solution is prepared and stirred. A second 5% sodium 
thiosulphate solution is also prepared and stirred. Firstly, 5% silver nitrate solution 
were added to the samples and then the samples were exposed to 15 minutes of ultra-
violet (UV) light. The samples are then rinsed in deionised water. The 5% sodium 
thiosulphate solution is then added to the samples for 5-10 minutes. This is then 
further rinsed for 5-10 minutes under tepid water. A final rinse of the samples is then 
conducted using 70% Ethanol solution. The samples are then viewed under normal 
microscopy.  
7.3.8 In-Cell Western 
As before then steps for ICW were conducted after three weeks of co-culture. The 
cells were fixed in 4% formaldehyde solution for 15 minutes at 37°C. The cells were 
then permeabilised in perm buffer at 4°C for 4 minutes. The buffer was removed 
before addition of a blocking solution (1% milk powder) for 1.5 hours at room 
temperature. The blocking solution is then removed and primary antibody, 
osteocalcin (1:50 ratio) is added and incubated in a 37°C hot room for 2 hours. The 
samples are then washed in 0.5% Tween/PBS and then the secondary antibody (Goat 
anti-mouse IRDye® 800CW (Licor®)) and CellTag 700 stain (Licor, Cambridge, 
UK) is added at a ratio of 1:1000 and 1:500, respectively, for 1 hour, covered. This is 
then thoroughly washed in 0.1% Tween/PBS and with the last wash in PBS only. 
The results are then analysed using an automatable infrared imager with a 2-channel 
imaging system (Odyssey Sa, Licor, Cambridge, UK).   
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7.3.9 Statistical Analysis 
The statistical analysis for the results of this Chapter has been conducted by using the 
computer program Prism®. Direct comparisons between the surface topographies 
was conducted using the statistical test, one-way ANOVA. 
 
7.4 Results 
The ratios of the co-cultures are much higher than that seen in the normal human 
body. Unfortunately, when using lower co-culture ratios, it was noted that at times it 
was difficult to confirm that MSCs have also adhered and this may be due to the 
seeding methodology, which may need further improvement.  
The morphologies for HUVECs and MSCs are very different. HUVECs have been 
considered to have a ‘cobblestone’ morphology especially when viewed under 
normal microscopy. MSCs have been described as having a fibroblast-like sharp 
spindle shape(126). As can be seen MSCs are much larger cells then HUVECs. 
 
Figure 7-1 These are phase-contrast microscopy images of a) HUVECs and b) mesenchymal 
stem cells (bone-marrow derived) cultured on the polycarbonate substrates (planar) [Scale Bar: 
10µm] 
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It is important to distinguish the difference between the morphology of the two cell 
types in the presence of a co-culture using phase-contrast microscopy. This was also 
deemed important as to judge the success of the adherence of the MSCs when 
seeding them onto the substrates.  
Again, using phase-contrast microscopy, it is possible to identify the presence of 
both MSCs and HUVECs on the substrates. Figure 7.2 shows an example of the 
image that can be seen. It shows the MSC adhering to the exposed surface of the 
planar substrate whilst surrounded by endothelial cells. It is also possible to notice 
the different morphologies of the two cell types which help distinguish them apart.  
 
Figure 7-2 This is a phase-contrast microscopy image of the co-culture of MSCs/ HUVECs on a 
planar substrate 2 days after seeing of the MSCs. The MSC (red arrows) is sitting surrounded 
by HUVECs and shows the effectiveness of the co-culture and hence successful ‘seeding’. [Scale 
Bar: 10µm] 
The use of Coomasie Blue also highlights the cell morphologies as well and illustrate 
the presence and success of the co-culture. Although Coomasie Blue is a technique 
which is closely linked to the Bradford Assay, it binds to protein and therefore will 
bind to the proteins in the cell cultures when fixed. It gives the contrast under 
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microscopy to further high-light cell morphology. Again, the two cell morphologies 
can be delineated using this stain.  
  
Figure 7-3 Coomasie Blue-stained images after 5 days of co-culture of the MSCs and HUVECs 
at a ratio of 1:50. Yellow arrows point out the presence of the MSCs, on the different 
topographies planar (left), NSQ (middle) and SQ (right). As can be seen, they are adhered quite 
sparsely on the staining and can be quite difficult to see. [Scale bar: 20µm] 
Further immunostaining was used to look at the co-cultures after 5 days of co-
culture. The fluorescent microscopy images on Figure 7.4 shows that on the 
topographies, the MSCs are able to adhere on the exposed surfaces which have not 
been colonised by HUVECs yet. The uptake of the Rhodamine stain is much stronger 
on the MSCs compared with the HUVECs. The actin fibres are more defined and the 
fibroblast-like spindle shape of the MSCs can also be visualised as long, thin stress 
fibres which are running in parallel to the orientation of the cell. This is unlike the 
endothelial cells which seem to have more of the known ‘cobblestone’ morphology 
and appear more rounded. The actin fibres are less stained also then the MSCs. The 
MSCs also appear to be much larger cells comparatively to the HUVECs and this can 
offer an explanation as to why the actin fibres are stained strongly as they will be 
larger and more organised then those in endothelial cells.  
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Figure 7-4 This figure shows a fluorescence microscopy image of the immunostaining of MSCs 
on topographical surfaces A) NSQ and B) SQ, where red is actin (rhodamine-phalloidin) and 
blue is the cell nucleus (DAPI). It is interesting to find that MSCs stain with rhodamine-
phalloidin more intensely and the actin fibres are more defined than endothelial cells. Note that 
on A) it is possible to compare with the endothelial cells on the left which are not as well stained. 
[Scale bar: 10µm] 
It is also possible to see that the MSCs are able to adhere on top of the endothelial 
cell sheets as well as adhering to the exposed surfaces of the substrates. This is 
possible on all three topographies, planar, NSQ and SQ. Therefore, this shows that 
the MSCs can also attached to the endothelial cell sheets as well as the exposed 
topographies. The MSCs, despite adhering to the top of the endothelial cell sheet 
seems to have retained its morphology of being spindle-shape.  
 181 
 
 
Figure 7-5 These are fluorescent microscopy images of the MSCs also noted to be adhering on 
the top of the endothelial cell sheets on all three topographies, a) planar, b) NSQ and c) SQ, 
where red is actin (rhodamine-phalloidin) and blue is the cell nucleus (DAPI). The yellow 
arrows point to the MSCs on top of the endothelial cells. 
 
To further distinguish the endothelial cells from the MSCs, the endothelial cells were 
immunologically tagged with anti-CD31, which is a known surface marker of 
endothelial cells. This is illustrated by Figure 7.6 where the endothelial cell sheets 
can be seen at the bottom and highlight the presence of the CD31 marker on the cell 
membrane (as seen as the green colour). The morphology of both cell types are 
maintained and this is important as it illustrates that both cell types are healthy and 
therefore co-culture of these two cell types is possible. Also the spindle-shape of the 
MSCs is maintained and therefore this is a visual confirmation that MSCs have not 
differentiated down a specific osteogenic lineage(126). The difference in actin fibres 
distribution also given an indication of the difference in cytoskeletal arrangement 
between the two cell types. 
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Figure 7-6 Fluorescence microscopy images highlighting the difference between the MSCs and 
HUVECs. CD31+ staining (green) is a surface marker for endothelial cells and therefore it is 
possible to differentiate between the two types of cells. Red highlights actin (rhodamine-
phalloidin) and blue is the cell nucleus (DAPI). [Scale bar: 10µm] 
Von Kossa staining is a well-known staining technique which is used to visualise 
mineralised nodules in cell culture. The Von Kossa method is based on the binding 
of silver ions to the anions (phosphates, sulfates or carbonates) of calcium salts and 
the reduction of silver salts to form dark brown or black metallic silver staining. The 
co-cultures were allowed to culture for 3 weeks and they were then fixed before 
visualising using Von Kossa to look for mineralised nodules under phase-contrast 
microscopy. On the cell cultures cultured on the 3 different topographies of the 
polycarbonate substrates, it was not possible to detect the presence of any 
mineralised nodules, indicating that there were no signs of calcification. The 
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presence of mineralised nodules can be seen by the positive reference sample (Figure 
7.7) as black deposits within the cell culture and this was not seen in the samples.  
 
Figure 7-7 This is phase-contrast microscopy to look at the results from Von Kossa staining on 
the different PC substrates and their topographies by the co-culture of MSCs/ HUVECs. A) is a 
positive reference sample and adapted from (127). A positive Von Kossa will show dark deposits 
which are not seen on our test samples on the three topographies, as highlighted. [Scale bar: 
10µm] 
Another study was conducted as a more sensitive detection method using ICW to 
look at the expression of osteocalcin. Again the co-cultures cell samples on the three 
PC topographies were cultured for 3 weeks before analysis. Interestingly, expression 
of osteocalcin can be seen on SQ topography followed by NSQ and then planar 
topography. Osteocalcin (OCN) is an extracellular maturation protein and is a marker 
of osteogenic lineage of the MSCs. This is an important indicator showing that on 
the SQ surface, there is a predominance towards osteocalcin expression and therefore 
differentiation into osteogenic lineage. This also gives an early indication that there 
is higher potential of calcification on this topography.  
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Figure 7-8 Graph to show osteocalcin expression on the different topographies by the co-
cultures of MSC/ HUVEC, using In Cell Western, after 3 weeks of cell culture. [Where * <0.05 
and *** <0.0001] (n=3) 
 
Examination of the cell stain intensities to give us an indication of cell density on the 
substrates shows that there are more cells in co-culture on the planar surfaces rather 
than on the topographical patterns surfaces, NSQ and SQ, to statistical significance.  
 185 
 
 
Figure 7-9 Graph to show a cell count comparison using cell stain of the ICW methodology. This 
shows that there are more cells on the planar surfaces with statistical significance over NSQ and 
SQ surfaces. [Where **<0.05] (n=3) 
7.5 Discussion 
This Chapter is focused on seeing if MSCs and HUVECs are able to exist in co-
culture so as to test out a hypothesis on whether MSCs can potentially cause a 
problem by differentiating into osteogenic lineage and thereby potentially causing 
calcification in the vascular graft.  
As mentioned, calcification within a vascular graft can cause lots of problems, not 
least of all, shear stress and alteration of haemodyanamic flow and dysfunction of the 
endothelial layer. In fact, even with normal vascular graft materials in current clinical 
use, calcification is a highly underestimated occurrence. Mehta(2) et al explanted 
PTFE grafts and found a large number of them were calcified and may represent a 
previously underestimated problem. Although registries have been set up to try and 
further elucidate this problem, it will take time before results will follow. However, it 
is known that calcification can cause problems leading to premature graft failure. 
This data can also be extrapolated from data which have looked at heart valve 
calcification, in which extensive work has been conducted looking at this.  
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In the experiments, the HUVECs are allowed to have time to adhere to the 
polycarbonate surfaces first prior to seeding with MSCs for the co-culture. The 
reason for this is to try simulate the probability that in an in vivo model, it is likely 
that there will be patchy endothelial monolayers with uncovered exposed areas of 
nanotopography in which circulating MSCs might ‘home’ towards. These are the 
areas which would be perceived to be the areas in which MSCs would be able to 
settle and be influenced by HUVECs to differentiation down an osteogenic lineage.   
Interestingly, although it was initially thought that these exposed surfaces would be a 
problem, it was quickly established that the MSCs are able to adhere to the 
endothelial monolayers as well as the exposed surfaces. These observations are in 
line with those seen by Luu et al(127). In the presence of flow, it has been seen that 
MSCs are unlikely to adhere to endothelial cells. However, in the presence of 
inflammation or injury, leukocyte capture molecules such as P-selectin or vascular 
cell adhesion molecule-1 (VCAM-1) are expressed by the endothelial cells and these 
are able to bind to MSCs. There appears to be a co-synergistic approach in which the 
MSCs which are bound to the ECs appear to upregulate IL-6 and together with IL-6 
receptor. In this case, although IL-6 is commonly known as an inflammatory 
cytokine, it does have a dual-effect, and has been identified as the major agent which 
acts on the endothelial cells to reduce leukocyte recruitment(127). 
In the immunostaining of the co-cultures, it was easy to distinguish between the 
MSCs and the HUVECs and see that MSCs adhere to both the exposed surfaces of 
the substrate and on to the top of the HUVECs. Although the experiments were 
conducted under static conditions, previous work has suggested that under low flow 
conditions MSCs adhere to HUVECs, illustrates the ‘homing’ ability of MSCs. The 
ability of MSCs to bind to HUVECs is due to leukocyte capture molecules. This is an 
interesting prospect as implantation of a synthetic vascular graft can illicit an initial 
inflammatory response and in some individuals, it has been shown that a persistent 
low-grade response can be seen for a long time post-implantation. It then leads to the 
postulation that under these circumstances there could be potentially increase of 
MSC recruitment, which can have some beneficial effect in suppressing the 
inflammatory response.  
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However, in the presence of the topography, there is an added risk of calcification. 
Using Von Kossa staining as an evaluation tool, there was no signs of calcified 
nodules after 3 weeks of co-culture. However, 3 weeks of co-culture may not be 
enough time for calcium and phosphate deposition for Von Kossa to be positive. 
Therefore, ICW was exploited to investigate the possibility of osteogenic 
differentiation more directly. 
 
Figure 7-10 Simplified diagram to show the three stages of MSC differentiation down towards 
osteogenic lineage and the timeline of the expression of different protein markers and deposition 
of calcium and phosphate. 
 
Osteocalcin was evaluated. Osteocalcin is upregulated in MSCs that differentiate 
down the osteogenic lineage and is present after Day 14. It is a protein which is 
expressed by mature osteoblasts and is a later stage osteogenic marker(124). ICW 
was used to evaluate the presence of this protein at Day 21. It was found to be highly 
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upregulated on the SQ surfaces followed by the NSQ surfaces and then planar 
surface. 
As previously mentioned, when MSCs are grown primarily on the SQ surfaces, they 
can be maintained as MSCs rather differentiating into an obvious osteogenic lineage 
as on the NSQ surfaces(97). This maintenance can be maintained for at least 8 weeks 
in cell culture. However, on the addition of endothelial cells, there seems to be a 
‘flip’ in the biology and it can be seen that on the SQ surfaces, there is a significantly 
higher expression of osteocalcin and therefore indicating that the MSCs are more 
likely to be going down the osteogenic lineage. This indicates there must be some 
‘cross-talk’ which is happening between the co-cultures which has driven the MSCs 
to differentiate at a higher rate than compared with those on the NSQ surfaces. 
Kaigler et al(124) conducted a series of astute experiments looking at the effect of 
endothelial cells on MSCs. They found that ECs enhance the osteogenic potential of 
MSCs when grown in co-cultures and this was due to close or direct cell-cell contact 
which is required for this to take place. They noticed that endothelial cells produce 
BMP-2 (bone morphogenetic protein -2), which is a potent bone morphogen, and this 
property seems limited to endothelial cells and no other cell type and is a primary 
factor which induces osteogenic differentiation of MSCs.  
BMP-2 is part of the transforming growth factor superfamily and is a cytokine. It 
was originally detected in bone and cartilage but is known to be produced by 
vascular endothelial cells. It is known to host and regulate a host of cellular 
functions, including cardiovascular development, neovascularization in tumours and 
smooth muscle chemotaxis in response to vascular injury. In addition to this, it has 
also been shown that endothelium-derived BMPs contribute to vascular calcification 
especially during the development of atherosclerotic plaques and BMP-2’s presence 
in atherosclerotic plaques has also been noticed(128).    
In the experiments conducted in this Chapter, the MSCs have been cultured in basal 
media and not in osteogenic induction culture media. This is important as this shows 
that there are no external stimuli to influence the osteogenic lineage progression. In 
the in vitro setting, the factors which are needed to add to the culture media to induce 
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the differentiation of the MSCs down either chrondrogenic, osteogenic or adipocytic 
lineage is well-known. For chrondrogenic differentiation, growth factors such as 
TGF-β is required whereas for adipocytic lineage, the MSCs have to be cultured with 
dexamethasone, insulin, isobutyl methyl xanthine and indomethacin. In contrast for 
osteogenic differentiation of MSCs in vitro the presence of dexamethasone, ascorbic 
acid and β-glycerol phosphate is required(129). In the co-culture culture media mix 
used in this set of experiments, which is a 1:1 ratio of basal media: endothelial cell 
culture as suggested by Bidarra et al(43), the above listed factors are not included in 
the culture recipes and therefore it is assumed that the culture conditions will not be a 
factor in osteogenic lineage induction.  
Furthermore, other experiments conducted by other researchers have shown that ECs 
can participate at different levels of osteogenesis as osteoinductive cells in a variety 
of ways. They do this by releasing BMPs and by controlling the three main 
transcription factors which are required for bone cell differentiation which are runx2, 
osterix and dlx5(130). In return, the vascular endothelial growth factor (VEGF) 
which can be expressed by MSCs can promote endothelial cell survival. After a long 
period of co-culture with endothelial cells and MSCs, the early osteoblastic markers 
slowly decrease with up-regulation of the markers associated with a mineralised 
matrix(131).   
These results indicate the synergistic relationship between HUVECs and MSCs 
which contributes towards osteogenesis. In the field of bone tissue engineering, these 
results hold promise and merits further investigation. However, in a vascular graft 
environment the presence of any mineralised tissue deposits leading to vascular graft 
calcification can be disastrous. The scenario described in this Chapter is considered 
as a ‘worst case scenario’ situation. The ratios that was used for MSC: HUVEC is 
very high and in reality there is a much lower ratio between the two. There is quite 
some discussion as to the presence of ‘actual’ circulating MSCs within the 
bloodstream and their actual definition. The majority of MSCs reside in the bone 
marrow and it is thought that under circumstances of injury and inflammation there 
would be an increased mobilisation of MSCs deployed through the bloodstream to 
‘home’ into the sites requiring immunological damping and also tissue repair and 
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regeneration. In addition, they have been found to express integrins and chemokine 
receptors which help in their ‘homing’ ability. An interesting study designed to 
investigate the presence of circulating MSCs by Hoogduijn et al(132) did not detect 
the presence of circulating MSCs in the bloodstream. They looked at the peripheral 
blood of patients who have undergone heart transplants or who fulfil the criteria for 
end-stage liver failure and kidney disease and were not able to detect cells which 
fulfil the criteria for MSCs. In the cases of poly-trauma patients who were also 
evaluated, they were able to detect MSCs in the bloodstream but this was thought to 
be due to release of MScs from the bone marrow following bone fractures. The 
alternative theory is that MSCs reside in small quantities in all tissues within the 
body with perivascular localization. Thus it is these local populations which would 
migrate to the tissues as and when required and therefore do not really require 
migrating through the bloodstream. Despite this, the MSC niche in which they reside 
in, besides the bone marrow, and whether they are able to use the bloodstream to 
migrate and ‘home’ to locations which require their presence, still remains a 
controversial area of discussion within stem cell biologists. In terms of whether it 
would affect an implanted vascular graft, there are implications that this can be a 
problem. The implantation of a vascular graft does propagate an area of injury and 
therefore this would attract stem cells to the site and the preliminary results seem to 
indicate that accelerated calcification of the vascular graft tends to be a problem in 
the presence of MSCs.  
The results for cell density for the co-cultures on the different topographies 
highlights an interesting result in which there are more cells on the planar substrate 
preferentially over NSQ and SQ. This might be due to the ability of the planar 
surface and the exposed surface area for the co-cultures to spread and adhere to the 
surface which is a bit more difficult on the nanopit topographies. It is not certain 
whether in the presence of another cell type as to how this would affect endothelial 
cell adhesion and proliferation on the surfaces but as described earlier, MSCs does 
have an effect on the behaviour of endothelial cells and this merits further 
investigation.    
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7.6 Conclusion 
This Chapter has shown that it is possible to grow MSCs and endothelial cells in a 
co-culture setting on the polycarbonate substrates with nanopits generated by 
injection molding. The MSCs are able to adhere to the monolayer of endothelial cells 
and also on the exposed surfaces of the substrates.  
Unfortunately, this Chapter has shown that there is potentially a problem with MSCs 
being directed towards an osteogenic lineage when co-cultured with endothelial 
surface leading to vascular graft calcification. This has recently been a topic of focus 
and can lead to premature vascular graft failure. It has been seen that the topography 
SQ seems to upregulate osteocalcin and therefore promote osteogenesis highly but 
this has been an unexpected ‘flip’ in results has SQ has previously been known to 
promote maintenance of MSC. It is evident that by co-culture of MSC and 
endothelial cells do promote osteogenesis and has important implications for bone 
tissue engineering. However, in the in vivo system, there are lots of different 
interactions between cells and chemokines and the mechanisms of how many 
different cells reside in tissues together synergistically and their ‘cross-talk’ to help 
to guide and direct each other in their environment. If the exact mechanisms were 
elucidated, this might help in further research in vascular calcification.        
7.7 Further Work 
In the results of this Chapter, one of the most interesting points which have been 
bought up has been the increase in osteocalcin production especially on the SQ 
surfaces, over the NSQ surfaces. This indicates that on the SQ topography 
endothelial cells may be stimulated to produce factors which would promote MSC 
differentiation towards an osteogenic lineage. This stimulation of the endothelial 
cells by the SQ surfaces seems to have more of an effect than the NSQ surfaces and 
at present, it is not entirely clear what these changes are. Further work would 
concentrate on elucidating the biological mechanisms underlying this ‘switch’ and 
this would be best approached using a high-throughput genomics approach such as 
Next Generation Sequencing. This would allow the study and analysis of multiple 
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genes at the same time and therefore identify ones which may require further 
investigation at a more focused level.   
Additionally, the well-known link of BMP-2 being expressed by endothelial cells in 
the presence, either close or direct cell-cell contact, of MSCs, is known. It is 
therefore wondered whether topography itself can increase the production of BMP-2 
within the endothelial cells and hence increase its osteoinductive properties. 
Therefore, experiments would be conducted on endothelial cells by themselves and 
looking for the expression of BMP-2 only on the different topographies. This would 
further confirm whether the stimulus for BMP-2 production is solely on close or 
direct contact with MSCs or whether external factors such as surface topography can 
have an effect on BMP-2 production. This would an interesting set of experiments as 
previous experiments by Yang(133) et al have shown that in the presence of NSQ 
topography, MSCs have been shown to upregulate BMP-2 production. Therefore, if 
it can be shown that topography have an additional effect on this with endothelial 
cells, there will therefore be at least double the amount of BMP-2 production present. 
In addition, this co-culture experiment needs to be further evaluated under flow 
conditions and to compare it with these experiments which have been conducted in a 
static in vitro environment. Flow conditions can have a separate effect on the cells 
and this might change the static experimental results. Flow conditions are very 
important especially in vascular graft engineering.  
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Chapter 8 Conclusion and Future Work 
The main aim of this research has been to find a way of modifying the surface of the 
POSS-PCU polymer so as to incorporate endothelialisation with the POSS-PCU 
vascular graft. Various techniques have been employed in this Thesis in an attempt to 
achieve this. A multidisciplinary approach has been undertaken over the course of 
this Thesis, using engineering, chemistry and biology, to try and achieve a surface in 
which endothelial cells are able to adhere to and also to try and understand the 
interaction between endothelial cell and the surface. 
Vascular research has employed a more multi-disciplinary approach over the last ten 
years. The concept of regenerative medicine has taken a more prominent place in 
vascular graft research. The ability to have an approach in which the body is able to 
regenerate a new vessel is a technology that current research tools do not have the 
advances to produce. Despite this, there is a plethora of ideas in which to achieve this 
technology. 
The path chosen in this Thesis is to try and modify an existing biomaterial to 
incorporate endothelialisation. As previously introduced, this biomaterial is a 
polyurethane-based polymer with a nanoparticle, POSS, incorporated within the 
polymer structure. This has allowed the polycarbonate urea urethane polymer to be 
mechanically reinforced as well as retaining compliant and biocompatible properties. 
This polymer has recently been the subject of intense investigation, least of all a 
‘first in man’ clinical trial. However, evaluation of this polymer has highlighted a 
similar deficiency which has plagued many other vascular graft materials, the 
inability to endothelialise. This deficiency means that no matter the superiority of the 
performance of this vascular graft when compared with ePTFE or Dacron®, it will 
lack the protective and beneficial measures given by the presence of an endothelial 
lining within the luminal surface of the graft. It has previously been mentioned that 
there are a three main ways to allow for endothelialisation post-implantation of a 
vascular graft. These have been described as inward migration, endothelial cell ‘fall-
out’ from the circulation and transmural tissue ingrowth(134). The concept of inward 
migration from neighbouring vessels was initially ‘binned’ as despite all sorts of 
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modifications used at the time, it was noted that inward migration did not extend 
beyond 2-3 cm and other techniques were used instead(86).   
There have been major technological advances in the field of nanoengineering over 
the last decade. This has properly allowed the study of cells on different 
topographical features since Harrison’s observations(72). In addition, plasma 
treatment is also another option for surface modification. As mentioned previously, 
plasma is referred to as the fourth state of matter as by Langmuir. It is partly ionized 
gas and is defined as a quasi-neutral particle system in either a gaseous or fluid-like 
mix of electrons, ions and free radicals. Within this mix, there are usually neutral 
particles such as atoms and molecules(135). When this high-energy mixture, is used 
to bombard the surface of a material, chemical bonds can be broken in which new 
surface chemical groups can be generated. In this Thesis, this property has been 
exploited to modify the surface so as to increase the surface contact angle. Both of 
these surface modification techniques are important to enhancing cell growth on the 
surface of vascular grafts, and have also been exploited by quite a few research 
groups.        
8.1 POSS-Nanoparticle for Chemically Altering the Surface 
 The POSS-nanoparticle is a very important nanoparticle in the research conducted in 
this Thesis. It is the nanoparticle which has been used to reinforce the polyurethane-
based polymer gives the mechanical properties which have been so desirable in this 
POSS-PCU polymer.  
As the polymeric solution is already developed in-house, the POSS-nanoparticle is 
sourced commercially via Hybrid Plastics Inc. It was thought that by being able to 
manufacture the POSS-nanoparticle in-house, it would also mean that we can further 
develop the polymer to have other different chemical and physical properties by 
harnessing the properties of the POSS-nanoparticle.  
It is possible to fabricate the POSS-nanoparticle in-house but unfortunately currently 
in the laboratories used for this work, it is not purpose built for chemical synthesis 
and techniques such as purification needs to be further optimized. However, as the 
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tests which have been conducted show, the final product is very similar to that 
produced commercially. The POSS-Chlorohydrin is the most important nanoparticle 
in this case.  
The POSS-PCU polymer has shown itself to have a hydrophobic surface, even more 
hydrophobic then ePTFE, and this means that cells, especially endothelial cells, are 
unable to adhere on the surface. This was especially evident in the preclinical studies 
for this polymer when investigating its use as a vascular graft(39). The surface can 
be fine-tuned to either enable cells to grow or to prohibit anything from adhering to 
super-hydrophobic surfaces. Super-hydrophobic surfaces were thought to be a 
potential avenue to explore as if the contact angle was raised > 150º this will deter 
biological material from adhering, especially platelets, to the surface.  However, it 
was not possible to alter the surface contact angle of the POSS-PCU polymer to an 
extent by mixing different POSS nanoparticles with different functional groups. 
Following recent disappointing clinical results for the FluoropassivTM(54) vascular 
grafts, which uses a similar rationale by increasing the availability of fluorine groups, 
which is hydrophobic and therefore hopes to decrease thrombogenicity, this was 
abandoned and focus was shifted to increasing the hydrophilicity of the surface so 
that cells are able to adhere and proliferate leading to endothelialisation.   
8.2 Plasma-Treatment for Increasing the Hydrophilicity and Biological 
Activity of the POSS-PCU surface 
It was demonstrated in Chapter 4 that it is possible to lower the water contact level 
using plasma treatment. This increases the hydrophilicity of the polymer surface and 
allows endothelial cells to adhere to the surface of the polymer. Lowering of the 
contact angle of the polymer surface does not affect the biocompatibility of the 
polymer and allows endothelial cells to grow on the surface, these properties do not 
appear to affect the bulk properties of the polymer, although this would require 
further confirmation with mechanical and compliance testing and would form further 
evaluation of this plasma-modified polymer. Although cells were able to grow on the 
POSS-PCU polymer, it was not clear if cell adhesion was adequate on the polymer as 
via the immunofluorescence, focal adhesions were not visualized. As the ECM exists 
as a complex entity in vivo, it is not clear if altering the surface contact angle is 
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enough and it is likely that other factors will come into play. Cell adherence is 
extremely important in the case of endothelial cells within a vascular graft as it needs 
to withstand the haemodynamic stress and pressure within the vessel. Failure of this 
will be seen by the endothelial cell sheet delaminating, and that is only if there is a 
chance that cell sheets have been given the chance to form.  
8.3 Combining Plasma Treatment with Surface Topographical Modifications 
on POSS-PCU 
It was then thought that a combination of surface physical and chemical factors 
would increase the adherence of the endothelial cells. Surface topographical cues 
have been shown to have an effect on cells, affecting them in processes such as 
migration, differentiation and adherence. This is important as it means that a 
combination of plasma treatment as well as surface topographical modification could 
enhance endothelial cell adherence.  
Using the optimal plasma treatment, 80W for 60s, the surface topography was tested 
with microgrooves and nanopits. It was found that it was possible to replicate these 
features with high fidelity on POSS-PCU. In addition, despite these topographical 
changes there was little appreciable changes in the surface contact angle. The surface 
topographical features also did not seem to have a detrimental effect on the 
endothelial cells and cells were able to adhere on the surface. This time it was 
possible to see the formation of focal adhesions (when staining for vinculin) on the 
nanopit topography, however this was not seen on the microgroove or planar 
(control) surfaces. However, this was such a subtle change and the decision was 
taken to further investigate the role of nanotopography on endothelial cells.  
8.4 Investigating the Effect of Nanopits on Endothelial Cells Adhesion 
Nanopits have been visualized to be part of the normal surface topographical in an 
arterial vessel in a rhesus macaque(75). As mentioned, it is still not possible to 
completely replicate the ECM in its entirety, however, the presence of these nanopits 
can potentially have an important effect on endothelial cells and this Chapter was 
designed to investigate this.  
 198 
The two main topographies used was NSQ and SQ on PC substrates with planar 
substrates acting as the control. It was possible to note that the nanopits do have an 
effect on endothelial cell adhesion but it is not 100% clear what that reaction is. The 
results indicate that there is a gradual increase in the expression of P-myosin over the 
first few days after cell seeding. NSQ topography increases the expression of P-
myosin whereas SQ topography increases the expression of VE-Cadherin, indicating 
that the 50nm offset seems to play an important role in dictating cell adhesion. The 
upregulation of P-myosin on the NSQ topography has also previously been seen with 
MSCs. However, the upregulation of VE-Cadherin on the SQ surfaces seem to be 
linked to the anti-proliferative effect also observed. This will require further 
investigation as to how SQ topography dictates this reaction in the HUVECS. 
8.5 Will Nanopit Topography have an effect on Calcification leading to 
Premature Vascular Graft Failure? 
The nanopit topographies used in this Thesis have gained significant interest after 
they were found to have a significant effect on MSCs especially in bone tissue 
engineering(42, 97). This Chapter was dedicated to looking if this could potentially 
have an effect on vascular graft development as this can cause a host of problems 
which will lead to premature vascular graft failure. 
The MSCs were found to be able to adhere to the patchy endothelial cell coverage on 
the different PC topography substrates as well as the exposed areas of the substrates 
and were able to co-exist in a co-culture system. Two experiments were then 
designed to look at whether calcification can be a problem in the co-culture system. 
Although on more conventional Von Kossa staining it was not possible to see signs 
of calcification after three weeks of cell culture, it was found that the SQ topography 
seem to upregulate the production of osteocalcin over NSQ and Planar. This was a 
surprise as SQ topography has traditionally been known to be the topography which 
promotes MSC maintenance but in a co-culture system, it was the topography which 
seem to direct MSC towards osteogenic lineage, even over the NSQ surface. It is 
known that in co-culture systems of MSC and HUVECs, the MSC can be directed 
towards osteogenic lineage. It is therefore hypothesise that it is primarily the 
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expression of BMP-2 by the HUVECs which causes this but it seems that the surface 
topography can also have an additional influence. 
8.6 Future Work 
The results presented in this Thesis have shown that there is potential in the use of 
nanotopography in the luminal surface of the vascular graft. Endothelial cells have 
been found to react to the nanotopography but it would seem that further 
understanding into the adhesion factors is important so this can be improved on. It 
would be important to have a more in-depth analysis of the focal adhesions involved 
in cell adherence on the different topographies and why this is changed on the 
different configurations of the nanopits. This understanding would be essential in 
counteracting against delamination when the endothelial cells are applied to flow.  
Calcification can be a problem when it occurs in vascular grafts and induces 
premature failure. It can be seen that this produces a lot of downstream effects such 
as endothelial dysfunction as well as alteration of the haemodynamic flow, all of 
which can contribute to the eventual failure of the graft. It can be seen that this can 
potentially be a problem especially topographies which have a strong effect on 
MSCs. Therefore, it is vital that further work is focused on the relationship between 
endothelial cells and MSCs to explore which is the trigger towards predisposition 
towards as osteogenic lineage. Especially with specific focus on replicating the in 
vivo ratios of MSCs to endothelial cells as this would dictate whether this is an effect 
which needs further research which would look to reducing the calcification effect.     
Finally, the most important part of future work should be focused on testing the 
endothelial cells on topography under stress flow conditions. This will test the 
endothelial cells adherence in an environment in which it will experience in vivo. As 
stress flow factors can also provide an additional cue to the endothelial cells, this will 
also need to be further investigated. Live cell imaging would be beneficial at this 
point This would be the ultimate test of the stability of the endothelial cell adherence.   
The overall aim of this research would be a create a self-endothelising small 
diameter vascular graft made from the POSS-PCU material utilizing surface plasma 
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treatment and topography to achieve this. These vascular grafts would benefit 
patients requiring peripheral bypass surgery, especially in emergency situations 
which would require ‘off the shelf’ grafts.   
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Chapter 11 Appendix 
Appendix A 
The production of POSS-Trisilanol was extremely difficult to replicate 
successfully each time. Unfortunately, despite changing a variety of 
conditions, as shown in the Table below, the final result was still T-gel. 
This process will need to be further optimized and it is thought that this 
should be handled by a professional chemists or by a commercial 
chemical synthesis company.   
Experimental Conditions Results 
Never Used Glassware T-Gel 
Slow Quenching with Hydrochloric Acid T-Gel 
Immediate Quenching with Hydrochloric 
Acid 
T-Gel 
Doubling of Quantities T-Gel 
Halving of Quantities T-Gel 
Continuous 18 hours of stirring T-Gel 
Continuous 9 hours of stirring T-Gel 
36 hours of stirring T-Gel 
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Mixture left to stir at 60º (boiling) T-Gel 
Stirring at reflux T-Gel 
Stirring without reflux T-Gel 
Post-quenching with HCl – stirring for 1 
hour 
T-Gel 
Post-quenching with HCl – stirring for 3 
hours 
T-Gel 
Post- quenching with HCl – stirring 
overnight 
T-Gel 
Figure 11-1 Table to show ‘trial and error’ of all the different conditions which were attempted 
to make the POSS-Trisilanol. This table illustrates that unfortunately despite altering of these 
conditions, T-Gel predominantly featured as the end product. (n=2) 
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Appendix B 
 
Figure 11-2 This graph shows the effect on water contact angle of POSS-PCU when the duration 
of plasma treatment (at 40W) is increased rather than power. ( * p<0.05, n=6) 
 
As attempts were made to lower the water contact angle of POSS-PCU, duration of 
plasma treatment was also tested. As the graph above shows, as the duration of 
plasma treatment increased, there was no difference seen between any of the 
treatment levels and there was no clear pattern of lowering the water contact angle. 
However, the graph does show that there is significant difference between the non-
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treated POSS-PCU and the treated but as there was no pattern discerned with these 
results, this methodology of lowering water contact angle was abandoned.  
